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Abstract
Haematopoietic activity in the murine fetal liver was observed to increase 
from the 12th day of gestation to reach a peak on the 15th day of gestation. 
Hepatic haematopoiesis is predominantly erythroid. As maturation proceeds 
the numbers of myelopoietic cells increase. Haematopoietic activity declines 
after the 15th day of gestation, though haematopoietic cells were still obvious 
in the liver of the 10 day neonate.
Cellular interactions were studied in vivo with the electron microscope and 
in vitro using long term cultures. Haematopoietic cell clusters were abundant 
in fetal liver both in vivo and in vitro. Macrophages and hepatocytes act as 
the central supporting cells of these clusters. There was evidence of 
communication between the central supporting cells and the blood cells 
precursors, which may be essential for the maintenance of haematopoiesis 
both in vivo and in vitro.
A high proportion of early HPP-CFC derived from fetal liver are synthesising 
DNA, while HPP-CFC derived from adult bone marrow are relatively 
quiescent. The kinetic properties of the HPP-CFC population are very similar 
to those of the CFU-S population both in fetal liver and in adult bone 
marrow. A high proportion of GM-CFC which are a more mature class of 
progenitor cells were cycling in both fetal liver and adult bone marrow.
Fetal liver extract was shown to have an overall inhibitory effect on 
haematopoiesis in normal bone marrow and irradiated bone marrow and on 
colony formation by leukaemic cells. Detrimental effects on normal bone 
marrow cells were observed only with high concentrations of fetal liver 
extract.
Fetal liver blood cell precursors were found to adhere preferentially to bone 
marrow stromal layers, which could not be attributed to the kinetic properties 
of these cells. This preferential adhesion may promote the in vivo 
accumulation of haematopoietic stem cells derived from fetal liver in the 
medullary cavities.
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Chapter 1
Introduction
1.1 Haematopoiesis
The bone marrow has been designated the seedbed of the blood (Tavassoli 
1980), which provides an ideal microenvironment for the proliferation and the 
differentiation of blood cell precursors. The stem cell population remains 
relatively quiescent (Lord et al 1976), while their differentiating progenies 
mature into various blood cells that are delivered into the circulation on 
demand. This entire process is known as haematopoiesis. Although it is 
appropriate to designate the bone marrow as the seedbed of the blood in adult 
mammals, blood cell production in the bone marrow is preceeded by blood 
cell production in the yolk sac, in the liver and in other extra-medullary sites.
1.2 Haematopoietic Development During Ontogeny
The earliest blood cells appear outside the body of the embryo in blood islands 
which form in the wall of the yolk sac at about the third week of gestation in 
the human embryo. In these blood islands cells which are usually considered 
to be of mesenchymal origin (Sadler 1985), but which have been attributed to 
endodermal origin (Gladstone & Hamilton 1942), are arranged in small 
groups. The peripheral elements of which give rise to endothelium, while the 
central elements give rise to the first blood cells. These haemocytoblasts are 
initially devoid of haemoglobin but gradually their nuclei become smaller, 
their cytoplasm becomes more dense and embryonic haemoglobin (HbE) 
begins to appear. The haemocytoblast has become a primordial erythroblast 
(Bessis 1973).
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The liver begins to function as a haematopoietic organ around the third month 
of gestation and continues to do so until the time of birth. Erythropoiesis is the 
predominant form of haematopoiesis in the fetal liver (Thomas, Russell & 
Yoffey 1960). The first granulocytes appear shortly thereafter and steadily 
increase in number, megakaryocytes are also seen. Electron microscopical 
techniques have demonstrated the existence of ferritin and rhopheocytotic 
vesicles (Sorenson 1960). Haematopoiesis is entirely extravascular at this 
stage.
Haematopoiesis is initiated in the thymus and the first primitive lymph nodes 
appear in embryos at approximately 3 months of gestation (Keleman et al 
1979). Haematopoiesis is often said to begin in the spleen during the 5th 
month of gestation and to persist for a month or so, although the role of the 
spleen as a preferential haematopoietic site has been questioned. The 
haematopoietic function of the liver decreases from the 5th month and ceases 
shortly before birth, during this period medullary, splenic and nodal 
haematopoiesis are initiated (Fukuda 1974).
The pattern of haematopoiesis is different in the liver than that of the bone 
marrow. The liver is particularly erythropoietic whilst the bone marrow is 
particularly granulopoietic (Thomas et al 1960). The preponderance of 
erythropoiesis and paucity of myelopoiesis, lymphopoiesis and 
megakaryocytopoiesis during intrauterine development may be due to 
decreased demand for such cells during this period on account of a protected 
germ-free environment. Unlike myeloid precursors, there is a tendency for 
lymphoid cells to increase in number as the fetal age advances (Sharma, 
Bhargava & Kochupillai 1985).
As hepatic haematopoiesis declines, the bone marrow, spleen, thymus and 
lymph nodes assume their adult specialisations. The mesenchymal cells, which
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gave rise to the primitive erythroblasts, are transformed into quiescent fixed 
cells which retain their potential to give rise to new haematopoietic islands 
(Bessis 1973).
Theories of the development of mammalian haematopoiesis have focused 
around two viewpoints:- One hypothesis proposes a model whereby a single 
stem cell pool originates in the yolk sac and migrates in the bloodstream to 
colonise the liver parenchyma (Moore & Metcalf 1970; Johnson & Moore 1975). 
During this course of time the stem cells undergo a gradual change both 
morphologically and in haemoglobin synthesis. The primordial erythroblasts 
are succeeded by a second generation of smaller cells which appear in the 
embryo of 10-12mm in length, multiply actively and have completely replaced 
primordial erythroblasts in a 50mm embryo. These definitive erythroblasts 
contain only adult haemoglobin (HbA) (Brotherton et al 1979). The other 
model suggests that hepatic haematopoietic tissue arises directly from the 
transformation of liver mesenchymal cells independently of vitelline 
haematopoiesis (Cole & Paul 1966; Rifkind, Chui & Epler 1969; Tarbutt & Cole 
1970; Samoylina, Gan & Medvinski 1990) or from endodermal cells (Thomas et 
al 1960; Riches & Hoyes 1972), which transform into lymphoid elements and 
eventually give rise to haemocytoblasts (Hoyes, Riches & Martin 1973).
Pre-haematopoietic fetal liver has been shown to be capable of supporting 
blood cell production if it was supplied with an exogenous source of 
haematopoietic stem cells. However, pre-haematopoietic fetal liver did not 
become a site of active blood cell production when grafted into an irradiated 
adult host (Johnson & Moore 1975). Long term repopulation by embryonic 
donor cells was reported following injection of yolk sac cells into anaemic 
mice, when the liver was the main site of haematopoiesis (Toles et al 1989). A 
dramatic depletion of the yolk sac BFU-E pool in human embryos occurs at the
3
5th week of gestation, when BFU-E become detectable in the blood stream and 
their number in the liver parenchyma increases considerably. The depletion of 
yolk sac BFU-E could not be attributed to differentiation as the number of yolk 
sac CFU-E did not increase (Migliaccio et al 1986). These results were 
interpreted as supporting the cell seeding hypothesis and invalidating the 
alternative theory of induction (Rifkind et al 1969). However other reports do 
not support the predominant role of the yolk sac.
Dieterlen-Lievre (1992), demonstrated two distinct waves of haematopoiesis in 
the avian system using quail-chick chimeras. The first wave is produced in the 
yolk sac and the progeny of this wave are transient. The second wave of 
haematopoiesis was of intra-embryonic origin, thought to be produced in the 
aortic region, the progeny of this wave are not transient. Data on the murine 
system also point to a succession of stem cells during ontogeny. CFU-S are 
initially detected in the body of the murine embryo, then in the yolk sac and 
blood, and finally in the liver (Samoilina et al 1990). The doubling time of CFU- 
S was more rapid at the initiation of hepatic haematopoiesis. It was concluded 
that yolk sac haematopoietic stem cells were incapable of differentiating into 
CFU-S, instead the CFU-S were derived from intra-embryonic stem cells, 
which are distributed to the yolk sac and liver via the circulation. The earliest 
T-cells detected in the fetal thymus are characterised by the V73 gene transcript 
(Ikuta et al 1990). It has been shown that only haematopoietic stem cells 
derived from fetal liver could give rise to T cells with this gene arrangement, 
adult bone marrow derived stem cells could not give rise to these characteristic 
early T-cells. Furthermore differentiation of early fetal stem cells into V73T- 
cells only takes place in the thymic microenvironment of the fetus (Ikuta et al 
1990). These observations suggest the existence of successive populations of 
stem cells in mammalian embryos.
To date the arguments over the two hypotheses have not been conclusively
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resolved. The question remains whether the successive populations of stem 
cells emerge independently, like the avian systems, hepatic haematopoiesis 
may arise de novo in a similar manner to that of the yolk sac. Alternatively, the 
successive stem cell populations may be the result of microenvironmental 
influences on seeded yolk sac derived stem cells.
1.3 Renewal and Commitment of Stem Cells
A structured hierarchy of multipotential haematopoietic stem cells (HSC), 
assay able in vitro and in vivo exists. The earliest stem cells have a high self­
renewal capacity and are the most important cells in the establishment of a 
graft. There are two separate stem cell compartments in
lymphohaematopoietic organs - lymphoid and haematopoietic, both of which 
are derived from a totipotent stem cell compartment. Populations of 
haematopoietic stem cells are defined by two characteristics:- they have a self­
renewal capacity, in order to maintain the size of the compartment at a fixed 
level, secondly they are multipotent and can thereby differentiate to produce 
specific cell lineages which ultimately form mature blood cells (Lajtha 1979). 
Several models have been proposed to explain the nature of commitment of 
HSC's. The presence of several models reflects the uncertainty of this subject 
which is of great theoretical importance. If a stem cell vacates its compartment 
to differentiate, haematopoiesis cannot be maintained, however if the stem cell 
only undergoes self-renewal it cannot respond to the body's demands for 
blood cell formation - both processes must take place in parallel. Each model 
focuses on a different aspect of stem cell function however, they are not 
necessarily exclusive of each other.
The stochastic model proposed by Till, McCulloch & Siminovitch (1964) 
suggests that the decision to remain in the stem cell compartment or to yield 
progeny committed to differentiation is governed by a probablistic rule. The
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control of the stem cell compartment may be achieved by changes in a 
distributional parameter, the probability of self-renewal of stem cells.
The haematopoietic inductive microenvironment (HIM) model proposed by 
Trentin and his associates (1970,1989) proposes that the commitment of 
pluripotent HSC to progenitor cells is determined by a specific inductive 
microenvironment surrounding individual stem cells. The microenvironment 
is not thought to be obligatory for stem cell commitment (Ogawa, Porter & 
Nakahata 1983), instead it may play a supportive role in the self-renewal of 
stem cells as observed in colony forming unit-spleen (CFU-S) maintenance in 
Dexter Cultures (Dexter, Allen & Lajtha 1977).
The third model is that of "stem cell competition", which proposes that 
humoral factors such as erythropoietin (Epo) and colony stimulating factors 
(CSFs) play an active role in stem cell commitment (Ogawa et al 1983). 
However it is generally believed that development of receptors for these 
growth factors occurs post hoc to the commitment.
The most viable model proposes that stem cell commitment is governed by 
progressive and stochastic restriction in the differentiation potentials of HSC. 
This model is supported by documentation of oligopotent haematopoietic 
progenitors which show differentiating potential for various combinations of 2 
or 3 lineages (Humphries, Eaves & Eaves 1979; Ogawa et al 1983; Allen 1992).
1.4 Haematopoietic Regulation
In view of the extent of the proliferative activity which is required simply to 
maintain the steady state levels of mature cell production, it is not surprising 
that occasional mistakes are made during replication resulting in the 
emergence of tumour cells. Obviously many controls are built into the system
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to maintain their integrity both intrinsic - genetic housekeeping of cells and 
extrinsic influences in the form of environmental components (Dexter 1989).
Many environmental components have been described which can regulate 
both proliferation and differentiation of HSC. These include interaction of cells 
with growth regulatory factors; direct cell-cell contact and interaction of cells 
with extracellular matrix molecules known to be important in the development 
of embryonic and adult tissue. One of the most intriguing problems is to 
determine how these factors combine to regulate homeostasis.
1.4.1-1 Growth Factors
Blood cell formation is controlled by a group of specific glycoprotein growth 
factors which initiate a mitogenic response by binding to a specific receptor 
usually located at the cell surface. The application of recombinant DNA 
technology allows molecular cloning of genes for these substances and 
production of synthetic material. A substantial number of factors have been 
characterised this way and named according to the lineage stimulated in vitro 
(Devalia & Linch 1991). In other cases haematopoietic growth factors have 
been recognised as lymphocyte secretory products and thus included in a list 
of factors known as interleukins (IL-1 - IL-7) or lymphokines (Plumb & 
Pragnell 1988; Nicola 1989). The first of these growth factors to be identified 
was erythropoietin (Epo), which is produced in the kidney and stimulates 
erythropoiesis in vivo in haematopoietic sites and also in vitro in culture 
systems (Devalia & Linch 1991).
Classes of growth factors are recognised: Class I are not lineage specific, they 
act mostly on pluripotent or oligopotent cells. Interleukin 3 (IL-3) or multi-CSF 
for example can recruit clonal proliferation and development of mixed colony 
forming cells (CFC-mix), burst forming unit-erythroid (BFU-E), granulocyte- 
macrophage colony forming cells (GM-CFC), eosinophil colony forming cells
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(Eos-CFC) and megakaryocyte colony forming cells (Meg-CFC) in addition to 
facilitating growth and survival of CFU-S. Granulocyte macrophage colony 
stimulating factor (GM-CSF) is a potent stimulus for growth and development 
of GM-CFC, Eos-CFC and in high concentrations can also recruit CFC-mix into 
proliferation (Dexter 1989).
Class E CSF's are more restricted in their target cells, they act on more mature 
cells and are required later on in the course of development. Granulocyte 
colony stimulating factor (G-CSF) has a direct effect only upon neutrophil 
specific restricted precursor cells (G-CFC), while macrophage-CSF (M-CSF) 
stimulates both GM-CFC and macrophage colony forming cells (M-CFC) to 
undergo growth and development into macrophages (Stanley & Heard 1977).
There is also evidence for a third class of factors, those with a synergistic 
activity for IL-3 or M-CSF. Acting alone these factors have no colony 
stimulating activity, however when added to appropriate growth factors of the 
other two classes their action is considerably enhanced (Stanley et al 1986).
The site of production of these haematopoietic growth factors has been the 
subject of intensive investigation. It appears that all organs can potentially 
synthesise CSF, however certain cell types in particular are known to produce 
these factors:- T-lymphocytes, monocytes, endothelial cells and macrophages 
(Devalia & Linch 1991).
1.4.1-2 Inhibitory Factors
Negative regulators of haematopoiesis are also considered to play an 
important role in the maintenance of a quiescent stem cell population. They are 
regarded to be responsible for the low number of stem cells engaged in DNA 
synthesis (Zipori & Hanigwachs-Sha'anani 1992). Inhibitory factors are also 
regarded to oppose the actions of stimulatory factors on the same cells and the
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balance of these two opposing factors determines whether or not a cell 
synthesises DNA (Axelrad 1990). Furthermore, such an arrangement has the 
advantage of permitting rapid proliferative responses to changes in 
haematopoietic demand. There is now increasing awareness that regulation of 
haematopoiesis, under normal conditions, involves inhibitory and stimulatory 
molecules (see Axelrad 1990; Wright & Pragnell 1992; Zipori & Hanigwach- 
Sha'anani 1992 for review).
Transforming growth factor p (TGF-P) was the first negative regulator of 
haematopoiesis to be cloned (Keller et al 1990). It is a potent inhibitor of 
haematopoietic stem cell and progenitor cell proliferation, however it has 
reduced effects on mature cells (Wright & Pragnell 1992). HP5b (pEEDCK) is a 
pentapeptide purified from extracts of rat bone marrow, which inhibits colony 
formation by GM-CFC and CFU-S (Axelrad 1990). A tetrapeptide inhibitor 
(Ac-N-Ser-Asp-Lys-Pro or AcSDKP), was first reported by Frindel and 
colleagues in 1977 (Lenfant et al 1989). This inhibitor prevents recruitment of 
CFU-S into S-phase, thereby protecting cells from S-phase cytotoxic agents, it 
has no effect on actively proliferating cells (Lenfant et al 1989).
A negative regulatory protein has been detected in murine bone marrow, 
which also inhibits DNA synthesis in the CFU-S population (Lord et al 1976). 
The active molecule of this inhibitor is thought to be macrophage 
inflammatory protein (MIP-la) (Plumb et al 1991; Wright & Pragnell 1992), 
which is produced by macrophages and has no inhibitory effect on mature 
progenitor cells (Broxmyer et al 1990).
1.4.1-3 Clinical Applications of Regulatory Factors
Erythropoietin, G-CSF, GM-CSF, IL-1, IL-3 and IL-4 have all reached the 
clinical arena. Epo has been successfully used in the treatment of anaemia in
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end stage renal diseases. The combination of G-CSF and GM-CSF has been 
used to reduce the period of neutropenia following conventional 
chemotherapy, autologous bone marrow transplantation and myelodysplastic 
syndromes (Devereux & Linch 1989). It has also more recently been used to 
enhance granulopoiesis and to reduce the rate of infection in patients with 
AIDS (Dexter 1989).
IL-1 together with GM-CSF have been shown to have a radioprotective effect 
by promoting granulocyte recovery following chemotherapy. IL-1 given 
intraperitoneally in mice can enhance harvesting of peripheral blood stem 
cells. One of the most exciting potential applications is the use of HGF's to 
allow dose escalation enabling high doses of drugs or radiotherapy to be given 
over a shorter period of time. HGF's may enable more efficacious treatment 
rather than just reduced toxicity. It is likely that combinations of HGF's will be 
more effective than single growth factors alone (Devereux & Linch 1989).
Negative regulatory factors also have important clinical applications. MIP-la, 
as a potent inhibitor of CFU-S proliferation should have a therapeutic potential 
to protect stem cells from damage during cancer chemotherapy (Broxmyer et al 
1990). AcSDKP can protect mice from lethal doses of cytosine arabinoside (Ara- 
C), without protecting malignant cells from its cytotoxic effects (Lenfant et al 
1989). It may be possible to use stem cell inhibitors in the treatment of 
leukaemia. Chronic myeloid leukaemia (CML) may be caused by loss of 
sensitivity to inhibitory factors leading to unregulated proliferation of 
leukaemic cells. It may be possible to use drug purging regimens to selectively 
eliminate leukaemic cells (Eaves et al 1986).
The role of haematopoietic regulatory factors in sustaining normal
haematopoiesis is not well defined. Under normal conditions, quiescence in the
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the stem cell compartment is essential - haematopoietic regulatory factors are 
not solely responsible for the maintenance of a quiescent state.
1.4.2 Haematopoietic Inductive Microenvironment
The term haematopoietic inductive microenvironment (HIM) is usually 
restricted to a localised environment in the stroma of haematopoietic organs 
which directly influences the haematopoietic cells and events governing 
haematopoiesis (Wolf 1979). Trentin (1970) was the first to approach this 
modern concept proposing the action to be that of a stromal cell line inducing 
differentiation of HSC in erythroid, granuloid or megakaryocytic lineages. The 
stromal cells were responsible for inducing commitment of a stem cell, hence 
the term haematopoietic inductive microenvironment was proposed.
Effective haematopoiesis is the product of interplay between HSC and it's 
supporting stroma, the latter providing a favourable environment for 
sustained and regulated proliferation and differentiation. A major function of 
the microenvironment is to protect the stem cell pool from excess 
differentiation by creating conditions which favour self-renewal. The stem cell 
niche hypothesis proposed by Schofield (1978), suggests that certain 
microenvironmental cells of the marrow stroma can maintain the stem cells in 
a primitive state, thus preventing differentiation. The cellular architecture of 
the niche is unknown, however several observations support the idea of 
microenvironments which facilitate either granulocyte or erythroid cell 
development in vivo (Trentin 1970; Wolf 1979) and in vitro (Dexter et al 1977; 
Allen & Dexter 1984).
Haematopoietic stromal tissues may thus control the organisation of 
haematopoietic organs by restricting growth and differentiation of particular 
cell types and by inducing self-renewal of stem cells. The most compelling 
evidence for this derives from the localisation of haematopoiesis to specific
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sites within the body (Trentin 1989). It is well documented that in normal 
animals HSC circulate freely in the peripheral blood (Loutit 1968; Tavassoli 
1980; Bentley 1982), however Till & McCulloch (1961) reported haematopoietic 
colonies developed only in the bone marrow and spleen in irradiated animals 
which had been reconstituted with donor bone marrow cells. HSC will only 
proliferate and differentiate in the haematopoietic tissue. These observations 
suggest that certain organs provide microenvironments which are unique in 
their capacity to support haematopoiesis (Bentley 1982). Other functions 
include influencing megakaryocyte differentiation and initiation of DNA 
synthesis which occurs in precursor cells resident in the adherent 
microenvironment (Choudhury & Sparks 1989).
1.4.2-1 Evidence for the Role of Microenvironment in Haematopoietic
Regulation
In the adult haematopoiesis is restricted to the marrow and, to a lesser extent 
other haematopoietic organs. This is evidenced by the "homing" of transfused 
marrow cells to the marrow and spleen of irradiated mice (Dexter et al 1977; 
Aizawa & Tavassoli 1988). In the embryo haematopoiesis begins in the yolk sac 
and finally settles in the bone marrow. As the stroma of one organ becomes 
unsuitable, HSC can move in the circulation and home to a more favourable 
microenvironment (Tavassoli et al 1990).
After high-dose radiation a biphasic aplasia is observed, the early phase is 
attributed to destruction of HSC, the late aplasia is the result of injury to the 
stroma. Subsequent recovery from insult by irradiation is invariably preceded 
by development of a stromal architecture, only when this has been functionally 
established does haematopoiesis resume (Bentley 1982).
Mutant anaemic Sl/Sld mice have defective microenvironments while W/Wv 
mice have defective stem cells. The two systems are cross-correcting both in
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vivo and in vitro (Bernstein 1970).
The most direct evidence comes from the observation that cultured adherent 
cells, derived from primary explants of bone marrow cells, apparently stromal 
in origin, provide a microenvironment which supports haematopoiesis in 
vitro. This evidence comes from the continuous bone marrow culture system, 
described by Dexter et al (1977), who were able to reconstitute the interactions 
of stromal cells and HSC in liquid culture. A layer of adherent non­
haematopoietic cells develops on the floor of the culture flask which can 
support HSC seeded onto it for extensive periods of time.
1.4.2-2 Bone Marrow Stromal Composition
(i) In Vivo
Haematopoiesis does not occur in vivo in the absence of site specific structures 
which both support and modulate stem cell expression. Reticular cells and 
macrophages are the two major stromal components in the bone marrow and 
other haematopoietic organs. Additional cellular components include 
endothelial sinusoids, which are coated by adventitial reticular cells, and 
adipocytes. Maturation of haematopoietic cells takes place within the 
intersinusoidal spaces closely associated with reticular cell processes (Singer, 
Keating & Wright 1985).
Reticular cells are histogenetically recognisable from haematopoietic cells, 
there are two types of reticular cells of the haematopoietic cord: adventitial and 
fibroblastic. Adventitial cells are located around the venous sinuses, partially 
covering the endothelial abluminal side (Shaklai 1989). They have slender 
cytoplasmic processes which extend deep into the haematopoietic
compartment and form a continuous anastomosing bridgework between 
sinuses. Fibroblastic reticular cells are characterised by their long thin
13
cytoplasmic extensions which envelop maturing blood cells.
Macrophages are found topographically in 3 sites, as a central macrophage in 
the erythroblastic island, perisinal macrophages on the abluminal side of the 
sinus endothelium and also dispersed between developing myeloid cells of the 
haematopoietic cord (Shaklai 1989). The central macrophage is an important 
constituent of in vivo erythropoiesis. It is possible that the central macrophage 
elaborates certain factors which are transferred to developing erythroid cells. 
The rhopheocytotic theory first proposed by Policard & Bessis (1962), for the 
transfer of ferritin, has not been conclusively proven by other investigators. 
However the assumption that the macrophage has a trophic function is 
plausible and is generally accepted.
(ii) In Vitro
Long term Dexter cultures have provided an invaluable model to study the in 
vitro microenvironment. In vitro the stroma also consists of several cell types. 
Stromal cells have the common characteristic of adhering to the substratum. 
The major component is a fibroblastic or epithelial cell which is capable of 
producing collagen types I and III in addition to fibronectin (Bentley 1982; 
Tavassoli & Takahashi 1982). This cell may be related to the in vivo reticular 
cells. These cells, together with macrophages endothelial cels and adipocytes, 
spread out over the surface of the culture dish, providing a "blanketing" 
floormat for haematopoiesis.
In murine long term bone marrow cultures, macrophages constitute a major 
component of the stroma. Adipocytes have also been described in continuous 
marrow culture (Dexter et al 1977). Both macrophages and epithelioid cells can 
accumulate fat under the conditions of culture, therefore fat cells could be 
considered as a culture related phenomenon, however other groups have 
demonstrated that fat cells do not derive from lipid-laden macrophages (Allen
14
& Dexter 1984). The presence of endothelial cells in long term culture has been 
debated (Bentley 1982), however Zuckerman & Wicha (1983) provided 
evidence of their existence by the demonstration of factor VIII antigen and 
other endothelial cell by-products such as collagen type IV and laminin.
1.4.2-3 Hepatic, Splenic & Thymic Microenvironments
It is postulated that haematopoietic inductive microenvironments of different 
kinds exist in fetal liver, spleen, bone marrow and thymus (Trentin 1989). 
These individual HIM's determine the differentiation of pluripotent stem cells 
into each of the haematopoietic lineages. Thomas (1971) compared 
differentiation of transplanted haematopoietic cells from murine bone marrow 
fetal liver and spleen. The cell populations established in the haematopoietic 
sites were all of similar composition and did not reflect the nature of 
haematopoiesis in the donor cells. The microenvironments of the host, not the 
donor cells, were responsible for determining the pattern of haematopoiesis. 
Erythropoietin may therefore induce erythroid differentiation of only those 
stem cells under the influence of an erythroid HIM, like the fetal liver or the 
spleen. Alternatively Epo may only act as a growth and function stimulator of 
those stem cells which have been induced by an erythroid HIM into a state of 
Epo responsiveness (Trentin 1989).
A cellular network of developing hepatocytes is present in the fetal liver and 
haematopoietic cells are scattered within the network. Ultrastructurally 
haematopoietic cells have many broad areas of cellular association with fetal 
hepatocytes such as the rosette formation observed by Medlock & Haar 
(1983).Their findings were evidence that when hepatic endodermal rudiments 
were cultured without mesenchyme interactions neither hepatocytes nor 
haematopoietic cells developed. Desmosome-like structures between 
erythroblasts and fetal hepatocytes have been observed (Fukuda 1974; Emura, 
Sekiya & Ohnishi 1984; Emura et al 1985). Emura and his associates (1985)
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reported that hepatocytes which were closely associated with immature 
haematopoietic cells showed marked differentiation compared to those in 
areas where haematopoiesis had not appeared. These observations together 
with those of Hata et al (1993) strongly suggest that hepatocytes together with 
phagocytic cells lining the sinusoids serve as stromal cells in the 
haematopoietic microenvironment of the fetal liver.
Two main roles of the macrophage associated with haematopoietic cells have 
been proposed. Yoffey & Yaffe (1980) proposed a scavenger role for ingesting 
extruded nuclei of erythroblasts, while Policard & Bessis (1962) proposed the 
transfer of ferritin with some form of information which could influence the 
development of erythroblasts with which the macrophage was associated. 
Emura et al (1984) suggest that the erythroblastic islet with its central 
macrophage in itself is a HIM, controlling maturation and differentiation of 
erythroblasts.
In the splenic microenvironment mesenchymal and reticular cells have been 
described as the stromal cells which support haematopoiesis (Medlock & Haar 
1983). While in the thymus reticuloendothelial cells are considered responsible 
for haematopoietic support. The fact that interaction between HSC and a niche 
occurs, of necessity at close range, might suggest that components of the cell 
surface and/or local extracellular matrix are involved.
1.4.3 Extracellular Matrix (ECM)
The extracellular matrix of BM and stromal cells has recently been a subject of 
investigation from two aspects: actual involvement of the ECM proteins in 
attachment and growth of the haematopoietic cells and secondly the role of the 
matrix proteins in holding CSF's which then act on tightly bound stem cells 
(Gordon et al 1987). Matrix proteins produced by stromal cells include 
haemonectin, fibronectin, collagen, laminin and proteoglycans. Collagen
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appears to be the major structural protein of bone and bone marrow. Some of 
the other matrix proteins are thought to play an important role in the 
promotion of cell-cell adherence and interactions of cells with other 
components of the organ stroma (Zuckerman, Prince & Gay 1989). The 
importance of the ECM was demonstrated by a study in which inhibition of 
the production of ECM components by stromal cells in vitro resulted in the 
abolition of haematopoiesis (Zuckerman et al 1985).
There is interest as to whether a receptor ligand complex can function as a 
homing system for haematopoietic and stromal cells. Anklessaria et al (1990) 
have shown that bone marrow stromal cells expressing a recombinant gene for 
transforming growth factor a (TGFa), which is known to compete for the same 
receptor as epidermal growth factor (EGF), stimulate homing of 
haematopoietic cells which contain the EGF receptor gene. In vitro mixing 
experiments with EGF sensitised cells, which proliferate in response to EGF, 
were cocultured with stromal cells producing TGFa. The EGF cells formed 
connections with the TGFa stroma which were indistinguishable from 
cobblestone islands in normal long term bone marrow cultures (Anklessaria et 
al 1987; 1989). Thus the first evidence was provided for juxtacrine stimulation 
of growth, which is thought to occur during bone marrow stem cell attachment 
to stromal cells in situ. This was also suggested by Gordon et al (1987) who 
reported the effect of ECM on the concentration of GM-CSF and other colony 
stimulating factors in the haematopoietic microenvironment. Components of 
the membrane associated ECM, in particular heparan sulphate proteoglycans, 
appear to be important molecules for binding IL-3 and GM-CSF and 
presenting these to the haematopoietic cells (Gordon et al 1987,1990; Roberts 
et al 1988). Erythroid maturation has been shown to be associated with a 
developmentally regulated change in fibronectin receptors (Vuillet-Gaugler et 
al 1990), which strongly suggests the fibronectin component of the matrix may 
regulate the maturation of erythroid cells. Dexter et al (1990) have suggested
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that in the bone marrow microenvironment the stromal cells and the ECM 
molecules secrete microenvironments which preferentially promote 
development of different cell lineages.
The mechanism by which the majority of stem cells are held in growth arrest is 
not known. In vitro experimental models cannot explain this mechanism as in 
almost every case, attachment, proliferation and differentiation follow in 
independent fashion (Greenberger 1991). The model of attachment without 
proliferation is the one which may be most relevant to in vivo haematopoiesis. 
It is more likely that a combination of GF's, ECM and crucial stem cell-stromal 
cell interactions combine to yield precise regulation of proliferation in the 
haematopoietic compartment.
1.5 Intercellular Relationships
Proliferation and differentiation of stem cells in vivo and in vitro are 
dependent on close interactions with stromal cells of that particular 
microenvironment.
1.5.1 In vivo
Morphological aspects of human haematopoiesis during embryonic and fetal 
life have been described extensively (Bessis 1973; Fukuda et al 1974; Emura et 
al 1984). The erythropoietic cell lineage is the first haematopoietic lineage 
observed in human embryonic liver at the 5th week of gestation and remains 
the largest of the haematopoietic cell populations during development. Large 
mononuclear cells morphologically of the myelomonocytic lineage appear at 
the 6th week of gestation. These cells are mainly located in the connective 
tissue of portal spaces (Emura et al 1984). At 5-6 weeks of gestation 
macrophages and Kupffer cells appear, both cell types increase in number with
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age (Timens et al 1990).
Electron microscopical studies have revealed that immature erythroblasts are 
commonly arranged around a central reticular cell. These "erythroblastic 
islets" were first described by Bessis in 1959, (Bessis & Breton-Gorius 1962). 
Erythroblastic islands have been observed in all haematopoietic organs during 
ontogeny from the yolk sac to the bone marrow, they are particularly prevalent 
during erythropoietic stimulation. Erythroblastic islands consist of a central 
reticular cell, usually a macrophage, surrounded by a ring of erythroblasts. 
Occasionally more than one ring of erythroblasts are observed surrounding the 
central cell, the more mature cells being always located on the periphery 
(Bessis 1973). The central macrophage has long stellate cytoplasmic processes 
which extend in all directions to embrace the maturing erythroblasts, and some 
cytoplasmic extensions completely surround developing erythroblasts. These 
cytoplasmic processes frequently invaginate the cytoplasm of the developing 
erythroid cells. The macrophage contains numerous micropynocytotic and 
endocytic vesicles, some of which contain ferritin, the end product of 
haemoglobin digestion. Iron also appears in the central macrophage in the 
form of haemosiderin which is derived from the breakdown of red cells and 
the rim of cytoplasm surrounding extruded nuclei (Bessis 1973).
Examination of the islets in fetal liver has revealed that there are two types of 
central cell: the macrophage and the hepatocyte (Emura et al 1984). 
Hepatocytes, like the macrophages, are considered to play an important role in 
the differentiation of erythroblasts. The haematopoietic component of the 
blood island is not only restricted to erythroblasts, cells of the granulocytic and 
megakaryocytic lineages have also been observed in close association with the 
central cells. The islands occupy considerable space in the liver parenchyma, 
altering the architecture of the cords and inducing irregularities in the profiles 
of cells. The bloodstream is reached through existent spaces in the sinusoidal
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walls or as suggested by Zamboni (1965) through interruptions induced by the 
pressure of underlying cells.
Two main roles have been assigned to the central cells of the islands; one is 
that of removal of extruded red cell nuclei-its so called "clearance function" 
(Yoffey & Yaffe 1980). The second role is the transfer of digestion products, 
such as ferritin, to the developing erythroblasts. This function was initially 
described by Pollicard & Bessis (1962) which they termed "rhopheocytosis". 
This latter role may be regarded as only one aspect of the trophic function of 
the central cell, other possible trophic actions include production of monokines 
to promote or inhibit erythroid growth and differentiation (Nathan 1987). 
Desmosome-like attachments have been observed between liver cells and 
proerythroblasts and between yolk sac endoderm and erythroid precursors. 
These points of contact are considered to play a role in the differentiation of 
erythroblasts (Fukuda 1974; Keleman & Balaugh 1976).
It is generally accepted that the central macrophage is an important constituent 
of in vivo erythropoiesis. The concept of a trophic function is supported by 
close apposition of the membrane of the central macrophage with the 
membranes of the surrounding erythroid cells which can lead to the transfer of 
hormones such as Epo. Further evidence supporting this functional 
relationship was provided by modifying erythropoiesis (Ben-Ishay & Yoffey 
1972; Yoffey & Yaffe 1980). By creating a hypoxic state, which stimulates red 
cell production, they observed an increase in the size of the central 
macrophage and enhancement of its phagocytic ability. Conversely when 
erythroid production is suppressed by hypertransfusion, the central 
macrophage is destroyed (Shaklai 1989). The proposed role for transporting 
ferritin to erythroblasts for haemoglobin synthesis remains unproven and 
controversial. It has not yet been possible to determine the direction in which 
the ferritin travels, whether it is transported from macrophage to erythroblast
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or vice versa.
1.5.2 In vitro
Long term bone marrow (LTBM) cultures have made a significant contribution 
to the understanding of the interrelationships between haematopoietic and 
stromal cells. These studies have helped to confirm Trentin's original 
hypothesis on the role of the haematopoietic microenvironment. A complex 
relationship is established between the stroma and haematopoietic cells which 
involves both production of growth-regulatory molecules and creation of an 
appropriate microenvironment. Granulocytes are normally produced in 
murine LTBM cultures, this production involves interactions with a 
macrophage subpopulation in addition to a stromal blanket cell population 
(Allen & Testa 1991).
Haematopoiesis is focal in long term cultures, the adherent layer showing 
variation over the growing surface. It can range from dense multi-layered 
regions of high proliferative activity to very sparse regions containing only a 
few macrophages and fibroblasts (Allen & Dexter 1984). Four or five days after 
plating the initial marrow inocculum, blanket cells appear to attract 
macrophages which migrate and proliferate underneath the blanket cells 
where they become fixed and are observed interspersed with fibroblasts (Allen 
& Dexter 1982). The blanket cells secrete both fibronectin and laminin both of 
which have been shown to promote cellular migration and may therefore play 
a role in the attraction of macrophages and granulocytes in their migration 
under the blanket cells, thus forming the "cobblestone" areas of 
haematopoiesis. These areas are the closest equivalent to the in vivo 'niches' 
for granulocyte development and maturation (Allen & Dexter 1984).
Concomitant with cell production there is proliferation of pluripotent stem
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cells into a variety of precursor cells. This occurs in the absence of detectable 
colony stimulating activity. It has been postulated that the adherent layer is 
acting as an in vitro microenvironment in which the stem cells become lodged 
and here they are capable of extensive and prolonged self-renewal (Dexter et al 
1977). Granulocyte precursors undergo rounds of division in close association 
with the central macrophages before migrating out from underneath the 
blanket cells to form aggregates with developing fat cells. Megakaryocytes are 
also evident in the long term cultures, though in fewer numbers than 
granulocytes. With extended periods of culture, granulocytes progressively 
disappear and phagocytic cells predominate (Dexter 1979; Radley et al 1991).
Erythropoiesis has normally ceased in bone marrow cultures by the end of the 
first week, although it has been known for some time that erythroid precursors 
persist in the cultures. These precursors are blocked at the BFU-E stage. 
Erythropoiesis can be manipulated however by addition of Epo with anaemic 
mouse serum (Allen & Testa 1991). Erythroid differentiation in culture is also 
focal in nature and is observed to occur in distinct foci directly associated with 
cells of the adherent layer. The stromal cells with which they associated were 
always macrophages, forming in vitro erythroblastic islands (Allen & Dexter 
1982). Cytoplasmic extensions of macrophages were observed in close 
association with erythroblasts similar to those in vivo.
Long term fetal liver cultures have been established under the same conditions 
as those of bone marrow, with very similar results (Vogt, Noe & Rich 1991). Fat 
cells are not observed in fetal liver cultures. Like bone marrow cultures, 
erythropoiesis lasts approximately 1 week, then is replaced entirely by 
granulopoiesis and megakaryocytopoiesis. However unlike bone marrow 
cultures, Epo has been detected in the erythroblastic islands. The source is 
presumed to be the central macrophage (Zucali et al 1977; Rich 1986).
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Gap junctions have been observed between macrophages, between 
macrophages and erythroblasts and between macrophages and blanket cells in 
long term bone marrow culture (Allen & Dexter 1982; Hasthorpe et al 1991). In 
freeze fracture specimens of erythroblastic islands, structures resembling 
intercellular bridges between membranes of macrophages and erythroid cells 
have been reported (Shaklai et al 1989). Rosendaal et al (1991) used a dye 
transfer technique to provide evidence for the existence of direct cell-cell 
communication between haematopoietic cells and stromal cells. Freeze fracture 
electron microscopy confirmed that the communication was via gap junctions.
The identification of proteins integrins and cell adhesion molecules involved in 
cell-cell adhesion, cell-cell interaction mediated by proteins such as fibronectin, 
vitronectin and fibrinogen in addition to the ECM molecules has enabled more 
detailed characterisation of the molecular basis for cellular interactions. The 
growth of blast cell colonies on stromal feeder layers requires adhesion to the 
stroma by the blast cells. Gordon, Riley & Clarke (1988) suggested heparan 
sulphate proteoglycan proteins are ideally suited to regulate specific 
intercellular interactions. Crocker, Morris & Gordon (1991) have defined two 
receptors involved in the binding of haematopoietic cells to murine 
macrophages. A divalent cation-dependent receptor which can mediate 
reversible attachment of erythroblasts in vitro, is present in both fetal liver and 
bone marrow. The second, exclusive to adult bone marrow, is a divalent 
cation-independent receptor which can mediate binding of erythroid and 
myeloid cells.
The observations that both erythroid and granulocytic proliferation and 
differentiation takes place in intimate contact with macrophage cell processes 
indicates a potential role for the macrophage in these interactions. This may be 
relevant to the evidence showing that macrophages can produce a variety of 
soluble regulatory factors (Quesenberry et al 1990). The close membrane
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oppositions of these cells, other stromal cells and haematopoietic cells together 
form a complex regulatory network (Allen & Dexter 1984).
1.6 Haematopoietic Colony Forming Cells
Exposure of Dexter cultures to lithium, stimulates virtually all haematopoietic 
stem cells in the culture system, these include colony forming unit spleen 
(CFU-S), high proliferative potential colony forming cells (HPP-CFC), 
granulocyte-macrophage colony forming cells (GM-CFC) and megakaryocyte 
colony forming units (CFU-Meg) (Quesenberry et al 1990). This stimulation is 
thought to be due to increased activity of CSF-1, GM-CSF, G-CSF and IL-3 in 
the long term cultures.
1.6.1 Colony Forming Unit Spleen
Till & McCulloch (1961) pioneered the in vitro experiments on early stem cells. 
They found that when irradiated mice were injected with fresh bone marrow 
cells, macroscopic nodules of proliferating cells appeared in the spleen. 
Erythroid, granuloid, and megakaryocytic cell nodules were detected. There 
was a linear relationship between the number of cells injected and the number 
of colonies formed in the spleen. These findings were compatible with the 
assumption that single viable cells from the bone marrow could give rise to 
colonies in the spleen. However since the marrow injections contained many 
different cell types the identity of the cells giving rise to the colonies was 
unknown and hence they were referred to as colony forming units spleen 
(CFU-S).
Moore & Metcalf (1970) demonstrated that the yolk sac was the first organ to 
contain detectable in vivo CFU-S. These cells were observed in murine yolk sac
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on the 8th day of gestation. By the 10th day of gestation CFU-S were found in 
the blood stream and in the liver. However other investigators have failed to 
find CFU-S in the 8 day embryo (Samoylina, Gan & Medvinski 1990). Instead 
they found CFU-S in the body of a murine embryo before they appeared in the 
yolk sac or liver. Samoylina et al, suggested that there are two sites of 
localisation of CFU-S, in the yolk sac and in the embryo body, from which HSC 
can migrate to the developing liver. Recently Medvinski et al (1993), have 
reported finding CFU-S activity in the aorta, gonad and mesonephros at a 
higher activity than in the yolk sac and appearing earlier in these regions than 
in fetal liver.
In the normal steady state the majority of CFU-S are non-proliferating, they 
can be stimulated into cell cycle by treatments which cause a decrease in cell 
number. The proportion of CFU-S which are synthesising DNA in normal 
murine bone marrow is 10-15% (Riches, Cork & Thomas 1981). Following 
treatment with cytotoxic drugs or X-irradiation the number of CFU-S in S- 
phase increases markedly (40-60%). There is a marked difference in the 
proliferative characteristics of normal bone marrow and those of fetal liver. In 
contrast to the quiescent state of CFU-S in bone marrow, the proportion of 
CFU-S which are engaged in DNA synthesis in fetal liver is 30-40% (Thomas, 
Cork & Riches 1981).
There is evidence that the control of the proliferative status of CFU-S is local. 
Proliferation of CFU-S in bone marrow, shielded from irradiation, is normal 
while CFU-S in the rest of the animal were depleted and undergoing intense 
proliferation (Wright & Lord 1977). More recently proliferation control by stem 
cell specific regulatory factors has been proposed. Maintenance of CFU-S in a 
quiescent state is thought to be brought about by an inhibitor of CFU-S 
proliferation (Lord et al 1976; Riches, Cork & Thomas 1981). Similarly, 
maintenance of an increased proportion of proliferating CFU-S in fetal,
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regenerating or physiologically stressed tissue is brought about by a stem cell 
specific stimulator (Thomas, Cork & Riches 1981; Dawood et al 1990).
1.6.2 High Proliferative Potential Colony Forming Cells
Bradley & Hodgson (1979) described a previously undetected population of 
colony forming cells which they demonstrated in post fluorouracil (5FU) 
treated mice and in normal mice treated with a combination of colony 
stimulating factors. These cells were characterised by their survival after 
treatment with 5FU and by their high proliferative capacity in vitro, colonies 
contained an average of 5xl04 macrophage cells. Hence they were named high 
proliferative potential colony forming cells (HPP-CFC). Unlike CFU-S, the 
HPP-CFC were not severely depleted following treatment with 5FU, 
suggesting they are a slow cycling population. Humphries, Eaves & Eaves 
(1979) described a similar cell in normal mouse bone marrow which was 
responsive to Epo and spleen cell conditioned medium. Acting alone the CSF's 
could not stimulate HPP-CFC proliferation, a combination of growth factors is 
required.
HPP-CFC are among the most primitive progenitors yet identified in vitro. 
They have many characteristics of stem cells with haematopoietic- 
reconstituting ability in vivo. They are highly quiescent, multipotential and 
generate transplantable haematopoietic cells and progenitor cells of various 
lineages in vitro (McNeice et al 1988; Muench & Moore 1992).
Three HPP-CFC populations have so far been defined. The early population 
detected by Bradley & Hodgson is termed HPP-CFCi. A second population, 
HPP-CFC2, is stimulated by IL-3 together with CSF-1/M-CSF (Falk & Vogel 
1988; McNeice et al 1988). These growth factors do not stimulate HPP-CFC 1 
proliferation and HPP-CFC2 are more severely depleted with 5FU treatment.
In vitro experiments have confirmed the existence of two populations of HPP-
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CFC and that HPP-CFC i differentiate to form HPP-CFC 2 and progenitor cells 
for the megakaryocyte, granulocyte, and macrophage lineages (McNeice et al 
1992). HPP-CFC2 in turn differentiate to produce macrophage colony forming 
cells (M-CFC), which further differentiate to produce macrophages.
The HPP-CFC3 population is also severely depleted with 5FU treatment and is 
present in normal mouse marrow at a higher incidence than the other two 
populations suggesting it is a more mature population. This population is 
stimulated by haemolymphopoietic growth factor and CSF-1. The precise 
relationship of HPP-CFC3 with the other subpopulations has not been clearly 
defined, it has been proposed that they are an intermediate population situated 
between HPP-CFC2 and M-CFC (McNeice et al 1990). All three populations are 
inhibited by transforming growth factor p (TGFp) (Keller et al 1990).
The kinetic properties of HPP-CFC are similar to the in vivo CFU-S. In normal 
bone marrow 9% of HPP-CFC are in S-phase, while in irradiated bone marrow 
this increases to 51% (Robinson & Riches 1991). There is also evidence for self­
renewal and sensitivity to the CFU-S stimulator and inhibitor (Pragnell et al 
1988; Eckmann et al 1988). However the effects of both stimulator and inhibitor 
are greater on CFU-S than on HPP-CFC, suggesting HPP-CFC is a relatively 
early component of the stem cell compartment (Robinson & Riches 1991).
1.6.3 Granulocyte-Macrophage Colony Forming Cells
Granulocyte-macrophage colony forming cells (GM-CFC) form colonies in 
vitro provided a suitable source of colony stimulating activity (CSA) is 
available, usually in the form of IL-3. Factors such as endotoxin, bacterial and 
viral infections can increase production of CSA but increase in number of GM- 
CFC does not necessarily correlate with this. In GM-CFC assays, macrophage, 
granulocyte-macrophage and granulocyte colonies are produced (Heyworth & 
Spooncer 1993).
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In normal murine bone marrow 40% of GM-CFC are engaged in DNA 
synthesis, while in human fetal liver < 14 weeks gestation only 5% of GM-CFC 
are in S-phase. Incubation of bone marrow cells with human fetal liver at this 
gestational age will decrease the proportion of GM-CFC in S-phase to 5%. In 
contrast the proportion of GM-CFC in S-phase in human fetal liver >14 weeks 
gestation is 30%. Incubating late fetal liver with bone marrow has no effect on 
the proliferative status of the bone marrow GM-CFC, it can however stimulate 
non-cycling GM-CFC into cycle (Cork, Wright & Riches 1982).
1.7 Adhesion of Haematopoietic Cells to Stromal Layers in Vitro
The growth of haematopoietic cells in tissue culture conditions is a well 
established practise. Haematopoietic stem cells require direct interaction with 
the components of a supportive microenvironment for optimal maintenance, 
proliferation and differentiation. The mechanisms underlying the homing and 
lodging of stem cells in the bone marrow and other haematopoietic organs are 
mediated by membrane interactions of stem cells with stromal cells and with 
components of the extracellular matrix. Fibronectin is involved in diverse 
adhesive interactions with a variety of cell types including haematopoietic 
progenitor and stem cells (Aizawa et al 1991).
Erythroid progenitor cells have been demonstrated to adhere to fibronectin- 
coated substrate, but this adhesion is lost upon differentiation (Coulombel 
1991,1992; Vuilet-Gaugler et al 1990). Restriction of this expression to colony 
forming units-erythroid (CFU-E) and the first subsequent cell divisions 
strikingly correlates with the migratory capacity of these cells. These findings 
emphasise the necessity of direct interactions between haematopoietic cells 
and stromal cells, however it has not been possible to accurately quantify the 
specific attachment of haematopoietic cells to stroma.
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Liesveld et al (1989) showed that CD34+ haematopoietic cells could bind to 
fibroblasts just as effectively as they bound to stromal cells, although the 
stromal cells were better at supporting haematopoiesis. Thus specific binding 
of haematopoietic cells to stromal cells may be required in haematopoiesis.
This could explain why haematopoietic cells home to specific sites.
Lineage and stage specific adhesion of haematopoietic cells to stroma or ECM 
has been reported. Gordon et al (1985), found blast progenitors would adhere 
to cells grown in the presence of methylcellulose but not to cells grown in its 
absence. More mature cells showed no preference to adhere to either layer. 
Bearpark & Gordon (1989) reported that CFU-S would readily adhere to 
stromal layers, while GM-CFC populations would not. Neuraminidase has no 
effect on the adhesion of blast cells, it can however increase the adhesion of 
GM-CFC. This suggests that the cell adhesion molecules alter with lineage and 
maturation. Gordon et al (1990) found that heparan sulphate proteoglycan 
(HS-PG) was essential for binding of blast-CFC to stroma. They suggested that 
haematopoietic cells of different lineages at different stages in development 
recognise and occupy specific microenvironments in the bone marrow. 
AcSDKP, which is a known inhibitor of entry into cell cycle, increased 
adhesion of CFU-S to stromal layers but had no effect on adhesion of GM-CFC 
to the layers (Lenfant et al 1989). Aizawa et al (1992), have suggested that 
AcSDKP improves binding through activation of stromal cells. Verfaillie et al 
(1990,1992) found that early progenitor cells had the capacity to adhere to pre­
established irradiated stroma while more committed progenitor cells lacked 
this capacity.
Aizawa & Tavassoli (1988) reported that homing of intravenously transplanted 
haematopoietic progenitor cells to the bone marrow occurs through a 
recognition system with galactosyl and mannosyl specificities. Both galactosyl 
and mannosyl BSA restricted homing of haematopoietic cells to bone marrow
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but had no effect on the homing of stem cells to the spleen. This may reflect a 
difference in the surface characteristics of stromal cells in the bone marrow and 
spleen and different molecular bases for the binding of progenitor cells in the 
two sites.
Houssaint & Hallet (1988) grafted a precolonised liver rudiment under the 
kidney capsule of an adult mouse. Hepatocytes developed as normal, however 
the rudiment was never colonised by HSC. These results are in accordance 
with those of Johnson & Moore (1975), who suggested a host with normal 
haematopoiesis had no requirement for extra-medullary haematopoietic sites. 
Houssaint & Hallet proposed that ontogenic maturation of HSC occurs around 
the time of birth, which would alter their homing capacity. The grafted liver 
rudiment would be receptive to embryonic HSC only. In contrast Fleischman, 
Custer & Mintz (1982), injected normal bone marrow cells into the placental 
circulation of an 11 day murine fetus. The adult HSC were able to seed the fetal 
liver environment, proliferate and subsequently colonise the bone marrow, 
indicating that adult HSC capable of colonising fetal liver, in the appropriate 
host environment, are present in adult bone marrow (Houssaint & Hallet 
1988).
Riley & Gordon (1987) and Gordon et al (1990), reported selective adhesion of 
Bl-CFC to adherent stroma. They found that marrow derived Bl-CFC would 
adhere to adult derived marrow stromal layers, but not to fetal liver or fetal 
marrow derived layers. Fetal derived HSC would not produce blast colonies 
when seeded onto adult derived stromal layers.
In vitro studies by Zanjani, Ascensao & Tavassoli (1993), suggest a hierarchy of 
homing sites, in which the bone marrow has the highest affinity for homing 
HSC. Before the bone marrow is haematopoietically active, transplanted HSC 
home to the liver and the spleen. Once the marrow has developed, its homing 
potential superseeds that of the other organs, despite the liver and spleen
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remaining the major haematopoietic sites till birth. From the initial stage of its 
development, the bone marrow is capable of engrafting circulating stem cells, 
but does not support their differentiation and proliferation. Thus while HSC 
can pool in the fetal bone marrow, the liver remains the main haematopoietic 
organ till birth. Recent information has emphasised the adhesive capacity as an 
important property of haematopoietic cells and of their microenvironment. The 
adhesive properties can determine the distribution of cells and influence their 
exposure and response to growth factors.
1.8 T rans pi antati on
1.8.1 Bone Marrow Transplantation
Bone marrow grafting is currently applied to a wide variety of malignant, non­
malignant and genetically determined diseases, particularly leukaemia. 
Infusion of bone marrow cells is usually performed following total body 
irradiation or cytotoxic therapy to destroy pre-existing diseased marrow.
The potential application of marrow grafting to protect the individual from 
radiation exposure and chemotherapy in the treatment of leukaemia was first 
reported in the early 1950's when it was a highly experimental procedure. It 
soon became clear that a successful allogeneic graft depended on close 
histocompatibility matching between the donor and the recipient if the 
occurrence of fatal graft-versus-host disease (GvHD) was to be minimised 
(Thomas 1991). Marrow transplants are most commonly performed using an 
HLA genotypically identical sibling donor. However such a donor is only 
available for 30% of patients who require a bone marrow transplant, if an HLA 
non-identical donor is used then graft failure, infection and acute GvHD are
more common.
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Several procedures have been used in an attempt to eliminate GvHD causing 
cells, with a limited degree of success. It is generally considered that the T-cell 
population present in the donor graft causes or promotes GvHD. Marrow 
grafts have been treated with antilymphocytic serum, anti-T cell sera and anti- 
T cell antibody to eliminate T cells from the donor marrow (Vallera et al 1982). 
However T cell depletion leads to an increased risk of graft failure and 
recurrence of malignancy (Thomas 1991).
Recent findings that the stroma of patients with aplastic anaemia becomes 
more effective at binding Bl-CFC than stroma from healthy individuals, in 
response to marrow failure, suggests that engraftment may be achieved more 
easily in these patients (Gordon 1994).
1.8.2 Reduction of Relapse Following Bone Marrow Transplantation
Improved preparative regimens are essential if graft failure is likely to occur. 
Intensifying the dose or schedule of high-dose chemoradiotherapy increases 
the incidence of graft take unfortunately it also causes increased morbidity and 
mortality from damage to other organs especially the lung, liver and heart 
(Touraine et al 1987; Sullivan et al 1989). Monoclonal antibodies are being used 
in vitro for selective removal of subsets of T-cells in an effort to prevent GvHD 
without increasing the possibility of graft rejection or recurrence of infection 
(Thomas 1991). Following an allogeneic marrow graft with immunosuppresive 
treatment of GvHD, the patients are profoundly immunoincompetent and 
therefore at greater risk from infection. A leading cause of death is 
cytomegalovirus (CMV) pneumonia. If both donor and recipient are CMV 
negative, then infection can be prevented by the use of CMV negative blood 
products (Reusser et al 1990).
Recent attention has been focused upon administration of haematopoietic
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growth factors to reduce the time taken for engraftment. Clinical trials in 
patients with acute myeloid leukaemia (AML) indicate that administration of 
rhGM-CSF and rhG-CSF was effective in elevating blood levels of 
granulocytes, monocytes and eosinophils and hence significantly reducing the 
duration of post-transplant leukopenia (Metcalf 1989). Pentoxyfylline (PTX) 
can partially reduce transplant related morbidity by suppressing circulating 
tumour necrosis factor (TNF) levels. TNF is thought to play an etiological role 
in venoocclusive disease of the liver, idiopathic pneumonia and GvHD 
(Nemunaitis & Singer 1992).
It has been reported that a stimulator and inhibitor of CFU-S are found in fetal 
liver (Cork et al 1982; Guigon & Wdzieczak-Bakala 1985). Wu et al (1989) have 
demonstrated the presence of a natural tumour suppressor in human fetal liver 
extract. Addition of this extract to culture systems had a suppressive effect on 
leukaemic cell lines. A suppressive effect was also observed on GM-CFU but 
not to the same extent as that observed on the leukaemic cells. This suggests 
selective suppression of leukaemic cells rather than normal bone marrow cells 
by the fetal liver extract. This selective suppression could be adopted as an 
effective method for the removal of leukaemic cells prior to autologous bone 
marrow transplantation for the treatment of AML (Pei & Wu 1990).
1.8.3 Fetal Liver Transplantation
It is of great interest that fetal liver stem cells can reconstitute the
haematopoietic and lymphopoietic systems of both animals and humans 
without causing GvHD, even when a mismatched donor is used. The 
immature human fetal liver stem cells, when confronted by the allogeneic host 
antigens, acquire immunological tolerance to these antigens (Barnes, Ibery & 
Loutit 1958; Uphoff 1958; Lengerova 1959), this accounts for the absence of 
GvHD (Billingham, Brent & Medawar 1956; Gale 1985).
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Infusion of fetal liver cells in patients infected with severe combined immune 
deficiency (SCID) syndrome, severe aplastic anaemia and acute leukaemia 
results in sustained engraftment and a possible cure even when the infused 
fetal liver cells were from a mismatched donor (O'Reilly 1985; Touraine 1991). 
Fetal liver transplantation (FLT) has also been used to treat a variety of inborn 
errors of metabolism, however the benefits in these patients are usually partial 
and transient (Touraine et al 1987).
Evidence for engraftment of donor cells following FLT is not abundant (Gale 
1985; Izzi et al 1985). It is thought that the immunogenetic fetal liver cells are 
rejected following transplantation into immune competent hosts. Immunologic 
recovery is incomplete despite sustained lymphoid engraftment. In many 
patients with acute leukaemia, graft failure and leukaemic relapse frequently 
occur (Champlin et al 1985).
Immune reconstitution following fetal liver transplantation has been enhanced 
by simultaneous transplantation of the thymus from the same donor. This 
provides a syngeneic environment for differentiation of the transplanted T- 
lymphocyte precursors (Touraine et al 1985). Roncarolo et al (1991) have 
reported a SCID patient reconstituted with non-compatible fetal liver and 
thymus cells. The patient's T cells are of donor origin while the B cells and 
natural killer (NK) cells are host derived. Sanhadji (1992) reported the cure of 
leukaemic mice following FLT. The absence of post-transplant leukaemic 
development or relapse was attributed to a graft versus leukaemic effect of the 
FLT. Increasing the number of transplanted fetal liver cells, when mismatched 
donors are used, together with higher doses of irradiation/ chemotherapy has 
considerably improved engraftment (Royo et al 1987).
Transplants of fetal liver cells have been successfully used for reconstitution of 
defective cell lines in fetal recipients by injection via the placental circulation.
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This method takes advantage of the immunological tolerance of the fetal 
recipients together with the optimal environment for differentiation of the 
transplanted fetal stem cells and the isolation of the fetus in the uterus. For 
optimal results the transplant should be performed as soon as possible after a 
diagnosis has been made (Flake, Harrison & Zanjani 1991).
Erythroid replacement in genetically anaemic W/Wv mice using in utero fetal 
liver transplantation has been demonstrated (Fleischman et al 1982). Long term 
analysis revealed sustained and co-ordinate production of various lineages 
together with progressive substitution of host cells with those of the donor. 
Harrison et al (1989) successfully engrafted fetal liver cells into fetal monkeys 
of the opposite sex, without occurrence of GvHD. Touraine et al (1991,1992) 
have successfully treated human fetuses which had been diagnosed as having 
SCID, bare lymphocyte syndrome or thalassaemia major by in utero infusion 
of fetal liver cells. Fetus-fetus haematopoietic stem cells transplants which can 
be performed without the need for cytoablative therapy, immunosuppression 
and GvHD may offer the earliest effective therapy of a genetic disorder 
diagnosed in utero (Zanjani et al 1991).
In the future bone marrow transplants and fetal liver transplants, as they are 
presently performed, may be replaced by purified stem cell transplants. Stem 
cell transplants may be combined with growth and differentiation factors to 
improve engraftment. Gene therapy is another potential method of correcting 
defective genetic diseases.
1.9 Prospects for Transplantation
1.9.1 Peripheral Blood Stem Cell Transplantation
The use of peripheral blood stem cells (PBSC) as an alternative to bone marrow
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stem cells following high dose myeloablative chemotherapy, in selected cases, 
was first reported in man in 1985 (Juttner et al 1989). The advantages of PBSC 
include decreased likelihood of contamination with malignant cells, infusion of 
immunocompetent cells which hasten the immune recovery and the ability to 
collect PBSC from the donor without general anaesthesia. An extremely rapid 
haematopoietic recovery was observed due to the high numbers of GM-CFU 
present in PBSC collections.
PBSC infusion after high dose irradiation/chemotherapy has been successfully 
used to treat both chronic and acute myeloid leukaemias, lymphoma and 
multiple myeloma. Kessinger et al (1991) used PBSC to successfully treat 
patients with bone marrow metastases and relapsed lymphoma. In most cases 
haematopoietic recovery was more rapid than that observed in patients treated 
with an autologous bone marrow transplant (Juttner et al 1989; Williams et al 
1990; Zander et al 1991).
Platelet recovery however is not so rapid, this may be due to infusion of 
insufficient numbers of PBSC or the nature of PBSC may be more committed to 
the granulocyte lineage rather than the megakaryocyte lineage (Williams et al 
1990). Further investigations are required to answer these questions and to 
extend the use of PBSC to more patients for whom a compatible bone marrow 
donor is not available.
1.9.2 Umbilical Cord Transplantation
The use of human umbilical cord cells (HUC) for therapeutic reconstitution 
was proposed by Boyse, who observed successful haematopoietic 
reconstitution in lethally irradiated mice which were infused with syngeneic 
neonatal blood (Broxmyer et al 1989). The use of HUC has several advantages 
namely, disposing of the need for bone marrow donors, providing a disease- 
free source of haematopoietic stem cells, a matched donor is not essential and
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as yet occurrence of GvHD has been minimal (Broxmyer et al 1991).
Cryopreserved HUC has been used as a source of HSC for HLA-identical 
transplantation of children with leukaemia or Fanconi's anaemia (Gluckman et 
al 1989; Hows et al 1992). HUC is a rich source of primitive haematopoietic 
progenitor cells and the T cells which it contains are immature, hence potential 
for inducing GvHD is reduced. Cell production in cultured HUC is greater 
than in normal bone marrow cultures. It may therefore be possible to treat 
adults with infusions of HUC (Hows et al 1992). To date haematopoietic 
engraftment has been successful following umbilical cord transplantation, 
however many questions remain unanswered. The use of the relatively limited 
number of cord blood progenitors in larger and mismatched recipients may 
amplify engraftment problems. The possibility exists that HUC may be 
contaminated with maternal cells. Transfer of mature T cells which are 
incompletely matched with the histocompatibility antigens of the recipient 
would almost definitely contribute to GvHD (Linch & Brent 1989). The 
hypothesis proposed by Boyse that use of cord blood as a source of stem cells, 
rather than bone marrow, might reduce the incidence and severity of GvHD is 
far from proven.
1.9.3 Gene Therapy
Gene transfer for the correction of genetic diseases is currently under intense 
investigation. Insertion of functioning genes into deficient cells is becoming a 
valid alternative to allogeneic cell transplantation in some inborn errors of 
metabolism. Methods have been devised for transferring specific genes with 
high efficiency into various cell types which exploit the use of replication- 
defective retroviruses as vectors. Murine studies have shown that genes can be 
incorporated into HSC which then reconstitute the marrow of syngeneic 
recipients (Lehn 1987).
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The adenosine deaminase (ADA) deficiency which results in SCID has been 
successfully corrected by this method. The defective gene in the T- 
lymphocytes was corrected and the cells were then reinfused into the patient 
(Steinberg 1991). A clinical protocol for ADA gene therapy has now been 
provisionally accepted (Moen 1991).
In vitro studies have shown that haematopoietic progenitors of dogs, cats 
monkeys and humans can be transduced, however at a lower rate than 
transduction in murine progenitors. Prestimulation with appropriate 
haematopoietic growth factors may enhance the rate of retroviral gene 
transduction in human progenitor cells (Lehn 1990). Tumour infiltrating cells 
can be transduced with retroviral vectors. The integrated genome directs a 
high level of antibiotic resistance promoting enzyme. When the tumour 
infiltrating cells are re-infused into the patient they home to the tumour sites. 
Some patients have had a remarkable tumour regression, however the results 
are very unpredictable (Moen 1991). In the future it may be possible to cure 
thalassaemias and haemoglobinopathies using gene therapy, unfortunately the 
barriers currently facing investigators are formidable and much research 
remains to be done (Steinberg 1991).
1.10 Aims of Research
The aims of this research were to (i) examine the relationships between fetal 
liver derived blood cell precursors and environmental cells using 
morphological criteria and to compare these relationships in fetal, and 
neonatal liver, (ii) compare the in vivo relationships between blood cell 
precursors and environmental cells with those observed in vitro using long 
term cultures of both adult bone marrow and fetal liver, (iii) investigate the
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proliferative status of early blood cells precursors derived from fetal liver and 
adult bone marrow, (iv) determine the effects of fetal liver extract on colony 
production by normal bone marrow and leukaemic cells and (v) investigate the 
ability of adherent stromal layers, derived from fetal liver and adult bone 
marrow, to retain and support early precursors of blood cells.
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Chapter 2
Materials and Methods
2.1 Transmission Electron Microscopy
2.1.1 Mice
CBA/H mice were used throughout, they were maintained on a 12 hour 
light/dark cycle and fed R & M No. 3 pellets and water containing 15ppm 
chloride free ions, ad libitum. Mice were mated and checked each morning for 
the appearance of a vaginal plug, this was taken to be Day 0 of gestation. Fetal 
and neonatal mice were studied on the 12th, 13th, 14th, 15th, 18th days of 
gestation, on the day of birth, and on the 10th day of the neonatal period. The 
progeny of 3 adult females, each containing an average of 8 fetuses, were used 
for each gestational age examined.
2.1.2 Fixation
Mice were killed by cervical dislocation and their livers were excised. Livers 
were immediately transferred into 5% glutaraldehyde/4% paraformaldehyde 
fixative (Emscope Biorad) buffered with phosphate (BDH Chemicals Ltd) at pH
7.3 (Karnovsky 1965). Specimens were sliced in the fixative and left for one 
hour then washed 3 times in 0.08M Na cacodylate buffer (BDH Chemicals Ltd) 
for 15 minutes each. Specimens were then post-fixed in 1% osmium tetroxide 
for one hour and washed in cacodylate buffer as before, then dehydrated 
through a graded series of alcohols. Specimens spent 10 minutes in each of 50%, 
70%, 80% and 90% ethanol then a further hour in 3 changes of 100% ethanol to 
ensure dehydration.
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Specimens were then passed through 3 changes of propylene oxide for 20 
minutes each to remove all traces of alcohol. Araldite resin was made up from 
27ml araldite CY212 (Emscope Biorad), 23ml hardener DDSA (Emscope 
Biorad), 0.60ml dibutyl phthalate and 1.2ml accelerator BDMA (Emscope 
Biorad). Specimens were infiltrated in a mixture of 2 parts propylene oxide to 1 
part resin for one hour, then in 1 part propylene oxide to 2 parts resin for a 
further hour. Specimens were finally embedded in resin and polymerised for 48 
hours at 60 °C.
2.1.3 Sectioning
Individual pieces of liver were cut out from the resin and mounted on araldite 
blocks for sectioning with a Reichart OM-U2 microtome using glass knives. 
Thick sections (1 pm) were cut and mounted on glass slides then stained with 
Methylene blue for analysis with a Zeiss WL light microscope.
Ultrathin sections (50-70 nm), silver/grey interference colours were cut for 
electron microscope analysis. Sections were stretched out with chloroform 
before being mounted on copper grids.
2.1.4 Staining
10ml of 70% ethanol was added to 0.2g uranyl acetate and the solution left in 
darkness for 30 minutes. 1.76g trisodium citrate and 1.33g lead nitrate were 
dissolved in 30 ml distilled water and left for 30 minutes. 8ml IN NaOH was 
added to clear the solution, which was then made up to a total volume of 50ml 
with distilled water. Both solutions were centrifuged for 15 minutes prior to 
use, (Reynolds 1963).
Drops of uranyl acetate solution were added to a piece of dental wax containing 
NaOH pellets Grids were transferred to the acetate drops, matt surface 
downwards and left to stain in the dark for 20 minutes. The grids were rinsed
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in three successive beakers of distilled water then transferred to drops of lead 
citrate solution on dental wax to stain for 5 minutes. Grids were initially 
washed in 0.2M NaOH then rinsed three times in distilled water (Reynolds 
1963). The grids were left to air-dry before analysis using a Philips 301 Electron 
Microscope at 60kV.
2.2 Confocal Laser Scanning Microscopy
2.2.1 Mice
Livers were excised from fetal CBA/H mice on the 15th day of gestation and 
from neonatal mice on the 8th day post partum.
2.2.2 Fixation, Dehydration and Embedding.
Segments of liver were fixed in neutral 4% formaldehyde buffer (BDH) for 4-6 
days. Liver segments were placed in 75% alcohol overnight to commence 
dehydration, this was completed with two changes in each of 96% alcohol and 
absolute alcohol. The tissue was then cleaned in two changes of chloroform 
(BDH) and impregnated with paraffin wax in a vacuum embedding bath at 
60°C.
2.2.3 Sectioning and Staining.
Liver segments were mounted on blocks. 7pm sections were cut, floated out in a 
water bath at 46°C, before mounting onto Subbed slides and left to dry 
overnight at 45 °C. (Subbed slides-acid cleaned slides washed in running tap 
water and dipped in a 1% gelatine (Biorad), 0.1% chrome alum mix (Biorad) at 
45°C and dried). Sections were de-waxed in xylene (BDH) and rehydrated 
through an alcohol series:- absolute, 96% and 75% then placed in distilled 
water.
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Ferric salt, present in the liver samples, was treated with Peris mixture of equal 
parts 2% potassium ferrocyanide (Sigma) and 2% hydrochloric acid (Sigma) for 
30 minutes. The samples were then washed several times with distilled water 
before treatment with 0.1% nuclear fast red (BDH) in 5% aluminium sulphate 
(BDH) for 90 seconds. Following this treatment nuclear material had a pale red 
appearance whilst cytoplasmic material appeared pale pink. Sections were 
washed in running tap water, dehydrated as before, then cleaned in xylene and 
mounted in DePeX (BDH).
2, 3 Long Term Bone Marrow and Fetal Liver Cultures
2.3.1 Mice
CBA/H x C57BL10 crossbred mice were used throughout. Fetal livers were 
removed on the 15th, 17th and 19th days of gestation. Bone marrow was 
removed from the femurs of young adult mice, at least 8 weeks post-partum.
2.3.2 Long Term Liquid Cultures.
(i) Bone Marrow
Bone marrow cultures were established as detailed by Dexter et al (1973,1974). 
The contents of a single femur were flushed through a 23G needle into a 25cm2 
tissue culture flask (Corning), containing 10ml Fischers growth medium (Gibco) 
supplemented with 20% horse serum (Gibco), 50 i.u./ml penicillin, 50mg/ml 
streptomycin (Sigma), 2mM glutamine (Flow Labs.) with 10"3 M hydrocortisone 
(Sigma).
(ii) Fetal Liver
An intact fetal liver was added to a tissue culture flask containing 10ml growth 
medium and gently disaggregated by aspiration through a 1ml syringe.
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Cultures were gased with 5% CO2 in air and incubated at 33°C. After 7 days 
and subsequently at weekly intervals, the cultures were demidepopulated and 
half of the supernatant medium was replaced with fresh growth medium. 
Suspension cells recovered after feeding were used for cytospin preparations, 
using a Shandon Cytospin 2, fixed and stained with Jenner/Giemsa (BDH). The 
establishment and appearance of a stromal cell layer in the culture flasks was 
monitored weekly by examination under an inverted microscope.
2.3.3 Flash Labelling of Long Term Layers
The supernatant was removed from flasks to be labelled. lOpCi 3H (Amersham 
International) was added to the flasks which were then left to incubate for 24 
hours at 37°C. Flasks were rinsed a few times with PBS buffer and allowed to 
air dry for 24 hours. The stromal layers were rinsed and fixed in methanol for 
15 minutes The base of the flasks were cut off and dipped in K2 emulsion 
(Ilford Nuclear Research) with 1% glycerol solution (1:1 dilution) for 1 second 
and left to dry for 6 hours. Once dry the flasks were put into boxes containing 
silica gel, taped closed and inserted into 2 black bags which were also taped 
closed, then stored in the fridge for 4 days exposure.
2.3.4 Developing
Samples were removed from boxes and submersed in Kodak D19b developer 
for 3.5 minutes, then rinsed with distilled water fo 30 seconds before fixation in 
Kodak acid fix (Hypo) for 5 minutes and a final rinse in tap water for 15 
minutes. Samples were allowed to dry before staining with Jenner/Giemsa and 
mounted with euparal (Raymond Lamb).
2.3.5 Irradiated Stromal Layers
To establish irradiated stromal cell layers, long-term bone marrow and fetal 
liver cell cultures were set up as described. Once a confluent stromal layer was 
established, after approximately 3 weeks for bone marrow culture and 6-8
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weeks for fetal liver, the cultures were irradiated with 15Gy y irradiation from a 
Cis IBL 437C source with a 137Cs radionuclide at a dose-rate of 4.6 Gy/min.
This was followed by a rinse and total change of medium 6 hours later 
(Spooncer, Lord and Dexter, 1985). This dose kills all haematopoietic cells, 
quiescent stromal cells however remain intact and provide a nude inductive 
stroma which can function to promote the growth of haematopoietic cells for 
several weeks. 6-10 days later the layers were reseeded with fresh bone marrow 
or fetal liver cells to re-establish haematopoiesis, the flasks were fed weekly as 
before.
2.4 High Proliferative Potential-Colony Forming Cell Assay,
2.4.1 Mice
The livers of CBA/H mice were used on the 13th, 15th, 17th and 19th days of 
gestation, on the day of birth and on the 3rd and 8th days of the neonatal 
period, bone marrow was obtained from the femurs of young adult mice. The 
livers of at least 4 mice were pooled for each experiment.
2.4.2 Haematopoietic Tissue Preparation
Pregnant mice and neonatal mice at appropriate stages in gestation were killed 
by cervical dislocation. The livers were excised, pooled and placed into a 
known volume of Dulbecco's medium supplemented with 50 i.u/ml 
benzylpenicillin (Gibco), 50(ig/ml streptomycin sulphate (Sigma), 2mM L- 
glutamine (FlowLabs) and 20% horse serum (Sigma). Normal adult mice were 
also killed by cervical dislocation and their femora removed. The contents of a 
single femur were flushed through a 23G needle into a known volume of 
Dulbecco’s medium. A single cell suspension of haematopoietic tissue was 
produced, by aspirating fragments of liver/bone marrow through 
progressively finer gauge needles (No. 23G to 25G) Cellularities were 
determined using a coulter counter ZM and adjusted to 5xl06 cell/ml.
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2.4.3 Determination of the Proportion of Cells in S-Phase (Fig. 2.4-1)
Two 1ml samples of 5xl06 haematopoietic cells were produced in centrifuge 
tubes and incubated at 37°C in either lOOgl medium alone, as a control, or in 
the presence of 100 pi Cytosine arabinoside (Ara-C) (Sigma) at a concentration 
of 250 pg/ml (10'4 M). Ara-C is an S-phase specific cytotoxic agent which kills 
all cells engaged in DNA synthesis. By comparing the number of colonies 
formed by cells treated with medium alone and those treated with Ara-C, a 
measure of the proportion of colony forming cells which are synthesising DNA 
can be determined. Samples were incubated for one hour with frequent vortex 
mixing.
After one hour the cells were put through a series of two washes:-7ml fresh 
medium was added to each sample and the cell suspension centrifuged at 1000 
r.p.m. for 15 minutes. The supernatant was removed to waste, the cell pellet 
resuspended in 8ml fresh medium and centrifuged for 15 minutes at 1000 r.p.m 
Supernatants were removed and pellets were resuspended as a single cell 
suspension in 1ml medium. Cellularities were determined and adjusted to 
2xl05 cells/ml.
Two millilitres of 2xl04 FL or BM cells/ml or 2ml 4xl04 neonatal liver cells/ml 
in supplemented Dulbeccos medium containing 0.3% (w/v) agar (Difco Bacto 
Agar) were aliquoted in 50mm, triple vent, tissue culture grade, plastic petri 
dishes (Cell Cult) over 2ml aliquots of Dulbeccos medium containing 0.5% 
(w/v) agar and 10% (v/v) each of medium conditioned by the WEHI3B 
myelomonocytic leukaemia cell line, a source of Multi-CSF/Interleukin 3(IL-3) 
(Ihle et al, 1982); and medium conditioned by the L929 fibroblast cell line, a 
source of M-CSF/CSF-1 (Stanley & Heard, 1977). Cultures were incubated in a 
fully humidified, 5% CO2 in air atmosphere for 14 days at 37°C (Fig. 2.4-2).
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Twenty-four hours prior to assay, 1ml of an autoclaved solution of lmg 
INT/ml 0.9% saline was added to each culture INT- 2 (4 iodophenyl)-3 (4 
nitrophenyl)-5 phenyltetrazolium chloride (BDH). Colourless INT is 
metabolised by viable cells and converted to a red tetrazolium salt which 
precipitates in the cells allowing macroscopic assay of colony numbers. 
Colonies in excess of 2 mm diameter were considered to be derived from the 
HPP-CFC population (Falk & Vogel 1988; Pragnell et al 1988). The difference in 
colony numbers in the absence and in the presence of Ara-C treatment gives a 
measure of the proportion of HPP-CFC in S-phase.
23 CFU-GM Assay
Haematopoietic tissue was obtained from the livers of 15 day fetal and 
newborn mice and from the bone marrow of young adult mice. This was 
added to a known volume of supplemented Dulbecco's medium and a single 
cell suspension produced. The cells were counted and diluted to 5x106 
cells/ml.
lml cell suspension was incubated in the presence of 100pi Ara-C, or lOOpl 
Dulbecco's at 37°C for one hour. Cells were washed twice, resuspended in lml 
medium and diluted to 5x10s cells/ml. lml aliquots of 5xl04 cells/ml in 
Dulbeccos medium containing 0.3% (w/v) agar and 10% (v/v) medium 
conditioned by the WEHI 3B cell line, as a source of colony stimulating 
activity, were plated in 30mm triple vent plastic petri dishes. The cultures were 
incubated in a humidified 5% CO2 in air atmosphere for 7 days and colonies 
(>50 cells) were counted using dark field illumination.
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2.6 Effect of Fetal Liver Extract on the Formation of HPP-CFC by
Normal and Irrariated Bone Marrow,
2.6.1 Mice
Adult CBA/H mice given lOGy, 7.5Gy, 5Gy, 2.5Gy or OGy y irradiation were 
sacrificed on the fourth day post-irradiation (Sharp & Thomas 1971). Femora 
were dissected free and their contents flushed into a teklab containing 3mls 
Dulbeccos medium supplemented with penicillin, streptomycin , glutamine 
and 20% horse serum. A single cell suspension was produced, cellularity was 
determined using a coulter counter ZM and adjusted to 2xl05 cells/ml.
2.6.2 Fetal Liver Extract
CBA/H mice were used for the preparation of fetal liver extract (FLE). On the 
15th day of gestation mice were killed by cervical dislocation and the fetuses 
removed. The fetal livers were excised and each suspended in 1ml Fischers 
medium supplemented with penicillin, streptomycin, glutamine and 10% 
horse serum. Single cell suspensions of fetal liver were produced and 
incubated at 37°C for 24 hours. Suspensions were centrifuged for 15 minutes at 
1200 rpm in a chillspin MSE. Supernatants were removed and stored at -10°C.
2.6.3 Assay
lml of 2x105 BM cells/ml was added to the standard HPP-CFC culture layer 
together with lml of FLE and lml of 3% agar, FLE was not added to the 
control group. 2mls of this solution were then plated over the standard HPP- 
CFC feeder layer, containing Wehi 3B, L929 and 0.5% agar. The colonies were 
incubated for 14 days in a fully humidified CO2 in air atmosphere, lml of INT 
was added to each dish one day prior to assay. The difference in the number of
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colonies produced in the absence and in the presence of FLE gives an 
indication as to whether FLE influences the production of HPP-CFC by 
irradiated bone marrow.
2.6.4 Effect of Diluted FLE on NBM.
These experiments were performed to establish the optimal concentration of 
FLE which would influence the formation of HPP-CFC by normal bone 
marrow. Experimental protocol was identical to the original experiments, 
however the volume of FLE added was diluted to 0.5,0.25, 0.125, 0.0625 and 
0.03125 of the original. Supplemented Fischers medium was added to the FLE 
to make the final volume up to 1ml. This solution was then added to the 
culture layer together with NBM cells and 3% agar. 2ml of the culture solution 
was plated over the standard HPP-CFC feeder layer and incubated for 14 days 
as before.
2.7 Effect of FLE on Leukaemic Cell Colony Formation
2.7.1 SA2 Leukaemic Cell Line
The SA2 cell line used was cloned from the SA2 T38 leukaemic cell line in 
liquid form. SA2 myeloid leukaemia was induced into CBA/H male mice 
following exposure to 3 Gy whole body X-irradiation (Hepburn et al 1987) and 
passaged routinely at 2-3 week intervals in CBA/H recipients (Hepburn et al 
1987). SA2 cells are removed from the medullary cavities of the 38th passage 
(SA2 FT38), grown in liquid culture and cloned (Riches et al 1991). The cloned 
SA2 cells are stored frozen in liquid N2 until required for use. The cells are 
thawed out rapidly in a water bath at 37°C then transferred to a centrifuge
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tube. 9ml Fischers medium supplemented with penicillin, streptomycin 
sulphate, glutamine and 10% horse serum is added drop wise whilst gently 
agitating the centrifuge tube to prevent osmotic rupture of the cells. The 
suspension is centrifuged at 1000 rpm for 10 minutes and the supernatant 
removed. The pellet is then resuspended in 10ml Fischers medium and 
transferred to a tissue culture flask. The flasks are stored at 37°C and passaged 
at regular intervals (Riches et al 1991).
A cell viability test must be performed prior to use. A single cell suspension is 
obtained by pipetting the cells through a 10ml pipette a few times, lml of the 
single cell suspension is removed, placed in a teklab with 50pl fast green and 
incubated in a water bath at 37°C for 15 minutes. The sample is removed, 
placed on a slide and a cell count is performed, non-viable cells are stained by 
fast green and appear green under the microscope. The percentage of viable 
cells is calculated (viability >90%).
2.7.2 Leukaemic Cell Assay
lml of 2xl03 SA2 cells together with 0.25, 0.5 or lml FLE were added to 
supplemented Dulbeccos medium and lml of 3% agar (standard GM-CFC 
layer), FLE was not added to the control groups, lml of this solution was 
added to 30mm triple vent non- tissue culture grade petri dishes and incubated 
for 7 days in a 5% CO2 in air atmosphere. Colonies containing >50 cells were 
counted using a dark field illumination microscope. The difference in colony 
number between experimental and control groups was considered to be a 
result of the presence of FLE.
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2.8 Adhesion of HPP-CFC to Irradiated Stromal Layers (Fig. 2.8-1)
2.8.1 Mice
CBA/H x C57BL10 mice were used throughout, regenerating bone marrow 
was obtained from mice which had been given 2Gy y irradiation 3 days prior to 
use. Mice were killed by cervical dislocation and experimental tissue was 
obtained from femora or fetal liver as appropriate, and flushed into 5mls 
Dulbeccos medium, supplemented with 50i.u./ml penicillin, 50|ig/ml 
streptomycin, 2mM glutamine and 20% horse serum. Single cell suspensions of 
haematopoietic tissue were produced by aspiration through progressively 
finer gauge needles. Cellularity was determined using a coulter counter ZM 
and adjusted as required.
2.8.2 Incubation of Stromal Layers with BM or FL cells.
Supernatants were removed from irradiated stromal layers 6-10 days after 
irradiation (Spooncer, Lord & Dexter, 1985), and replaced with lml of a known 
concentration of either normal bone marrow (NBM), regenerating bone 
marrow (RBM) or fetal liver (FL) cells in 6mls Fischers medium.The flasks were 
gased and incubated for 2 hours at 33°C (Gordon et al, 1987).
2.8.3 HPP-CFC Assay.
2mls of 2xl04 control NBM, RBM or FL cells/ml in supplemented Dulbeccos 
medium containing 0.3% (w/v) agar were aliquoted in 50mm triple vent 
plastic petri dishes over 2ml aliquots of Dulbeccos medium containing 0.5% 
(w/v) agar and 10% (v/v) each of Wehi 3B and L929. After 2 hours incubation 
the supernatant was removed and the stromal layer rinsed with 3ml Fischers
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Fig. 2.8-1 Adhesion of HPP-CFC to Irradiated Stromal Layers
Establish Long Term Cultures
Bone Marrow Fetal Liver
Reseed Layers with 
Bone Marrow or Fetal Liver Cells
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I
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54
medium. This was then removed, added to the supernatant and 
centrifuged at lOOOrpm for 10 minutes. 10 ml of fresh supernatant was 
added to the flasks, which were gased, returned to the incubator and 
maintained as before for several weeks. After centrifugation, the pellet was 
resuspended as a single cell suspension in lml Dulbeccos medium, the 
cellularity was determined and adjusted to 2xl05 cells/ml. As with the 
controls, 2ml aliquots of 2x104 cells/ml in Dulbeccos medium containing 
0.3% agar were plated over 2ml aliquots of medium containing 0.5% agar 
with Wehi 3B and L929.
Cultures were incubated for 14 days at 37°C in a fully humidified 5% CO2 in 
air atmosphere. Twenty four hours prior to assay, lml of INT was added to 
each culture. The difference in colony numbers between the control and 
experimental group gives a measure of the proportion of cells which had 
adhered to the stromal layer.
All results were statistically analysed, using the Students t-test and analysis 
of variance (ANOVA).
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Chapter 3
Inter-Cellular Relationships
During the 21 day period of embryonic and fetal development in the 
mouse, there is a sequential change in the site of haematopoiesis together 
with changes in haemoglobin type and production of annucleate 
erythrocytes. Haematopoiesis is initiated in the fetal liver at around the 
10th day of gestation and continues almost until birth, when it is 
supplanted by the spleen and the bone marrow.
3JL In Vivo
The relationships between the cells and morphological changes which 
occur in fetal and neonatal liver during development have been 
investigated by electron microscopy.
Confocal laser scanning microscopy was used to examine fetal liver and 
neonatal liver which had been stained for iron with Perl's Prussian Blue.
Results
3.1-1 Fetal Liver
The earliest liver sample examined was that of the 12 day fetus. At this 
stage the hepatic parenchyma had not fully developed. The hepatic tissue 
formed a loose mass of cells. Hepatocytes (figs. 3.1-1 & 3.1-2) were relatively
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low in number, they exhibited a number of lipid inclusions and had 
characteristic pyramidal outlines, in the absence of large numbers of 
haematopoietic cells. Haematopoietic cells were not obvious at this early 
stage. A few erythroblasts were observed randomly situated within the 
hepatic parenchyma. Occasional monocytes were observed (fig. 3.1-3), 
which was unusual in such an early stage.
In the 13 day fetus, with the development of the hepatic cords, the 
hepatocytes appeared to be much more cohesive. Some fenestrations 
remained in the parenchyma, however it was considerably more compact 
than that of the 12 day fetus (fig. 3.1-4). Haematopoietic cells were observed 
extravascularly, arranged in distinct clusters around a central hepatocyte 
(fig. 3.1-5 & 3.1-6) with resulting irregularities in the oulines of the 
hepatocytes.
In the 14 day fetus, the hepatic stroma is very cohesive due to increasing 
numbers of cells, which are very closely packed. Endothelial cells which 
line the liver sinusoids were apparent, with their characteristic long 
flattened outline. The number of haematopoietic cell clusters or 
"erythroblastic islands" had markedly increased. Developing erythroblasts 
were seen to form cell clusters around a central macrophage (fig. 3.1-7) in 
addition to those arranged around a central hepatocyte (fig. 3.1-8).
The number of constituent cells in each cluster was relatively high at this 
stage. Cytoplasmic extensions of the central cell were seen to be intimately 
associated with the adjacent blood cell precursors. Gap junctions and 
desmosome-like attachments between the blood cell precursors and the 
cytoplasmic processes were numerous (fig. 3.1-7). In addition, cytoplasmic 
processes of the blood cell precursors were observed in close proximity to 
the processes of the central cells (fig. 3.1-8). Gradients of differentiation were
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apparent in the clusters. The immature erythroblasts were situated in close 
proximity to the central macrophage or hepatocyte whilst more mature 
elements were located peripherally. Nuclear expulsion by erythroid cells 
was observed (fig. 3.1-9) and macrophages were observed with ingested red 
cell nuclei in their cytoplasm (fig. 3.1-7).
Other haematopoietic lineages became apparent at this stage in
development. In addition to monocytes, occasional granulocytes were seen 
as part of an erythroblast cluster (fig. 3.1-10). Megakaryocytes were also 
observed at this stage in development, however they did not form an 
integral part of the mixed-lineage cell clusters, they remained as a single 
entity in close proximity to hepatocytes (fig. 3.1-11).
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12 Day Fetal Liver
Fig. 3.1-1 x5 265
Cluster of three early hepatocytes (H), forming a loose network of cells. 
Mitochondria and RER are not abundant in these early cells
59
12 Day Fetal liver
Fig. 3.1-2 x 14 250
Early hepatocyte (H) closely associated with adjacent hepaocytes. Only a few 
organelles are visible within the cytoplasm. A few lipid vacuoles (arrows) 
are present in the neighbouring hepatocytes.
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12 Day Fetal Liver
Fig. 3.1-3 x3 000
Early monocyte (Mn), closely associated with a hepatocyte (H). The 
monocyte extends cytoplasmic processes towards the hepatocyte.
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13 Day Fetal
Fig. 3.1-4 xll 171
Cluster of hepatocytes (H) forming a compact cell network. Mitochondria 
and RER are more predominant in the cytoplasm. In addition to close 
apposition of the cell mebranes, cytoplasmic processes can be seen 
extending towards adjacent cells (arrows).
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13 Day Fetal
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Fig. 3.1-5 x 14 200
Cluster of immature erythroblasts (Eb) around a hepatocyte (H). The cell 
membranes of the erythroblasts are closely apposed to that of the 
hepatocyte, desmosomes and gap junctions can be observed in these 
regions.
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13 Day Fetal
Fig. 3.1-6 x 18 525
Cluster of erythroblasts (Eb) around a central hepatocyte (H). Cytoplasmic 
processes of the hepatocyte can be seen passing between and in close 
apposition to the adjacent blood cell precursors. Cytoplasmic processes of 
the erythroblasts can be seen extending towards the central hepatocyte 
(arrow).
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14 Day Fetal Liver
Fig. 3.1-7 x9 000
Central macrophage (M) surrounded by a large number of immature 
erythroblasts. There is close apposition of the macrophage cell membrane 
with those of the surrounding cells. Ingested debris can be seen in the 
cytoplasm of the macrophage.
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14 Day Fetal Liver
Fig. 3.1-8 x9 000
Developing erythroblasts arranged around a central hepatocyte (H). The 
blood cell precursors are intimately associated with the cytoplasmic 
processes of the hepatocyte through desmosomes, gap junctions and their 
own cytoplasmic projections.
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14 Day Fetal Liver
Fig. 3.1-9 x2 500
Nuclear expulsion by an erythroblast. A narrow rim of cytoplasm remains 
around the expelled nucleus. This cell was situated at the periphery of an 
erythroid cluster.
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14 Day Fetal Liver
Fig. 3.1-10 x 10 400
Mixed-lineage cluster around a hepatocyte (H). An early neutrophil (N) 
forms an integral part of the cluster together with the developing 
erythroblasts (Eb). Granules are apparent in the cytoplasm of the 
neutrophil.
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14 Day Fetal Liver
Fig. 3.1-11 x 9 500
Early megakaryocyte in close apposition to the cell membrane of a 
hepatocyte (H). Demarcation membranes can be seen within the cytoplasm 
of the megakaryocyte.
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Haematopoiesis, in particular erythropoiesis, was maximal on the 15th day 
of gestation. The hepatic parenchyma was congested with cells of different 
haematopoietic lineages, erythroid cells however were by far the dominant 
lineage.
The number of haematopoietic cell clusters had increased, however the 
number of clusters with a central hepatocyte (fig. 3.1-12), remained higher 
than those with a central macrophage (fig. 3.1-13). The blood cell precursors 
remained intimately associated with the cytoplasmic extensions of the 
central cells. Some early blood cell precursors were completely enveloped 
in the extensions of central cells (fig. 3.1-14). Finger-like cytoplasmic 
projections of the central cells were frequently associated with the adjacent 
blood cell precursors. Evidence of cell-cell contact in such a manner was 
abundant. Granules which may contain glycogen were dispersed 
throughout the cytoplasm of both central cells and blood cell precursors. 
Siderosomes, which are considered to be aggregates of ferritin (Bessis 1977), 
were present in the cytoplasm of erythroblasts (fig. 3.1-13) and small 
granules which may also contain ferritin were present in all other blood 
cell precursors and the central cells. These granules were present in 
rhopheocytic vesicles of cytoplasm which appeared to be passing between 
the central cells and the adjacent blood cell precursors (figs. 3.1-15 & 3.1-16). 
These rhopheocytic vesicles were numerous where the cell membrane of 
the central cells was closely apposed to that of the blood cell precursors (fig. 
3.1-17). It is plausible that the central cell may be furnishing the 
surrounding blood cell precursors with substances to promote their 
proliferation and differentiation.
Desmosomes connecting the cytoplasm of early blood cells and that of the 
central cells were numerous (fig. 3.1-18). Such attachments were also
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observed between the cytoplasmic processes of adjacent hepatocytes. Gap 
junctions through which substances could pass from one cell to another 
were observed between blood cell precursors and central cells. Some 
peripheral blood cell precursors were connected to each other via 
cytoplasmic processes.
The number of granulocytes, monocytes and megakaryocytes had steadily 
increased. Both granulocytes (fig. 3.1-19) and monocytes (fig.3.1-20) were 
associated with cell clusters and displayed cytoplasmic processes which 
were closely apposed to neighbouring cells and the processes of the central 
cell. Cell clusters consisting of myelomonocytic cells only were not 
observed. Cells of the erythroid (fig. 3.1-21), granuloid and monocytic 
lineages were observed undergoing mitosis at this stage. Megakaryocytes 
remained isolated from the clusters, however close membrane associations 
with hepatocytes were retained. A number of megakaryocytes, closely 
situated to sinusoids, displayed organelle-free pseudopdia of their 
cytoplasm (fig. 3.1-22).
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15 Day Fetal Liver
Fig. 3.1-12 x 7 500
Large number of developing erythroblasts (Eb) arranged around a central 
hepatocyte (H). Cytoplasmic associations between the central hepatocyte 
and the erythroblasts are numerous. Some erythroblasts are almost entirely 
encircled in the cytoplasmic processes of the hepatocyte.
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15 Day Fetal Liver
Fig. 3.1-13 x9 000
Erythroblasts of various stages in maturation clustered around a central 
macrophage (M). The central macrophage contains a considerable amount 
of ingested debris in its cytoplasm, including recently extruded nuclei. A 
siderosome can be seen in the cytoplasm of an erythroblast (arrow).
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15 Day Fetal Liver
Fig. 3.1-14 x 14 200
An erythroblast (Eb) completely surrounded by hepatocyte cytoplasmic 
processes (H). There is close apposition of the cell membranes in places. A 
small piece of cytoplasm appears to be passing between the two cells 
(arrow).
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15 Day Fetal Liver
Figs. 3.1-15 & 3.1-16 x 45 OOP
Movement of rhopheocytic vesicles between a hepatocyte (H) and an 
erythroblast (Eb). Fragments of hepatocyte cytoplasm (h) appear to attach to 
the cell membrane of the erythroblast and to the cytoplasmic extrusion of 
the erythroblast. The cytoplasmic vesicles may contain ferritin.
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15 Day Fetal Liver
Fig. 3.1-17 x 68 OOP
Cytoplasmic vesicles, which may contain ferritin, in an area of close 
association of cell membranes of a hepatocye (H) and a megakaryocyte (Mg). 
Fragments of cytoplasm appear to be breaking off from both cells and could 
be moving between the cells.
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15 Day Fetal Liver
Fig. 3.1-18 x 50 000
Desmosome-like attachment at the junction of the cytoplasmic processes of 
two hepatocytes (arrow). A dense plaque which may contain intercellular 
proteins can be observed at the junction of the two processes.
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15 Pay Fetal Liver
Fig. 3.1-19 x 14 200
Early granulocyte (G) in close association with a hepatocyte (H). There is 
very close apposition of the membranes of the two cells in many places and 
gap junctions are observed (arrows), vessicles of cytoplasm are also 
apparent. A centriole can be seen in the cytoplasm of the neutrophil
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15 Day Fetal Liver
Fig. 3.1-20 x 22 000
Monocyte (Mn) closely associated with a hepatocyte (H) and an adjacent 
erythroblast (Eb).Cytoplasmic processes of the monocyte extend towards the 
hepatocyte. Cytoplasmic vessicles of the hepatocyte are also observed in 
close association with the monocyte cell membrane.
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15 Day Fetal Liver
Fig. 3.1-21 x 24 267
Erythroblasts (Eb) undergoing cytokinesis in close proximity to a hepatocyte 
(H). Microtubules are evident in the midbody.
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15 Day Fetal Liver
Fig. 3.1-22 x 15 200
Megakaryocyte (Mg) which is positioned close to a sinusoid and intimately 
associated with a hepatocyte (H). The megakaryocyte displays pseudopodia 
which do not contain any organelles. This phenemenon appears to be 
common in hepatocytes which are situated close to sinusoids.
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The liver of the 18 day fetus was very different from that of the 15 day fetus. 
There was a reduced number of cell clusters and the number of cells within 
each cluster was also reduced. The number of blood cell precursors of the 
erythroblast lineage had decreased together with the number of 
megakaryocytes present. However undifferentiated stem cells were still 
observed to form distinctive cells clusters around macrophages (fig. 3.1-23) 
and hepatocytes (fig.3.1-25), while megakaryocytes remained associated with 
hepatocytes only.
In contrast to the reduction in the number of erythroblasts and
megakaryocytes, the number of granulocytes and monocytes had increased. 
Early monocytes were observed completely enveloped in the cytoplasmic 
processes of hepatocytes. Rhopheocytic vesicles (fig. 3.1-24), desmosomes 
and gap junctions between the cytoplasm of central cells and the 
surrounding precursors remained numerous. Cytoplasmic processes of 
blood cell precursors were observed closely associated with the processes of 
the central cells (fig. 3.1-25).
The number of hepatocytes was also markedly increased and those not 
associated with haematopoietic cells were arranged in compact groups (fig. 
3.1-26). Morphological differences were apparent in hepatocytes which had 
not been involved in haematopoiesis when compared to those hepatocytes 
which had. The hepatocytes which were closely associated with 
haematopoietic cells exhibited a distinct cytoplasmic arrangement to form 
close associations with haematopoietic cells, an increase in glycogen and 
ferritin deposits and a lamellar stacking arrangement of the endoplasmic 
reticulum. These charactersistics were not observed in hepatocytes which 
had not been associated with haematopoiesis, nor did they display
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cytoplasmic processes, however the cell membranes of adjacent hepatocytes 
were closely associated and connected via gap junctions.
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18 Day Fetal Liver
Fig. 3.1-23 x 11 400
Central macrophage (M) of an erythroblastic island. The macrophage 
contains a large amount of degradation products within its cytoplasm, 
including a few extruded nuclei. Intimate associations with the 
macrophage and the surrounding erythroblasts are observed.
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18 Day Fetal Liver
Fig. 3.1-24 x 85 OOP
Cytoplasmic vesicles derived from a hepatocyte process (H). The vesicles 
are observed closely associated with the cell membrane of an erythroblast 
(Eb) and may form an attachment to the erythroblast.
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18 Day Fetal Liver
Fig. 3.1-25 x 12 780
Monocytic cells (Mn) around a central hepatocyte (H). The monocytes 
extend numerous proceses and rhopheocytic vesicles are abundant between 
the cell membranes of the hepatocyte and the monocytes.
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18 Pay Fetal Liver
Fig. 3.1-26 x 31 240
Cluster of hepatocytes which have not been associated with haematopoietic 
cells. These hepatocytes did not display a stacking arrangement of their RER 
nor an increase in ferritin deposists. The cell mebranes of the adjacent 
hepatocytes are closely apposed but cytoplasmic processes and rhopheocytic 
vesicles are not observed.
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3.1.2 Neonatal Liver
The pattern of haematopoiesis in the newborn liver showed further 
changes from those observed in the 18 day fetus.
The number of granulocytes and monocytes had further increased, 
erythroid cells however remained the dominant lineage. Definitive 
lymphoid cells were apparent (fig. 3.1-27). These cells could be 
distinguished from both erythroid and granuloid cells, in that they were 
non-granular and had uniform ultrastructural features such as irregular 
nuclei and their pattern of nucleochromatin was different to that of 
erythroblasts.
Distinct cell clusters were still obvious, however they appeared to consist of 
more mature elements rather than very early precursors. Clusters consisted 
of mixed lineage cells, although the more central positions remained 
mostly occupied by erythroid cells (fig. 3.1-28). The number of clusters with 
a central hepatocyte far outnumbered those with a central macrophage, 
which appeared to have decreased in number. The configuration of most of 
the clusters had changed, the blood cell precursors were often surrounded 
by hepatocytes (fig. 3.1-27), rather than one central cell surrounded by blood 
cell precursors. Intimate associations with the central cells of the cluster 
and the blood cell precursors remained obvious (fig. 3.1-29), thus the 
potential for transfer of substances between the cells remained high. 
Cytoplasmic processes of blood cell precursors and rhopeocytic vesicles (fig. 
3.1-30) remained abundant and bridges connecting adjacent blood cell 
precursors had increased in number (figs. 3.1-28 & 3.1-31).
The number of hepatocytes had further increased and many were seen to be 
associated with adjacent hepatocytes through cytoplasmic projections (fig.
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3.1-32). The hepatocytes had a more regular outline, contained a number of 
lipid vacuoles and a considerably higher number of mitochondria, with 
well defined cristae, than those previously observed.
The most dramatic changes were observed in the neonatal liver on the 10th 
day after birth. The number of hepatocytes had further increased and they 
were organised into cords. This organisation restricted haematopoietic cells 
to anatomically isolated foci, close to the sinusoids, rather than the diffuse 
distribution of haematopoietic cells observed at other developmental 
stages. The mitochondria, with well defined cristae, and endoplasmic 
reticulum of the hepatocytes were prominent (fig. 3.1-33), suggesting a high 
degree of cellular activity and numerous lipid vacuoles were observed in 
the cytoplasm. Cell membranes of adjacent hepatocytes were very closely 
apposed to each other or linked via interdigitating cytoplasmic projections 
forming a dense network of cells.
The number of haematopoietic cell clusters was markedly reduced and 
their composition was restricted. Single-lineage clusters of erythroid, 
granuloid or lymphoid cells were observed. The number of cells in each 
cluster was lower than those observed in fetal liver, however intimate 
associations with hepatocytes remained abundant (fig. 3.1-34). Macrophages 
were present, however they were not associated with haematopoietic cells. 
Isolated monocytes were commonly observed closely associated with 
hepatocytes (fig. 3.1-35). Megakaryocytes were present in lower numbers 
than previous liver samples. They remained closely associated with 
hepatocytes and did not form single-lineage clusters.
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Newborn Liver
Fig. 3.1-27 x9 000
Cluster of lymphocytes (L) surounded by hepatocytes. This arrangement is 
more common, than haematopoietic cells forming clusters around a 
central cell, in the newborn liver. Intimate associations of the cytoplasmic 
processes of the hepatocytes with the lymphocytes are observed.
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Newborn Liver
Fig. 3.1-28 x9 000
Mixed-lineage cluster of erythroblasts (Eb) and monocytes (Mn) arranged 
around a central hepatocyte (H). The erythroblasts remain in central 
positions, closer to the hepatocyte, while the monocytes are situated on the 
periphery. Intimate associations of the hepatocyte cytoplasm with the blood 
cell precursors remain abundant.
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Newborn Liver
Fig. 3.1-29 x7100
Erythroblasts (Eb) at various stages in development surrounded on either 
side by two hepatocytes (H). Cytoplasmic processes of the hepatocytes pass 
between the erythroblasts and in places the cell membranes of the 
hepatocytes are closely apposed to those of the erythroblasts.
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Newborn Liver
Fig. 3.1-30 x 18 333
Cytoplasmic vessicles and processes between the cell membranes of a 
hepatocyte (H) and three erythroblasts (Eb). A hepatocytic process can be 
seen investing into the cytoplasm of an erythroblast. Siderosomes are 
present in the cytoplasm of an erythroblast (arrows).
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Newborn Liver
Fig. 3.1-31 x 18 200
Erythroblasts (Eb) and a monocyte (Mn) which are linked to each other by 
bridges. Such linking of adjacent blood cell precursors was never seen at 
earlier stages in development. In newborn liver however, it was a common 
occurence.
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Newborn Liver
Fig. 3.1-32 x 17 100
Erythroblasts (Eb) and a monocyte (Mn) clustering around a group of 
hepatocytes (H). The erythroblasts are associated with cytoplasmic processes 
of the hepatocyte. The number of mitochondria and lipid vacuoles within 
the hepatocytes has increased and adjacent hepatocytes are closely 
associated via cytoplasmic processes.
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10 Day Neonatal Liver
Fig. 3.1-33 x 18 200
Three hepatocytes of neonatal liver. The membranes of the hepatocytes are 
closely apposed to form a tight network of cells. The number of 
mitochondria has increased and the cristae are well defined. There is also 
an increase in the number of lipid vacuoles. These observations suggest a 
high degree of hepatocytic activity.
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10 Day Neonatal Liver
Fig. 3.1-34 x 11 400
Erythroblasts (Eb) completely surounded by the cytoplasm of a hepatocyte 
(H). Gap junctions are apparent between the erythroblasts and the 
hepatocyte cytoplasm (arrows) and cytoplasmic vesicles, in close proximity 
to the erythroblasts are evident.
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10 Day Neonatal Liver
w *
Fig. 3.1-35 x 15 620
Isolated monocyte (Mn) observed surounded by the cytoplasm of 
hepatocytes (H) and an endothelial cell (En). The cell membrane of the 
hepatocyte is very closely apposed to that of the monocyte.
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3,2 Confocal Laser Scanning Microscopy of Fetal and Neonatal Liver
Fetal and neonatal liver tissue were stained with Perl's Prussian Blue 
which is specific for iron. The iron within the cells can be easily recognised 
by its diffuse blue colour when examined by light microscopy. Examination 
with the confocal laser scanning microscope, permits the addition of colour 
to the field of view. The ferritin containing cells are easily recognised as the 
brightest and most intensely stained cells, regardless of the colour applied 
to the field of view.
3.2.1 Day 15 Fetal Liver
Cell clusters were abundant at this stage in development, randomly 
dispersed throughout the sections examined (fig. 3.2-1). The blood cell 
precursors were observed arranged around central macrophages (fig. 3.2-2) 
and hepatocytes (fig. 3.2-3). Gradients of differentiation, as previously 
described, were apparent in the clusters. The least mature cells, which were 
the most intensely stained, were situated close to the central cell (fig. 3.2-2). 
The more mature blood cell precursors were situated in peripheral 
positions and did not display the intense colour to the same degree as the 
immature precursors.
Cytoplasmic processes of the central cells were observed in close association 
with the adjacent blood cell precursors, ferritin particles were observed 
within the cytoplasmic processes. Some immature cells were observed 
completely enveloped in the cytoplasmic processes of the central cells (fig. 
3.2-4). A high degree of ferritin was present in both the enveloped cell and 
within the cytoplasmic processes.
Megakaryocytes were observed, (figs. 3.2-3 & 3.2-5), dispersed throughout 
the parenchyma, usually closely associated with adjacent hepatocytes. The
99
megakaryocytes also displayed positive staining for ferritin, though not to 
the same extent as the immature erythroblasts.
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15 Day Fetal Liver
Fig. 3.2-1 Scale bar IQix
Random distribution of haematopoietic cells throughout the hepatic 
parenchyma in the 15 day fetus. The bright, red cells are the immature 
precursors which contain a considerable amount of ferritin.
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15 Day Fetal Liver
Fig. 3.2-2 Scale bar 10u
Blood cell precursors of various maturation states clustered around a 
central macrophage (M). The most immature, brightly stained cells are 
centrally located while, the more mature, less intensely stained cells are 
peripherally situated.
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15 Day Fetal Liver
Fig. 3.2-3 Scale bar 10u
Blood cell precursors arranged around a central hepatocyte (H). Ferritin 
particles can be seen dispersed throughout the cytoplasm of the hepatocyte 
and in particular, in the cytoplasmic proceses which are associated with 
early precursors.
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15 Day Fetal Liver
Fig. 3.2-4 Scale bar lOu
Immature blood cell precursor (bcp) enveloped in the cytoplasmic 
extensions of a hepatocyte (H). The precursor cell displays intense staining 
for ferritin, as do the cytoplasmic processes which surround it.
104
15 Day Fetal Liver
Fig. 3.2-5 Scale bar lOu,
Megakaryocytes (Mg), which were observed randomly situated in the 
parenchyma, usually closely associated with hepatocytes. Megakaryocytes 
were observed to contain a considerable amount of ferritin in their 
cytoplasm.
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3,2.2 Day 8 Neonatal Liver
The 8 day old neonate, like the 10 day neonate, showed a very different 
pattern of haematopoiesis in comparison to the fetal liver.
Haematopoiesis was minimal (fig. 3.2-6) and restricted to isolated foci. 
Hepatocytes were the predominant cell lineage and at this stage displayed 
very little reaction to the ferritin stain. Ferritin granules were usually only 
observed within their nuclei.
The haematopoietic cells were easily identified as they retained a high 
ferritin content in comparison to the hepatocytes. They were observed in 
isolated clusters surrounded by hepatocytes (figs. 3.2-7 & 3.2-8).
A few megakaryocytes were observed (fig. 3.2-9). Ferritin was also observed 
within their lobar nuclei but also, to a lesser extent, dispersed throughout 
the cytoplasm.
Reticulocytes were observed in the sinusoids (fig. 3.2-10). The majority of 
these cells contained a little peripheral ferritin, however some cells 
retained a very intense degree of stain, like that observed in the immature 
blood cell precursors.
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8 Day Neonatal Liver
Fig. 3.2-6 Scale bar lOu.
Hepatic parenchyma of the 8 day neonate. At this stage the parenchyma 
consists mainly of hepatocytes, only a few brightly stained precursor cells 
are observed.
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8 Day Neonatal Liver
Fig. 3.2-7 Scale bar lOu
Clusters of blood cell precursors surrounded by hepatocytes. The 
haematopoietic cells retain a high ferritin content in comparison with the 
hepatocytes. The hepatocytes display a few ferritn particles both within 
their nuclei and cytoplasmic processes associated with the haematopoietic 
cells.
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8 Day Neonatal Liver
Fig. 3.2-8 Scale bar lOu,
Isolated foci of erythroblasts surrounded by hepatocytes. The hepatocytes 
contain a very small amount of ferritin compared to the erythroblasts.
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8 Day Neonatal Liver
Fig. 3.2-9 Scale bar lOu
Clusters of haematopoietic cells and a megakaryocyte (Mg), surrounded by 
hepatocytes. Like the other haematopoietic cells, the megakaryocyte retains 
a high concentration of ferritin both in its nucleus and in its cytoplasm.
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8 Day Neonatal Liver
Fig. 3.2-10 Scale bar lOu
Large number of reticulocytes in a sinusoid. Most of the reticulocytes only 
retain a small amount of peripheral ferritin, however some cells appear to 
retain more than others.
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3.3 Haematopoietic Activity of Fetal Liver and Adult Bone Marrow in
Vitro
Long term Dexter cultures of adult bone marrow (BM) and fetal liver (FL) 
were established as described previously. Once a confluent stromal layer 
had been established, some flasks were re-seeded with either BM or FL cells 
and monitored over a period of time. Cytospin preparations of the culture 
supernatants were performed regularly.
3.3.1 Long Term Bone Marrow Cultures (LTBMC)
A confluent stromal layer was established in cultures 3 weeks after the 
infusion of normal bone marrow cells (fig. 3.3-1). The stromal layer 
consisted mainly of macrophages and fibroblasts, which were distributed 
throughout the entire culture, and adipocytes also formed a substantial 
component of the supportive stromal layer. "Blanket cells" with long 
cytoplasmic processes were also observed throughout the layer. Confocal 
microscopy of the intact layers revealed structures similar to gap junctions 
between cytoplasmic processes of adjacent blanket cells. The blanket cells 
are considered to be derived from fibrobasts, however an endothelial origin 
has also been suggested (Hasthorpe et al 1992).
Following infusion of BM or FL cells, the cultures became
haematopoietically active (figs. 3.3-2 & 3.3-3). LTBMC are predominantly 
myeloid and foci of haematopoiesis were observed on top of and within the 
stroma, resulting in the "cobblestone appearance" of the stroma. The 
haematopoietic foci were usually associated with one or more
macrophages. Erythrobasts and erythrocytes were present, up to the end of 
the first week in culture (fig. 3.3-1).
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Loosely adherent groups of maturing metamyelocytes were observed on 
top of the adherent stromal layer (fig. 3.3-4). These cells eventually detach 
from the layer and are released into the supernatant. Metamyelocytes were 
easily identified in cytospin preparations of supernatants by their 
distinctive nuclei (fig. 3.3-2).
Proliferation of cells was observed to occur over periods of several months. 
The majority of cells present in the supernatants were granulocytes at all 
stages of maturation (figs. 3.3-2 & 3.3-3). Megakaryocytes and mast cells were 
also present in the cytospin preparations.
Bone marrow layers which had been re-seeded with fetal liver cells (figs. 
3.3-3 & 3.3-4), demonstrated active granulopoiesis which was not 
morphologically distinct from that observed in bone marrow layers re­
seeded with BM cells (fig. 3.3-2). With extensive periods of time in culture, 
5-6 months, the granulocytes progressively disappeared and macrophages 
predominated.
LTBMC which had not been re-seeded with haematopoietic cells were also 
observed to be haematopoietically active. However granulopoiesis persisted 
for a shorter period of time, around 16 weeks, before the phagocytic cells 
took over, than cultures which had been re-seeded with haematopoietic 
cells.
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Bone Marrow Culture
Eb >
Fig. 3.3-1 xl 750
Range of haematopoietic cells in normal bone marrow - erythroblasts (Eb), 
erythrocytes (E), early and late granulocytes (G) and lymphocytes (L).
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Bone Marrow Culture
Fig. 3.3-2 x 484
Cytospin of BM stromal layer re-infused with bone marrow cells. Clusters 
of granulocytes at all stages in maturation are observed, together with a cell 
in metaphase (arrow).
115
Bone Marrow Culture
Fig. 3.3-3 x 1 750
Cytospin preparation of BM stromal layer infused with FL haematopoietic 
cells. A cluster of granulocytes of various maturation states is observed, 
from myeloblasts (mb), promyelocytes (pm), myelocytes (m), 
metamyelocytes (mt) band cells (be) to the end stage cells with segmented 
nuclei (s).
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Bone Marrow Culture
Fig. 3.3-4 x625
Cluster of fetal liver derived granulopoietic cells at various stages in 
maturation growing upon a bone marrow stromal layer. Metamyelocytes 
are observed growing on top of stromal cells.
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3.3.2 Long Term Fetal Liver Cultures (LTFLC)
Cultures of fetal liver cells formed confluent stromal layers in a manner 
similar to that observed in the bone marrow cultures. This however took a 
longer period of time, usually 4-6 weeks, before a confluent layer was 
established.
The stromal layers, like those of BM origin, consisted predominantly of 
macrophages and fibroblasts. Fat cells were only rarely observed in FL 
cultures (Fig. 3.3-5). Cells which closely resemble hepatocytes were observed 
in the stroma of the FL cultures. These cells were more numerous in the 
cultures of day 17 (fig. 3.3-6) and day 19 FL cells (fig. 3.3-7) than in the 
cultures of fetal liver on the 15th day of gestation. The hepatocytes were 
evident in culture of Day 17 and Day 19 FL four days after their initiation 
and were observed to increase in number with time in culture. Channels 
appeared between groups of the hepatocytes which resembled the bile 
cannaliculi of mature liver (figs. 3.3-6 & 3.3-8).
Fetal liver haematopoiesis in vivo is predominantly erythropoietic (fig. 3.3­
9), however like the BM cultures, erythroblasts and erythrocytes were not 
evident in cytospin preparations of the supernatant after the 9th day in 
culture. At this time the fetal liver cultures became predominantly 
granulopoietic (Fig. 3.3-10), metamyelocytes were observed in the 
supernatants together with megakaryocytes and monocytes.
Autoradiographs were performed on the adherent layers of Day 17 and Day 
19 FL cultures (Fig. 3.3-11). A large number of cells were very heavily 
labelled and therefore close to cell division, providing evidence that the 
cultures were haematopoietically active. Granulocytes and megakaryocytes 
persisted for up to 10 weeks in FL cultures which had not been re-seeded 
with haematopoietic cells (Fig. 3.3-12), then decreased with time and
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macrophages predominated thereafter. In the corresponding BM cultures 
large numbers of granulocytes and megakaryocytes persisted for up to 16 
weeks of culture, after this time their numbers progressively decreased.
Established fetal liver stroma supported haematopoietic cells derived from 
both FL (fig. 3.3-13) and BM (fig. 3.3-14). Haematopoiesis in these cultures 
was evident for longer periods of time, up to 5 months, compared to the 
cultures which had not been re-seeded with haematopoietic cells. However 
stroma derived from fetal liver on the 15th day of gestation appeared to 
support haematopoiesis more effectively than stroma from day 17 or day 19 
FL. Granulocytes and megakaryocytes were evident in cultures with a day 
15 FL derived stroma (fig. 3.3-14) one month after it had ceased in the day 17 
and day 19 cultures.
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Fetal Liver Culture
Fig. 3.3-5 Scale bar lOOu
Intact fetal liver stromal layer observed with a confocal laser scanning 
microscope, demonstrating the presence of fat cells (arrows) in fetal liver 
stroma.
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Fetal Liver Culture
L
ifL I
Fig. 3.3-6 x960
17 day fetal liver cell culture at 10 weeks. A band of hepatocytes is observed 
to form an integral component of the stromal layer. Distinct channels are 
observed between adjacent hepatocytes.
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Fetal Liver Culture
Fig. 3.3-7 x 1 580
Day 19 fetal liver stromal layer after 6 weeks in culture. The stromal layer 
consists of large numbers of hepatocytes, on top of which refractile cells are 
observed.
122
Fetal Liver Culture
Fig. 3.3-8 Scale bar lOOu
Confocal micrograph of day 19 fetal liver stromal layer, demonstrating the 
large expanse of hepatocytes and the distinct channels between adjacent cells.
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Fetal Liver Culture
Fig. 3.3-9 xl 750
Full range of erythroid cells in normal fetal liver, from early proerythroblasts 
(pEB) to red blood cells. A mitotic cell is observed (arrow).
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Fetal Liver Culture
Fig. 3.3-10 x 781
Haematopoietically active day 19 fetal liver layer, after 6 weeks in culture, 
demonstrating, early granulocytes (g), metamyelocytes (mt) and stromal cells.
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Fetal Liver Culture
Fig. 3.3-11 x688
Autoradiograph of the adherent layer of a day 17 fetal liver culture. Labelled 
hepatocytes are observed, some more heavily than others, indicating the cells 
are actively synthesising DNA.
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Fetal Liver Culture
Fig. 3.3-12 x 2 083
19 day fetal liver stromal layer after 10 weeks in culture. Metamyelocytes 
(mt), band cells (be) and increasing numbers of macrophages (M) are 
observed.
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Fetal Liver Culture
Fig. 3.3-13 x890
Fetal liver stromal layer re-infused with fetal liver cells. Granulopoiesis is 
active in the culture, indicated by the presence of early and later 
metamyelocytes.
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Fetal Liver Culture
Fig. 3.3-14 x 146
Fetal liver stromal layer re-infused with bone marrow cells after 20 weeks in 
culture. Clusters of granulocytes are observed closely associated with the 
fibroblasts of the stromal layer.
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3.4 Discussion
3.4.1 Haematopoietic Activity of Fetal and Neonatal Liver in Vivo
This present study confirms the preponderance of erythropoiesis and 
paucity of myelopoiesis, megakaryocytopoiesis and lymphopoiesis 
throughout the development of the fetal and neonatal liver reported by 
Thomas et al (1960). It also demonstrates the reciprocal relationships 
between immature blood cell precursors of erythroid, granuloid and 
lymphoid lineages with macrophages and hepatocytes, in similar 
formations to Bessis' "Erythroblastic Island" (Bessis & Breton-Gorius 1962).
It has been postulated that on the 10th day of gestation the fetal liver 
assumes active haematopoietic activity, taking over from the yolk sac 
(Rifkind, Chui & Epler 1969). The earliest developmental stage examined in 
the present investigation was the fetal liver on the 12th day of gestation. At 
this stage the hepatic tissue consisted of a loose mass of cells, hepatocytes 
had a regular outline and were not compressed or distorted by large 
numbers of haematopoietic cells. Haematopoietic cells were present, 
though not in high numbers, this finding is not surprising as 
haematopoiesis has just been initiated in the liver at this stage (Hata et al 
1993). The haematopoietic cells were observed to be randomly distributed 
throughout the hepatic parenchyma in accordance with previous reports 
(Medlock & Haar 1983; Grossi, Velardi & Cooper 1985). The haematopoietic 
cells were predominantly erythroid, however a few isolated monocytes 
were observed. This was unusual as haematopoiesis did not appear to be 
fully underway at this stage in gestation. It may be possible that these 
monocytes are the precursors of the central macrophages observed in
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haematopoietic islands in the liver on the fourteenth day of gestation 
(Crocker et al 1991).
Hepatic cords had developed by the 13th day of gestation and the hepatic 
parenchyma was much more cohesive than that observed on the 12th day 
of gestation. An overall increase in cell number was observed, which 
would contribute to the compact the structure of the parenchyma, only a 
few fenestrations remained. Haematopoiesis now appeared to be fully 
underway, the number of haematopoietic cells had increased and they 
formed distinct clusters around a central hepatocyte, throughout the 
parenchyma. The cell clusters were similar to the erythroblastic island 
described by Bessis. The erythroid cells were relatively immature and very 
little maturation had taken place. Haematopoiesis was entirely 
extravascular.
In the liver of the 14 day fetus the parenchyma had further developed and 
haematopoietic activity was high. Blood cell precursors formed clusters 
around central macrophages in addition to those with a central hepatocyte. 
Cytoplasmic processes from the central cells were intimately associated 
with the adjacent blood cell precursors. The presence of desmosome-like 
attachments and gap junctions between the cells strongly suggests that the 
central cell may be acting as a "nurse cell" which furnishes homeostatic 
substances to the erythroblasts (Bessis 1973; Emura 1984; Shaklai 1991). This 
was further substantiated by the presence of rhopheocytic vesicles between 
the central cells and the blood cell precursors. The observed gradients of 
differentiation within the cluster have been reported previously (Jones 
1970). The peripheral positions of the more mature elements suggests they 
are less dependent on the central cell. At this stage the cell clusters no 
longer consisted entirely of erythroid cells, granulocytes and monocytes 
were observed on the periphery of the clusters. These mixed-lineage
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clusters remained throughout development and their constituent elements 
were further expanded when lymphoid cells appeared in the newborn 
liver.
The haematopoietic activity was observed to peak on the 15th day of 
gestation. The hepatic parenchyma was densely packed with cells of various 
haematopoietic lineages, which were observed to be undergoing mitosis 
and hence further distorting the hepatocytes. The number of clusters was 
greater than in the 14 day fetal liver and the number of cells within each 
cluster had increased, granuloid and monocytic cells were more evident. 
Central macrophages contained expelled red cell nuclei and other cell 
debris. Granules which may contain ferritin were present in the cytoplasm 
of the central cells and the blood cell precursors in addition to the 
siderosomes (Bessis 1977) present in the cytoplasm of erythroblasts. These 
granules were also present in the cytoplasmic processes of the central cells 
and haematopoietic cells. It is possible that ferritin was being transferred 
from the central cell to the developing cells in the abundant rhopheocytic 
vessicles.
Haematopoiesis was declining in the 18 day fetus, this gradual decline and 
change from a haematopoietic site to a metabolically active organ was 
progressively observed in all other developmental stages examined. The 
number of cell clusters was reduced and there was a reduction in the 
number of erythroblasts, in particular. This was mirrored by a reduction in 
the number of megakaryocytes. In contrast the number of granulocytes and 
monocytes increased indicating a wave of myelopoiesis which occurs later 
than that of erythropoiesis. The hepatocyte population increased with 
development and cytological differences were apparent between 
hepatocytes which had been involved in haematopoiesis and those which 
had not (Emura et al 1984). Adjacent hepatocytes were closely associated via
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interdigitating projections of cytoplasm or close apposition of the cell 
membranes.
In the newborn liver early precursors of erythropoiesis were few in 
number. Cell clusters remained obvious, however the number of 
constituent cells of each cluster had decreased. Monocytes, granulocytes and 
now lymphoid cells most commonly occupied peripheral positions within 
the clusters. Intimate associations of the central cells with the surrounding 
haematopoietic cells remained numerous.
Further changes were observed in the hepatic environment in later stages 
of the neonatal period. In both confocal microscopic examination of 8 day 
neonatal liver and electron microscopic examination of 10 day neonatal 
liver, the vastly diminished population of haematopoietic cells was 
restricted to anatomically isolated foci, in contrast to the fetal liver 
environment where haematopoietic cells were randomly dispersed 
throughout the hepatic parenchyma. This focal arrangement is probably 
due to the increased number of hepatocytes and their structural 
organisation into cords (Grossi et al 1985). The number of cell clusters was 
further reduced and they no longer consisted of cells of mixed lineages. 
Macrophages were no longer a component of cell clusters. The blood cell 
precursors of the 8 day neonatal liver displayed intense staining for ferritin 
in comparison to the extensive hepatic stroma which showed a minimal 
response to the stain. Hepatic production of haematopoietic cells has 
almost entirely ceased by the end of the second post-natal week, during this 
time the bone marrow becomes the main site of haematopoiesis and thus 
remains in the adult (Grossi et al 1985).
The erythropoietic cell lineage was the first haematopoietic cell lineage 
observed in murine fetal liver and remained the largest haematopoietic
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cell population throughout all developmental stages examined. The cells 
were observed in circumscribed clusters randomly dispersed throughout 
the hepatic parenchyma as previously described (Jones 1970; Fukuda et al 
1974; Keleman et al 1979; Emura et al 1984; Migliaccio et al 1986). The 
classical features of erythropoiesis were apparent from the 14th day of 
gestation, these included; decrease in cell size, disappearance of the 
nucleoli, increased nuclear density and peripheralisation of the nucleus. 
The nucleus is finally expelled and removed by macrophages. The 
enucleate cells were frequently observed alongside the sinusoidal wall, 
when they have extruded their nuclei the cells traverse the sinusoidal wall 
by diapedesis and then ultimately pass into the circulatory system.
Myelomonocytic cells were present in the fetal liver from the fourteenth 
day of gestation and progressively increased with development to reach a 
peak in the newborn liver. This peak occurs at a later stage than that of 
erythropoiesis. Thus there may be two waves of haematopoiesis in the fetal 
liver, the first is that of erythropoiesis and the second occurring later in 
development is that of granulopoiesis which is shorter and less 
pronounced than that of erythropoiesis. Granulocytes and monocytes were 
observed extravascularly in close association with hepatocytes and 
erythroid cells (Jones 1970; Fukuda et al 1974; Timens 1990). They were 
commonly found impinging on the periphery of erythroid clusters. As the 
number of erythroid cells decreased, the myelomonocytic cells occupied 
more central locations within the clusters. The milieu of the fetal liver is 
primarily inductive of erythropoiesis, however unlike the yolk sac, it does 
permit differentiation of other cell lineages.
Megakaryocytes were observed in fetal liver from the 14th day of gestation 
and persisted throughout development. Concomitant with erythropoiesis, 
the number of megakaryocytes was high in fetal liver and was observed to
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decline in neonatal liver. These cells were usually observed as single cells 
in close apposition to hepatocytes. At most two megakaryocytes were 
observed closely associated with each other and with the surrounding 
hepatocytes. Megakaryocytes were never observed associated with cell 
clusters (Jones 1970). Megakaryocytes displayed positive reactions for 
ferritin staining in both the 15 day fetal liver and the 8 day neonate, their 
close associations with hepatocytes may permit the transfer of ferritin 
between the cells.
At birth megakaryocytes were observed to be fully differentiated, when the 
tubules were arranged in long chains throughout the cytoplasm. The 
presence of demarcation membranes in the cells suggests they are actively 
producing thrombocytes (Thomas 1974). In the 15 day fetal liver, some 
megakaryocytes displayed organelle-free membrane pseudopodia. This was 
also reported by Jones (1970) and Fukuda (1974) who suggested that this type 
of budding occurs prior to the megakaryocyte passing into the sinusoids.
Lymphoid cells were the last lineage to appear. In the newborn liver they 
were randomly distributed within the parenchyma, in fewer numbers than 
all other haematopoietic cells. Lymphoid cells were observed in cell clusters 
of mixed lineages with a central macrophage or a hepatocyte. In the 10 day 
neonate their distribution was restricted like that of the other lineages.
They were observed as lymphoid foci closely associated with hepatocytes. 
These lymphocytes are most probably B-cells (Jones 1970; Timens 1990).
Hepatocytes which were involved in the haematopoietic activity of the 
liver underwent a marked differentiation in comparison to hepatocytes 
which were not involved. In the 12 day fetal liver, hepatocytes formed a 
loose mass of tissue and exhibited a typical pyramidal shape. Their size was 
variable and the number of mitochondria and lipid vacuoles was small.
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When haematopoietic activity was high, 14th & 15th days of gestation, the 
hepatocytes formed a cohesive stroma. Prominent nucleoli were observed 
and chromatin was finely dispersed. The hepatocytes exhibited a distinct 
polarity of cytoplasm to form close associations with haematopoietic cells 
and their rough endoplasmic reticula were arranged in parallel stacks. 
There was an increase in the number of mitochondria, glycogen and 
ferritin particles. This difference appears to be dependent on their intimate 
relations with erythroblasts (Emura et al 1984). The hepatocytes exhibited 
various shapes due to compression by the large numbers of haematopoietic 
cells. These observations suggest that the hepatocytes serve as a stromal cell 
in the haematopoietic environment of the fetal liver.
In neonatal liver, while the number of hepatocytes had increased in both 
size and number, the number of haematopoietic cells had decreased. The 
hepatocytes acquired a more regular outline and contained a few lipid 
vacuoles. The number of mitochondria had increased and well defined 
cristae were observed indicating a high degree of activity. Many hepatocytes 
were closely associated with each other through cytoplasmic processes or 
through close apposition of cell membranes. This close association may 
reflect a change in functional status from a stromal element in a 
haematopoietic environment to that of a parenchymal component of a 
metabolically active liver (Medlock & Haar 1983).
3.4.2 Haematopoietic Activity of Fetal Liver and Adult Bone Marrow in
Vitro
Proliferation and differentiation of murine haematopoietic cells can occur 
for several months in culture in the presence of adherent stromal layers. 
The production and maintenance of particular cell lineages depends on the 
composition of the cultures. Primitive haematopoietic progenitor cells can
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be maintained in the absence of exogenously added growth factors. Under 
these conditions the stromal cells are responsible for both the maintenance 
and subsequent proliferation of the haematopoietic cells (Sutherland et al 
1991).
Stromal cell production of a number of growth factors, including IL-6, G- 
CSF, GM-CSF and IL-1 (Quesenberry et al 1992), can be enhanced by the 
addition of fresh culture medium. Stromal cells have been genetically 
engineered to produce high levels of a specific growth factor which can 
enhance the maintenance and differentiation of the cells, responsive to the 
growth factor, without reducing their proliferative potential (Coutinho et 
al 1990; Sutherland et al 1991).
Stromal cells can also play a role in returning primitive haematopoietic 
cells to a quiescent state. TGF-p and MlP-la are produced in the adherent 
layer of LTBMCs, these inhibitors are specific for primitive haematopoietic 
progenitors (Eaves et al 1992). Thus stromal cells can control
haematopoiesis by enhancing and inhibiting its different stages. Gordon et 
al (1983) showed that fibroblasts, fat cells and macrophages were essential 
stromal elements for maintenance of haematopoiesis in LTBMC. They 
suggested that fat cells and fibroblasts could trap progenitors and sustain the 
proliferation of primitive cells added to the cultures. Cilia have been 
reported on blanket cells, in long term cultures, which may be able to trap 
and transport progenitors into the haematopoietic compartment (Tavassoli 
1989).
Endothelial cells have been proposed as an important constituent of the 
murine stromal layer (Zuckerman & Wicha 1983). Adjacent endothelial 
cells show intercellular contacts in the form of desmosomes. These cells 
have also been reported in human LTBMC (Keating et al 1982). Recently,
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Hasthorpe et al (1992) demonstrated the presence of endothelial cells in 
LTBMC using cell specific markers. The endothelial cells were observed to 
cover the differentiating cells with a thin layer of cytoplasm. From these 
observations, Hasthorpe et al suggested that "blanket cells" are in fact 
endothelial cells. Other groups remain unconvinced and believe the 
blanket cells are derived from fibroblasts (Allen & Dexter 1984; Tavassoli 
1989). Blanket cells cover the adherent layer, separating it from the 
supernatant, thus compartmentalising the culture system. This is 
analogous to bone marrow haematopoiesis in vivo which is
compartmentalised both intra and extravascularly by the marrow sinus 
endothelium (Tavassoli 1989).
Endothelial cells can secrete GM-CSF and G-CSF, together with the fact that 
numerous gap junctions between endothelial cells and macrophages have 
been reported, it is possible that endothelial cells may play an important 
role in the regulation of both granulocyte and macrophage proliferation 
and differentiation in long term cultures. In this investigation it was not 
possible to identify endothelial cells using an inverted microscope. It is 
assumed however that these cells form an important part of the stromal 
layer.
The stromal cells formed a confluent layer on the floor of the flasks by the 
end of the 3rd week in bone marrow cultures, this took a little longer in FL 
cultures, usually 4-6 weeks. The stromal layers of both LTBM and LTFL 
cultures were essentially of similar composition. One difference being the 
very rare occurence of fat cells in the FL cultures compared to the numbers 
of these cells in the BM cultures, stroma of both origins contained 
macrophages and fibroblasts. Furthermore an additional stromal element 
was observed in FL cultures. These cells which are believed to be 
hepatocytes were not observed in BM cultures. The hepatocytes were fewer
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in number in cultures of 15 day FL compared to those in the 17 day and 19 
day FL, however this is consistent with the increase in hepatocyte numbers 
observed as development advanced in vivo. The numbers of hepatocytes 
were observed to increase with the length of time in culture. The 
hepatocytes had polygonal shapes and were observed to grow in a mosaic­
like arrangement. Intercellular cannalicular structures were observed, 
which had a similar appearance to bile cannaliculi. Refractile cells were 
often observed on the surface of the hepatocytes or closely associated with 
them. These observations suggest that the hepatocytes are supporting the 
dividing cells and may strengthen the in vivo evidence for the supportive 
role of hepatocytes in haematopoiesis. Cells of a similar nature have been 
recently reported (Hata et al 1993). They suggested that the cells are 
epithelial, derived from a hepatic origin. Hata et al observed tight junctions 
and desmosomes between the cells and demonstrated that these cells could 
produce GM-CSF and M-CSF. Thus the hepatocytes may be the fetal liver 
equivalent of the endothelial cells in LTBMC.
Fetal liver cultures were observed to be less cellular than those of the bone 
marrow, and granulocyte production was observed to fall off earlier in the 
FL cultures. This earlier decline in colony numbers in FL cultures 
compared to those of BM origin has bee previously reported (Hassan et al 
1979). The temporary nature of haematopoiesis in the fetal liver in vivo 
could be an explanation for this phenomenon.
The stromal layer of LTBMC maintained beyond the stage when 
haematopoietic cell production has ceased, (16-20) weeks, remains intact 
and is capable of supporting renewed haematopoiesis when re-infused with 
a source of blood cells (Cappellini et al 1984). When BM or FL cells were re­
infused onto a BM layer, which was no longer haematopoietically active, 
there was a rapid infiltration of the layer by the haematopoietic cells and
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foci of haematopoiesis were observed, after one week. Haematopoietic cells 
were produced in the layer and released in to the supernatant for up to 6 
months, after which time haematopoiesis was observed to decline. Similar 
observations were made when BM or FL cells were re-infused onto "burnt- 
out" FL stromal layers. Refractile cells were observed on the surface of the 
hepatocyte-like cells, suggesting these cells can support haematopoiesis, 
even from cells of an alternative origin. Haematopoietic activity lasted for 
around 5 months in these cultures before phagocytic cells became 
predominant in the supernatant.
Erythroblasts and erythrocytes were observed in both FL and BM cultures 
up to the end of the first week in culture. After this time erythroblasts were 
never observed again and granulopoiesis became dominant in the BM 
cultures and in the FL cultures of all three developmental stages. 
Granulocytes were observed in all stages of maturation after 3 weeks in 
culture. They were observed to form cobblestone foci of haematopoiesis 
within the cultures closely associated with macrophages and fat cells, these 
observations have also been reported (Allen & Dexter 1976). The 
granulocytes proliferate in these foci and extensive interactions have been 
reported between granulocytes and macrophages (Allen 1992). Thus it is not 
unreasonable to suggest that stimulatory factors may be passed from the 
macrophage to the granulocyte. Once the granulocytes mature they move 
out of the adherent layer and undergo no further proliferation only 
differentiation. Some mature granulocytes are observed to form islands 
with isolated macrophages not associated with stromal cells (Allen 1992).
As the cells mature they are released in to the supernatant, thus mature 
cells form the major component of cytospin preparations.
There have been many reports of the disappearance of erythroid cells after 1 
week in culture. This is especially surprising in FL cultures, as
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erythropoiesis is the predominant form of in situ FL haematopoiesis. The 
disappearance of erythroid cells is thought to be due to a lack of suitable 
culture conditions. Dexter et al (1977) demonstrated that the standard 
culture conditions, used in this investigation, clearly favour granulopoiesis 
however, they could not detect humoral inhibitors of erythropoiesis in the 
culture medium.
Gordon, Kearney & Hibbin (1983) demonstrated that marrow derived 
stromal fibroblasts inhibited burst formation by peripheral blood BFU-E.
The BFU-E survive in long term culture but cannot proliferate or 
differentiate unless they are specifically stimulated by the addition of 
anaemic mouse serum and/or Epo (Allen & Testa 1991). However 
Cappellini et al (1984) could not significantly stimulate erythropoiesis by 
addition of anaemic mouse serum and Epo. This could be explained by the 
fact that they were unable to recover BFU-E from FL cultures, one week 
after initiation. Other investigators have reported the formation of 
erythroid colonies from fetal liver cells, following addition of Epo (Johnson 
& Barker 1985), and in the absence of added Epo (Rich & Kubanek 1980; 
Zucali et al 1980). They were also able to demonstrate the presence of both 
CFU-E and BFU-E. Zucali et al (1980) reported that trypsin digestion of FL 
cultures produced an erythroid stimulating activity which increased with 
the length of time in culture. They concluded that this stimulatory activity 
was produced by the cultured fetal hepatic cells.
Megakaryocytes were also observed closely associated with macrophages in 
the stromal layer. The numbers of these cells were small in comparison to 
the number of granulocytes. More mature megakaryocytes migrated from 
the adherent macrophages and were released into the supernatant, where 
they were detected in cytospin preparations.
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Concomitant with cell production there is proliferation of pluripotent stem 
cells. CFU-S can be maintained in the cultures for several months and 
function as normal. They can produce erythroid, granuloid, megakaryocytic 
and spleen colonies and can protect mice from potentially lethal irradiation 
(Dexter et al 1977). Erythroid precursors are also known to exist however, 
these are blocked at the BFU-E stage, their more mature progeny, CFU-E, 
have not been detected (Dexter 1982). CFU-C produced in the cultures 
undergo maturation into granulocytes and macrophages, this occurs in the 
absence of detectable colony stimulating activity. Tavassoli & Takahashi 
(1982) reported that CFU-C numbers were related to the accumulation of fat 
cells and suggested that the fat cells served as an energy source for stem cell 
proliferation. Direct cellular interactions between the stromal cells and 
precursor cells may be a mechanism of regulation of haematopoiesis in 
culture.
3.5 Cellular Interactions
3.5.1 Erythroblastic Islands in Vivo
A central macrophage surrounded by maturing red blood cells, to form a 
distinct anatomical unit is commonly referred to as an erythroblastic island. 
These islands have been extensively reported in human and murine bone 
marrow (Bessis 1958, 1973), in the yolk sac of guinea-pigs (Sorenson 1961) 
and embryonic liver (Rifkind et al 1969).
Erythroblastic islands were initially observed in the 13 day fetal liver, 
randomly dispersed throughout the hepatic parenchyma. At this stage in 
development the erythroblasts were arranged around a central hepatocyte, 
not a macrophage. Both hepatocytes and macrophages can function as a
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central reticular cell of a blood island (Emura et al 1985). This arrangement 
is thought to be essential for differentiation of both the erythroid cells and 
the hepatocytes. Blood cell precursors arranged around a central 
macrophage were not evident until the 14th day of gestation, however 
throughout development the number of clusters with a central hepatocyte 
far outnumbered those with a central macrophage. The outstanding 
morphological characteristic of a central macrophage was the presence of 
large numbers of inclusions of breakdown products of ingested red cells, 
extruded nuclei of red cells, lysosomes and phagosomes. The central cells 
have long cytoplasmic processes which extend in all directions to embrace 
the maturing cells in its vicinity. Some immature blood cell precursors 
were observed to be completely enveloped in the cytoplasmic processes. 
Intimate associations of blood cell precursors with the cytoplasmic 
processes were evident in all the erythroblastic islands. Desmosome-like 
attachments (Fukuda et al 1974) and gap junctions between the central cells 
and the adjacent blood cell precursors were numerous, thus there is 
potential for the transfer of substances between the cells of the islands.
The number of cells which constituted a cluster was high in the 14 and 15 
day fetal livers, on average 10-15 cells. This could be due to the high 
numbers of haematopoietic cells present in fetal liver relative to the 
numbers of macrophages and hepatocytes present. The number of cells in 
each cluster was observed to decrease as fetal development proceeded. This 
is most probably due to the increase in numbers of hepatocytes and 
macrophages combined with the decrease in number of haematopoietic 
cells. Gradients of differentiation were observed in the clusters. The most 
immature cells occupied positions close to the central cell, some cells were 
entirely surrounded by the cytoplasmic processes of the central cells. More 
mature cells occupied peripheral positions however they usually remained
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in close association with at least one cytoplasmic process of the central cell. 
These observations suggest that the early precursors are more dependent 
on the central cell and as they mature they migrate, possibly along the 
cytoplasmic processes of the central cell (Shaklai 1990), to occupy more 
peripheral positions within the clusters. Granuloid, lymphoid and 
monocytic cells occupied peripheral positions within the mixed clusters 
when haematopoietic activity was high. Only when the number of 
erythropoietic cells had decreased were they seen to occupy more central 
positions. It may be that myelomonocytic and lymphoid cells are less 
dependent on the central cell than erythroblasts or that the large numbers 
of erythroid cells restricts cells of other lineages to peripheral positions.
3.5.2 Mixed and’ Lineage-Restricted Clusters
The cell clusters in fetal and newborn liver were not restricted to 
haematopoietic cells of a single lineage (Jones 1970; Grossi 
1985).Granulocytes and increasing numbers of monocytes observed in the 
14 day fetal liver, formed constituent parts of cells clusters. The 
myelomonocytic cells were also closely associated with the cytoplasmic 
extensions of the central cells. Cytoplasmic and desmosome-like 
communications between the processes of the central cell and the 
myelomonocytic cells were abundant. When lymphoid cells first appeared 
in the newborn liver, they too were observed as an integral part of the cell 
clusters. Only when the number of erythroid cells was declining did the 
cells of other lineages occupy more central positions.
In the 10 day neonatal liver the cell clusters exhibited marked
morphological differences from those observed earlier. Only single lineage 
clusters were observed surrounded by hepatocytes and the number of cells 
in each cluster was reduced. Cells were not observed arranged around a
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central macrophage. The cell clusters themselves were restricted to isolated 
foci within the parenchyma, however the intimate associations between 
the hepatocytes and the adjacent blood cell precursors remained abundant. 
The presence of single-lineage colonies in neonatal liver have been 
described previously (Grossi et al 1985; Rossant et al 1986). The authors 
suggest that progenitor cells committed to specific lineages are present in 
the neonatal liver and that these precursors give rise to discrete foci of 
single-lineage cells. An alternative explanation would be that 
multipotential precursors are restricted to specific lineages by local 
environmental differences. However this seems unlikely in that within 
haematopoietic foci of the 10 day neonate, clusters of all three lineages were 
observed, erythroid clusters were often seen in the vicinity of granuloid 
clusters, not restricted to a local erythroid environment as the latter 
hypothesis would suggest.
3.5.3 Cellular Interactions in Vitro
Intricate cellular interactions have also been observed in vitro.
Granulopoiesis takes place in close proximity to macrophages, and 
hepatocytes in FL cultures. Granulopoietic islands have been observed 
using time lapse video, where the central macrophage was observed to 
phagocytose dead granulocytes (Allen 1992). Interactions are also observed 
with blanket cells.
As previously mentioned, addition of anaemic mouse serum permits 
erythropoiesis in these cultures. In vitro erythroblastic islands have been 
reported in cultures initiated this way (Allen & Dexter 1982). The 
production of red cells in the long term cultures appears to mimic almost 
exactly their production in vivo. All red cell maturation is observed to take 
place on the surface of the adherent layer in association with macrophages
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(Allen 1992), to form in vitro erythroblastic islands. The erythroblasts 
within the islands have been observed to undergo mitosis in synchrony, 
this was not reported in the granulopoietic islands. In addition 
erythroblast-macrophage interactions were not transient like the 
granulocyte-macrophage interactions observed (Allen & Testa 1991). Thus 
it is feasible that direct and continuous association with macrophages is 
essential for proliferation and differentiation of erythroblasts.
Cytoplasmic extensions of macrophages have been observed to be 
associated with the haematopoietic cells of the island. Like erythroblastic 
islands observed in vivo, numerous membrane contacts have been 
reported between macrophages and early erythroblasts, while more mature 
cells are not so intimately associated with the extensions (Allen & Dexter 
1982). Macrophages have been observed to phagocytose extruded nuclei and 
rhopheocytosis has also been observed (Breton-Gorius et al 1991). Vesicular 
activity at closely apposed membranes and gap junctions has been observed 
(Rosendaal 1991; Allen 1992), gap junctions have also been reported 
between endothelial cells and macrophages (Hasthorpe et al 1991).
The extensive observation of erythroblastic and granulocytic islands both in 
vivo and in vitro has led to a general acceptance that true haematopoiesis 
takes place in a similar manner. The focal nature of the islands, taken 
together with the cellular interactions described, observations of 
rhopheocytosis, desmosomes and gap junctions in addition to recently 
demonstrated receptors for cell binding strongly suggest the central 
macrophage has an important role to play in haematopoietic regulation, in 
addition to those currently recognised- providing a substratum for cell 
differentiation, removal of extruded nuclei and cell debris, aiding passage 
of mature erythrocytes into the venous sinuses (Shaklai 1989).
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3.5.4 Function of the Haematopoietic Islands
Three physiological functions have been ascribed to erythroblastic islands 
a metabolic function which introduces ferritin and other molecules into 
the erythroblasts (Bessis & Breton-Gorius 1962). Secondly the central 
macrophage is necessary for phagocytosis of expelled nuclei and thirdly 
phagocytosis of old red blood cells (Bessis 1973). Thus the central 
macrophage plays the roles of both a "nurse cell" and the grave of the red 
cell.
The latter two functions are universally accepted. In the fetal liver on the 
15th day of gestation and in subsequent stages, macrophages were observed 
both in the process of engulfing extruded nuclei and also to contain 
ingested nuclei and all sorts of cell debris within their cytoplasm. A 
phagocytic function of the central hepatocytes has not been clearly 
demonstrated, however they play a very important metabolic role in the 
differentiation of blood cell precursors. The metabolic role of the 
erythroblastic islands is much more difficult to prove and has remained a 
very controversial aspect for many years.
The term rhopheocytosis was introduced to describe the presence of coated 
vesicles containing ferritin in erythroblasts. However electron microscopy 
is static and to this day the direction of transfer of the ferritin cannot be 
accurately determined. Bessis proposed that ferritin constituted an iron- 
reserve which was passed from macrophage to erythroblast for the 
synthesis of haemoglobin (Bessis 1973). As the erythroblasts mature and 
become advanced in haemoglobin formation they no longer require this 
supply of ferritin. The observations of 15 day fetal liver stained with Pearls 
Prussian Blue are in accordance with this theory. The cells in closest 
proximity to the central cell were more intensely stained than the more
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mature cells on the periphery. The fact that numerous ferritin molecules 
are present in the cytoplasm of the proerythroblast at the time of initiation 
of haemoglobin (Hb) synthesis suggest that ferritin does not represent an 
excess of iron not required for (Hb) synthesis (Breton-Gorius 1991).
However other groups dispute this.
Zamboni (1965) reported that as rhopheocytic vesicles were so rare they 
represented aggregates of excess iron not required for (Hb) synthesis. This 
excess is then removed by the central cell. Electron microscopic 
observations of ferritin in immature erythroblasts have indicated that the 
iron content of the cells was greater than was necessary for Hb synthesis 
(Mohandas 1991). Thus the less intently stained erythroid cells observed on 
the periphery of cell clusters in the 15 day fetal liver may contain sufficient 
ferritin for Hb synthesis and the excess may have been transported from 
these cells to the central cell. Zamboni (1965) only observed iron exchange 
between central cells and erythroblasts advanced in Hb formation. 
Intracellular ferritin is observed in 0.01% of circulating erythrocytes of 
normal individuals but in 3% of circulating erythrocytes in splenectomised 
individuals (Pollycove 1991). Thus the spleen may complete the removal of 
reticulocyte ferritin. This would account for the presence of some intensely 
stained erythrocytes in the hepatic sinusoids of the 8 day neonate.
It is known that circulating Hb is maintained by reclamation of iron from 
the Hb of phagocytosed erythroblasts and nuclei by the central 
macrophages. This is then promptly re-released for utilisation by immature 
cells (Pollycove 1991). It is possible therefore that ferritin is transported in 
both directions. Intercellular components initially required for normal 
development and intermediate metabolism of immature blood cell 
precursors, may be provided by the central cell. At later stages in 
development these products may become unnecessary and their removal
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may be essential for further maturation to progress. The central cells would 
also be responsible for the removal of these waste products. Thus the 
ubiquitous presence of the central cell in the haematopoietic islands may be 
essential for normal intermediary metabolism and function of its adjacent 
blood cell precursors.
Macrophages are now known to produce multiple molecules such as Epo, 
G-CSF, M-CSF, GM-CSF and IL-1 (Rich 1986; Nathan 1987). Zucali et al 
(1977) demonstrated that production of Epo and colony stimulating factor 
by murine fetal liver macrophages was maximal in day 14 and day 15 FL 
cultures. The erythropoietic stimulating activity was capable of stimulating 
both in vivo and in vitro erythropoiesis (Zucali et al 1980). Vogt, Pentz & 
Rich (1989), demonstrated that murine macrophages were positive for the 
Epo gene, therefore it is plausible that the central macrophage could be the 
source of growth factor for its adjacent erythroid cells. Macrophages can 
respond to varying oxygen concentrations by increasing or decreasing 
production of Epo and CSF accordingly (Rich 1986). In hypoxic conditions 
an increase in size and enhancement of phagocytic activity is observed 
(Yoffey & Yaffey 1980).
Medlock & Haar (1983), also proposed the fetal hepatocyte as a likely 
candidate for synthesis and secretion of substances important to the 
haematopoietic functioning of the liver. This would explain the close 
associations observed in this investigation, of hepatocytes and 
haematopoietic cells both in vivo and in vitro. Megakaryocytes have been 
reported to respond to Epo and possess receptors for Epo (Krantz 1991). The 
close associations observed between hepatocytes and megakaryocytes in 
vivo in all stages of liver examined may thus be Epo mediated.
149
In addition to the array of stimulatory molecules produced by macrophages, 
inhibitory molecules, TNF-oc, IL-la, TGF-P and Interferons a and y, are also 
secreted (Nathan 1987). Through their abundance, distribution, motility 
and versatility, macrophages can influence an array of diverse activities 
from induction of haematopoiesis to cell death, in addition to their roles in 
the immune and inflammatory responses.
The focal nature of the cell clusters both in vivo and in vitro and the close 
range cellular interactions involved, suggest that ECM molecules and 
components of the cell surface are also involved in haematopoietic 
regulation. How the central cells recognise the cells with which they 
become intimately associated has not been elucidated. In addition 
macrophages must have the capacity to distinguish between an expelled 
nucleus and mature erythrocytes, otherwise a high degree of red cell 
destruction would result.
It is thought that very early precursor cells, the proerythroblasts may be 
associated with erythroblastic islands (Breton-Gorius et al 1991), however 
the mechanism involved in the erythroblast macrophage binding as yet 
remains unclear. It is known that macrophages and erythroid progenitors 
express receptors for fibronectin and thrombospondin, in addition to the 
respective macrophage ligands, these molecules could be potentially 
involved in the formation of an erythroblastic island. Crocker et al (1990, 
1991) reported that interaction of fetal liver cells with fetal liver 
macrophages occurs through a divalent-cation dependent adhesion 
receptor, the molecular nature of which is unknown to date. Such a 
receptor is also involved in erythroid-macrophage interactions in the adult 
bone marrow however, a second receptor is also involved in the adult.
This receptor is divalent-cation independent and is known to be a plasma
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membrane glycoprotein expressed specifically by bone marrow
macrophages.
The ECM of the adherent layer of LTBMC consists of collagens types I, III, 
and IV, laminin, fibronectins and proteoglycans (Zuckerman & Wicha 
1983). The collagens are produced by all stromal cell types, fibronectin is 
produced by endothelial cells, macrophages and fibroblasts while laminin is 
produced by endothelial cells only. The importance of these molecules for 
the integrity of the adherent layer is evident, perturbation of collagen 
synthesis impairs the outgrowth of the adherent layer. When an intact 
stromal layer is treated with antibody against fibronectin, the adherent layer 
is completely destroyed (Zuckerman et al 1985).
Heparan sulphate is the most abundant glucosaminoglycan (GAG) chain of 
the proteoglycans which constitute the adherent layer in murine LTBMC, 
while chondroitin sulphate predominates in human LTBMC (Gallagher, 
Spooncer & Dexter 1983). Gordon, Riley & Clark (1988) demonstrated that 
heparan sulphate was necessary for binding blast-colony forming cells, (Bl- 
CFC), to stromal layers in vitro. This binding was stage specific and 
reinforced the idea that lineage and stage specific microenvironments exist 
in the bone marrow and also that segregation of different haematopoietic 
progenitors facilitates their regulation and interaction with appropriate 
growth factors (Gordon et al 1987; Roberts et al 1988; Dexter et al 1990). 
Zuckerman & Wicha (1983), reported that haematopoiesis in long term 
cultures was preceded by extensive deposition of ECM by stromal cells by 
almost 1 week.
Fibronectin is synthesised by a large number of cells including endothelial 
cells, macrophages and hepatocytes. One of the main functions attributed to 
fibronectin is the property to bind cells together, it also has binding
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capacities to collagens, GAGs and proteoglycans, thus it is regarded as an 
ECM promoter of cell attachment. It has to strike a balance between 
promoting anchorage of cells and permitting their migration. Early 
erythroid cells posses receptors for fibronectin unlike circulating red blood 
cells (Vuillet-Gaugler et al 1990). Thus one can speculate that attachment to 
the ECM can regulate cell migration within the marrow and loss of 
expression of adhesion receptors during differentiation will favour 
migration of mature cells (Coulombel et al 1992).
It is likely that bone marrow haematopoiesis is regulated through co­
operation of locally synthesised growth factors, adhesion molecules and 
ECM proteins and the crucial stem cell stromal cell interactions, in short 
the haematopoietic inductive microenvironment. Most growth factors are 
locally synthesised by medullary stromal cells and can be secreted in a 
soluble form, which binds to heparan sulphate proteoglycans for 
presentation to haematopoietic cells, this mechanism was proposed by 
Dexter et al (1990) and is illustrated in Fig. (3.3-1).
In contrast it has been recently shown that human haematopoietic 
progenitors did not require direct contact with the bone marrow stroma for 
long term in vitro haematopoiesis (Verfaille 1992). However repeated 
addition of cytokines was necessary to maintain haematopoiesis in these 
cultures. Thus the main role of the stromal cells may be to promote the 
differentiation of haematopoietic progenitor cells. In addition Zipori & Lee 
(1988), suggested that stem cell self-renewal is maintained by novel stromal 
cell factors distinct from known colony stimulating factors. The biological 
importance of actual haematopoietic cell associations with stromal cells 
and ECM proteins, and the functional mechanism for proliferation and 
differentiation are unknown.
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Fig, 3,3-1 Haematopoietic Regulation in the Bone Marrow 
Microenvironment
Adult bone marrow 
(proposed by Dexter et al 1990).
Regulatory factors are synthesised by the stromal cell and secreted in a 
soluble form. The regulatory factors bind to heparan sulphate proteoglycan 
for presentation to the haematopoietic cell, which retained in close 
proximity by cell adhesion molecules
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While the ECM and adherent stromal layer of LTBMC has been the subject 
of intense investigation in recent years, in LTFLC however, these 
properties have not been so well documented. It is known that 
macrophages and hepatocytes can both produce fibronectin and regulatory 
factors for haematopoiesis. However information is lacking on the other 
ECM components and cell adhesion molecules of fetal cultures. Gordon et 
al (1988), demonstrated that FL-GAGs were inefficient in binding GM-CSF, 
in comparison to BM-GAGs. In another series of experiments Gordon and 
her associates (1990) found that binding of very early progenitors to marrow 
stromal layers did not appear to involve known cell adhesion molecules. 
Thus in the early stages of haematopoiesis, in particular fetal 
haematopoiesis, GAGs may not be essential for presentation of growth 
factors and cell adhesion molecules may not be required to maintain the 
integrity of the clusters. The morphological observations of fetal liver 
haematopoiesis undertaken both in vivo and in vitro, in the present 
investigation reveal the importance of the cellular interrelationships 
between macrophages and blood cell precursors as well as between 
hepatocytes and blood cell precursors. The form and arrangement of the 
cytoplasmic extensions, the presence of gap junctions, rhopheocytic vesicles 
and desmosome-like attachments are consistent with extensive 
interchange of material between the central cells and the blood cells 
precursors which surround them.
Whereas in adult bone marrow, under steady state conditions, regulatory 
factors appear to be fixed in relation to their target cells by specific 
molecules, as Dexter has envisaged (1990). In stimulated bone marrow, the 
more intimate relationships between differentiating erythroblasts and 
stromal cells (Yoffey & Yaffey 1980), may provide circumscribed 
microenvironments in which regulatory factors can be localised.
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Similarly in fetal liver, the localisation of regulatory factors within 
circumscribed micoenvironments may be important for the regulation of 
haematopoiesis in addition to the mechanism proposed by Dexter (fig. 3.3­
2).
Fig, 3.3-2 Haematopoietic Regulation in Fetal Liver
haematopoietic
cell
cell adhesion
HS-PG
Haematopoietic regulation in fetal liver may involve circumscribed 
microenvironments of haematopoietic cells and stromal cells in which 
growth factors can be localised, in addition to the mechanism proposed by 
Dexter.
155
Chapter 4
Haematopoietic Colony_J.or.ming Cells
The earliest precursors of blood cells cannot be adequately characterised 
using morphological criteria. It is therefore necessary to exploit operational 
assays in order to obtain information about these cells upon which the 
maintenance of haematopoiesis is dependent (Wright & Lord 1977). The 
proportion of stem cells which are in the cell cycle is regulated by locally 
produced factors (Devalia & Linch 1991). Stimulators and inhibitors have 
been demonstrated which act specifically at the stem cell level (Dexter 1989). 
The stimulators and inhibitors regulate the proportion of cells in cycle, in 
response to the body's demands. In normal murine bone marrow the 
proportion of CFU-S synthesising DNA is very low, probably reflecting 
quiescence in the stem cell pool. In contrast, the haematopoietic stem cells 
are actively cycling in murine fetal liver (Thomas, Cork & Riches 1981).
This investigation was devised to evaluate the kinetic properties of high 
proliferative potential colony forming cells (HPP-CFC) and of granulocyte- 
macrophage colony forming cells (GM-CFC) derived from murine fetal and 
neonatal liver and adult bone marrow. The standard "suicide assay" 
technique as detailed in Chapter 2 was used to determine the proportion of 
cells in DNA synthesis.
Single cell suspensions of murine fetal and neonatal liver and bone 
marrow were incubated with cytosine arabinoside, Ara-C, which is cytotoxic 
to DNA synthesising cells. The difference in the number of colonies 
produced by control samples and Ara-C treated samples gives a measure of
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the proportion of cells in the S-phase. Colonies produced which are in excess 
of 2mm diameter are considered to be derived from the HPP-CFC 
population. These HPP colonies contain more than 50, 000 cells. A dramatic 
decrease in the number of these large colonies produced by Ara-C treated 
samples is observed (Fig. 4.1-1).
. «
, • •
* K * w *•* • * '
•
* *# • f . -F' * -f
•
* ‘ *
to
• •••
I
*
w
r »* *
- »
Hr. • 9 > * ♦
•• • •
# * 4B *
w
Fig1_41l=l Reduction of HPP-CFC Colony Formation by Ara-C 
The sample of fetal liver on the right has been treated with Ara-C, the 
sample on the left has not.
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Results
£1 HPP-CFC
A considerable proportion of HPP-CFC derived from fetal liver were found 
to be cycling in contrast to cells derived from adult bone marrow, of which 
only a small proportion were in S-phase (Table 4.1-1, Fig. 4.1-2).
39% of HPP-CFC derived from 13 day fetal liver were engaged in DNA 
synthesis. The proportion of cycling cells increased to a maximum of 53% 
in the 15 day fetus, this value then declined to 34% in 19 day fetal liver. As 
development proceeded, a corresponding decline in the proportion of 
cycling cells was observed, from 23% in the newborn liver down to a 
minimum of 13% in 8 day neonatal liver. This value corresponds to the 
10% of HPP-CFC engaged in DNA synthesis detected in normal adult bone
marrow.
Anova showed a significant difference in the mean scores (F = 53.66, d=6, p 
< 0.0001). Tukey’s post-hoc testing of comparisons revealed that the 
proportion of cells synthesising DNA in the 15 day fetal liver was 
significantly different from all other values obtained. The values obtained 
for 13 day fetal liver, 19 day fetal liver and newborn liver were not 
significantly different. The proportion of cells synthesising DNA in the 
newborn liver was significantly different from the values obtained for 
adult bone marrow. The proportion of cells engaged in DNA synthesis in 
the 3 day neonate, the 8 day neonate and adult bone marrow were not 
significantly different.
158
Table 4.1-1 Proportion of HPP-CFC in S-phase in
Fetal and Neonatal Liver and Adult Bone marrow
Tissue
Sample
% HPP-CFC in S-phase 
(mean ± S.E.)
No. of
Experiments
13 Day Fetal Liver 39 ± 2.4 7
15 Day Fetal Liver 53 ± 2.6 10
19 Day Fetal Liver 34 ± 2.4 6
Newborn Liver 28 ± 0.4 4
3 Day Neonatal Liver 23 ± 1.0 4
8 Day Neonatal Liver 13 ±1.7 3
Adult Bone Marrow 10 ±0.7 8
Fig. 4.1-2 Proportion of cycling HPP-CFC in Fetal and Neonatal Liver 
and in Adult Bone Marrow
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Colony production was maximal, (103 colonies/105 cells), in fetal liver on 
the 15th day of gestation (Table 4.1-2, Fig. 4.1-3). This corresponds to the 
maximum proportion of HPP-CFC synthesising DNA. Colony production 
in the liver samples declined with developmental age, only 50 colonies/105 
cells were produced by newborn liver. As neonatal development proceeded 
colony production further declined from 36 colonies in the 3 day neonate to 
a minimum of 29 colonies /105 cells in the liver of the 8 day neonate, 
corresponding to the decline in the proportion of cells synthesising DNA.
In adult bone marrow however a high number of colonies were produced 
(87 /105 cells) despite the low number of DNA synthesising cells in this 
tissue.
Table 4.1-2 Number of HPP-CFC Colonies Produced / 10^ cells
Tissue
Sample
No. of Colonies
Mean ± S.E.
No. of 
Experiments
13 Day Fetal Liver 77 ±7.2 7
15 Day Fetal Liver 103 ± 8.3 10
19 Day Fetal Liver 60 ±8.0 6
Newborn Liver 50 ±2.4 4
3 Day Neonatal Liver 36 ± 7.1 4
8 Day Neonatal Liver 29 ±1.6 3
Adult Bone Marrow 87 ±7.4 8
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Fig.4.1-3 Number of HPP-CFC Colonies Formed / 10- Cells
Tissue
4£ GM-CFC
The proportion of GM-CFC synthesising DNA was evaluated in murine 
fetal liver on the 15th day of gestation, on the day of birth and in normal 
adult bone marrow (Table 4.2-1, Fig. 4.2-1).
The proportion of GM-CFC in S-phase was high in tissue derived from all 
three samples. The highest proportion of cycling cells was detected in liver 
of the 15 day fetus (50%), this value declined to 47% in the newborn liver. 
Adult bone marrow was found to have the lowest proportion of DNA 
synthesising cells (37%). Although the differences in the proportion of GM- 
CFC synthesising DNA in the three tissue samples were not dramatic, 
Tukey's post-hoc testing of analysis of variance showed that the values 
obtained for both liver samples were significantly different to those of adult
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bone marrow (F=92.39, df=2, pcO.OOOl). There was no significant difference 
in the values obtained for 15 day fetal liver and newborn liver.
Table 4.2-1 Proportion of GM-CFC Engaged in DNA Synthesis in 
Fetal and Newborn Liver and in Adult Bone Marrow
Tissue
Sample
% GM-CFC in S-phase
Mean ± S.E.
No. of
Experiments
15 Day Fetal Liver 50 ±0.0 3
Newborn Liver 47 ±0.8 4
Adult Bone Marrow 37 ±0.7 3
Fig. 4.2-1 Proportion of cycling GM-CFC in Fetal and Newborn Liver 
and in Adult Bone Marrow
Tissue
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In contrast to the decline in the proportion of cycling GM-CFC in fetal and 
newborn liver, there was no significant difference in GM-CFC colony 
production in the two samples, p > 0.3, (Table 4.2-2, Fig. 4.2-2). Fetal liver 
produced an average of 40 colonies /105 cells, while newborn liver 
produced 38 colonies /IO5 cells. Adult bone marrow produced a 
significantly higher number of colonies (60 / IO5 cells), than either of the 
two liver samples (p « 0.001).
Table 4.2-2 Number of GM-CFC Colonies Produced /10^ Cells
Tissue
Sample
No. of Colonies
Mean ± S.E.
No. of
Experiments
15 Day Fetal Liver 40 ±2.3 3
Newborn Liver 38 ±2.1 4
Adult Bone Marrow 60 ± 2.6 3
Fig. 4.2-2 Number of GM-CFC Colonies Produced /10^ cells
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Discussion
43 HPP-CFC
The in vivo CFU-S assay has permitted the investigation of murine 
haematopoietic stem cell behaviour and regulation. This assay is however 
restricted by its in vivo nature and species limitation. More recently, the 
use of combinations of haematopoietic colony stimulating factors (CSFs), 
has led to the cloning of a developmentally early haematopoietic precursor 
cell population, which is characterised by its high proliferative potential. 
These HPP-CFC are considered to be a component of the stem cell 
compartment (Fig. 4.3-1).
To date three subpopulations of HPP-CFC have been described (McNeice et 
al 1990). HPP-CFCi, which is responsive to IL-1 and CSFl, is considered to be 
the most primitive of the HPP-CFC populations. HPP-CFCi in turn 
differentiate to produce HPP-CFC2, responsive to IL-3 and CSFl. It is 
proposed that HPP-CFC2 differentiate to produce a third subpopulation 
which is responsive to hemolymphopoietic growth factor (HLGF) and 
CSFl. This HPP-CFC3 population is a more mature lineage restricted 
population, which differentiates to produce GM-CFC (McNeice et al 1988, 
1990).
The kinetic properties of the HPP-CFC2 population, responsive to IL-3 and 
CSFl, were evaluated in this investigation. Conditioned medium 
containing a combination of WEHI 3B, as a crude source of IL-3, and L929, 
as a crude source of CSFl/M-CSF, was used to stimulate the production of 
colony forming cells with a high proliferative potential. Ara-C was used to 
eliminate cells which were engaged in DNA synthesis.
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The difference in colony numbers produced in the absence and in the 
presence of Ara-C gives an indication of the proportion of HPP-CFC which 
were synthesising DNA.
The proportion of HPP-CFC which were synthesising DNA was found to be 
high in the 13 day fetal liver (39%), this increased to a maximum of 53% in 
the liver of the 15 day fetus, then declined progressively as development 
proceeded. At birth the number of HPP-CFC in S-phase had declined to 28% 
and the numbers of HPP-CFC synthesising DNA further declined in the 
neonatal period to reach a minimum of 13% in the 8 day neonatal liver. In 
adult bone marrow the majority of stem cells are quiescent this was 
confirmed by the finding that only 10% of the HPP-CFC were synthesising 
DNA.
HPP colony production was greatest in the 15 day fetal liver (103 
colonies/105 cells), corresponding to the highest proportion of cells in S- 
phase. Colony production declined with fetal development to a minimum 
of 29/105 cells in the liver of the 8 day neonate. This observed decline in 
colony production mirrors the decline in the proportion of cells 
synthesising DNA. In adult bone marrow the number of HPP colonies 
produced, (87/105 cells), was greater than any of the liver samples, with the 
exception of the 15 day fetus. Although a large number of HPP-CFC 
colonies were produced by bone marrow cells, the HPP-CFC derived from 
bone marrow are quiescent. In contrast only rapidly cycling 15 day fetal 
liver HPP-CFC produced colonies on this scale. The high number of 
colonies in the bone marrow compared to the liver indicates that the bone 
marrow contains a larger population of HPP-CFC than the liver. The 
majority of these cells in the bone marrow are quiescent only 10% were in 
S-phase. In the fetal liver however the majority of cells were actively
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cycling, correlating with previous reports of in vivo CFU-S studies (Riches, 
Cork & Thomas 1981).
The high proportion of HPP-CFC which were synthesising DNA in the 15 
day fetal liver coincided with the morphological evidence of extensive 
hepatic haematopoiesis at this stage in development. Morphological 
investigations have revealed a gradual decline in hepatic haematopoiesis 
as development proceeds. This corresponds to the decline in the number of 
HPP-CFC engaged in DNA synthesis as development progresses.
In the 8 day neonatal liver only 13% of HPP-CFC were in S-phase, at this 
stage the liver has ceased to be the main site of haematopoiesis. The 
proportion of cycling HPP-CFC present in the 8 day neonate approximates 
to the 10% of HPP-CFC synthesising DNA in the adult bone marrow. Thus 
it is reasonable to assume that like the stem cells of normal adult bone 
marrow, the considerably smaller number of stem cells in the 8 day 
neonate are quiescent.
The high proportion of HPP-CFC synthesising DNA in the 15 day fetal liver 
coincides with the availability of a stem cell specific stimulator of DNA 
synthesis. The decrease in the proportion of HPP-CFC synthesising DNA in 
the 8 day neonatal liver coincides with the disappearance of this putative 
regulator (Dawood et al 1990). The stimulator from 15 day fetal liver is 
produced by plastic adherent cells and by fractionated cells in the 1.064 and 
1.076 g/cm3 density bands and it has the ability to switch quiescent normal 
bone marrow cells into cycle in vitro. The stimulatory activity declines 
from the 15th day of gestation, it can be detected in 1 week old neonatal 
liver, however after this time its production ceases and it cannot be 
detected in liver 3 weeks after birth.
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In normal adult bone marrow the stem cells are quiescent, only 10-15% of 
CFU-S are in S-phase (Thomas et al 1981). The reduced proportion of 
cycling cells is maintained by an inhibitor of DNA synthesis, which can 
reduce the proportion of CFU-S in regenerating bone marrow or fetal 
haematopoietic tissue (Lord et al 1976; Riches et al 1981; Tejero et al 1984). 
Maintenance of an increased proportion of cycling CFU-S in regenerating 
tissue, physiologically stressed tissue or fetal tissue is brought about by a 
stimulator of DNA synthesis (Wright & Lord 1977). Both the inhibitor and 
the stimulator are produced by macrophages (Lord 1988).
There is evidence that the control of proliferation occurs locally as the 
kinetic properties of haematopoietic stem cells can differ at different sites 
within the same animal (Wright & Lord 1977). The stimulator and the 
inhibitor are not thought to interact directly, instead the stimulator acts on 
inhibitor-producing cells leading to a reduction in the production of 
inhibitor. Like wise the inhibitor interacts with stimulator-producing cells 
to decrease stimulator production (Tejero et al 1984). Stem cell numbers are 
considered to play an important role in this regulatory process. In 
regenerating bone marrow, when the number of CFU-S has recovered to 
their normal value, a negative feedback signal leads to the inhibition of 
stimulator production. Similarly when CFU-S numbers are low, inhibitor 
production is decreased and stimulator production is increased (Toksoz et 
al 1980). However, this mechanism of regulation cannot operate in fetal 
liver.
Stimulator production in fetal liver has been shown to be maximal on the 
15th day of gestation, when the numbers of CFU-S are highest (Dawood et 
al 1990). This correlates with the high number of HPP-CFC observed in the 
15 day fetal liver. Thus in the fetal liver microenvironment a high number
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of stem cells does not lead to reduced stimulator production. The number 
of CFU-S in fetal liver has been reported to decrease from the 15th day of 
gestation onwards. A similar result was obtained with HPP-CFC numbers, 
which were maximal on the 15th day of gestation and had declined 
considerably by the end of the first neonatal week. In the bone marrow 
microenvironment such a reduction in stem cell number would increase 
stimulator production and increase the output of the stem cell 
compartment. However in the studies of Dawood et al (1990), stimulator 
had decreased by the end of the first week of the neonatal period. This 
decrease in stimulator production correlates with their reported depletion 
of CFU-S numbers, in a similar manner to the reduction of HPP-CFC 
numbers in this investigation.
The number of HPP-CFC produced by adult bone marrow was considerably 
higher than those produced by fetal and neonatal liver, with the exception 
of the 15 day fetal liver. Only a small proportion of bone marrow cells were 
in S-phase (10%), it is possible that the high number of HPP-CFC in adult 
bone marrow leads to inhibition of the production of a stimulator of HPP- 
CFC proliferation. Thus in adult bone marrow an inverse relationship 
appears to exist between the number of stem cells and stimulator 
production, unlike that observed in fetal liver where a high number of 
stem cells existed concomitantly with a high degree of stimulatory activity
The kinetic properties of the in vitro HPP-CFC population are similar to 
the in vivo CFU-S population, in both fetal liver and in adult bone marrow 
(Fig. 4.3-2). In the 15 day fetal liver 30-40% of CFU-S are synthesising DNA, 
in the adult bone marrow however only 10-15% of CFU-S are in S-phase 
(Thomas et al 1981). The difference in the proliferative status of CFU-S 
derived from fetal liver and those derived from bone marrow is very 
closely correlated with the difference in the proliferative status of HPP-CFC
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derived from 15 day fetal liver and HPP-CFC derived from adult bone 
marrow. The kinetic properties of CFU-S and HPP-CFC are also closely 
correlated in both cycling 15 day fetal liver and in quiescent adult bone
marrow.
The numbers of HPP-CFC present declined during the latter part of 
gestation, after reaching a peak in the liver of the 15 day fetus. This 
reduction parallels the decline in the number of CFU-S from the 15th day 
of gestation which has been reported previously. About 4 x 104 HPP-CFC 
colonies were derived from the liver of the 15 day fetus (103 colonies /105 
cells) and about 7.9 x 103 from neonatal liver on day 8 (29 colonies /105 
cells). The size of the HPP-CFC population is comparable with that of CFU- 
S population, which forms colonies within 10 days. On the 15th day of 
gestation the liver cells would be expected to form 4-10 CFU-S colonies /105 
cells (Thomas, Smith & Sumpster 1976), assuming an F factor of 15-20, this 
would represent a population of 2.4 x 104 - 8 x 104 CFU-S.
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Fig. 4.3-2 Kinetic properties of HPP-CFC and CFU-S Derived from 15 
Day Fetal Liver and Adult Bone Marrow
<uco
There is also evidence for HPP-CFC self-renewal and sensitivity to the stem 
cell specific CFU-S stimulator and inhibitor (Robinson & Riches 1991). 
However the magnitude of the HPP-CFC stimulation and inhibition was 
less than that of CFU-S. This finding may suggest that the HPP-CFC are a 
more primitive population than CFU-S. Within the CFU-S population 
there is a hierarchical sensitivity to the regulators. The primitive day 12 
CFU-S is more sensitive to inhibitor than stimulator while the more 
mature day 7 CFU-S is more sensitive to stimulator. Such a hierarchical 
arrangement may exist in fetal liver. The primitive HPP-CFC i may be more 
sensitive to inhibitor while the more mature HPP-CFC2 population, 
assayed in this investigation may be more sensitive to stimulator.
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HPP-CFC were originally operationally distinguished from other 
haematopoietic progenitor cells by their resistance to 5 FU treatment, their 
requirements for multiple haematopoietic growth factors acting in synergy 
and their ability to form colonies >lmm in vitro, containing in excess of 50, 
000 cells. It was suggested that they were a slowly cycling population, 
similar to marrow repopulating cells, but very different from CFU-S which 
are markedly depleted by treatment with 5 FU (Bradley & Hodgson 1979).
However more recently subpopulations of HPP-CFC have been defined 
(McNeice et al 1988; Falk & Vogel 1988), and it has been revealed that only 
the most primitive subpopulation, HPP-CFCi, is resistant to treatment with 
5 FU. The other HPP-CFC populations with more restricted growth factor 
requirements are severely depleted following 5 FU treatment, like CFU-S 
(McNeice et al 1988). Rhodamine-123 (Rh) uptake has also been used as a 
parameter to determine the hierarchical order of haematopoietic stem cells. 
Primitive transplantable stem cells with long term haematopoietic 
reconstituting ability, in vivo, are Rh-dull. Rh-bright cells have a rapid but 
limited haematopoietic reconstituting capacity. Investigations have 
revealed that HPP-CFCi are Rh-dull, while HPP-CFC2 and more restricted 
populations are Rh-bright (Bertoncello et al 1992). The very primitive day 
16 CFU-S, a candidate pre-CFU-S stem cell subset, like the HPP-CFCi 
population are also Rh-dull (McNeice et al 1990).
When developing colonies derived from HPP-CFCi are harvested they 
have been found to contain myeloid, erythroid and megakaryocytic 
progenitors in addition to transplantable haematopoietic stem cells. HPP- 
CFC2 colonies contain mainly macrophage precursors and have a reduced 
ability to sustain long-term survival of lethally irradiated mice, compared 
to HPP-CFCi (Bertoncello 1992). The exact interrelationship of HPP-CFC3,
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with the other subpopulations is unclear. This subpopulation is present in 
murine bone marrow at a higher incidence than the other populations 
suggesting it is a more mature population. It has been proposed that they 
are located between the HPP-CFC2 population and the GM-CFC progenitors 
(McNeice et al 1990)
It is likely that the HPP-CFC compartment is a continuum in which gradual 
changes in growth factor requirements occur as the HPP-CFC mature and 
differentiate. Within this continuum, the most primitive cells have the 
greatest long-term repopulating ability and are most sensitive to 
proliferation and differentiation stimuli (Wright & Lord 1992). The HPP- 
CFC are among the most primitive stem cells identified in vitro to date, 
having many characteristics similar to CFU-S. The HPP-CFCi 
subpopulation is regarded as a very primitive cell population, Bradley & 
Hodgson (1979), reported them to be highly quiescent. Recent studies have 
confirmed the quiescence of this subpopulation and proposed HPP-CFCi as 
candidate pre-CFU-S cells (McNeice et al 1990). The more mature HPP-CFC2 
population investigated in the present study display kinetic properties 
similar to the CFU-S in both fetal liver and in adult bone marrow, 
suggesting it is a developmentally early haematopoietic precursor cell 
population (Fig. 4.3-3).
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Fig. 4.3-3 Proposed Hierarchical Organisation of HPP-CFC, CFU-S 
and GM-CFC
o o
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4.4 GM-CFC
GM-CFC are a more mature precursor cell population than the HPP-CFC 
population. GM-CFC will form colonies in vitro providing a suitable 
source of colony stimulating activity is available, IL-3, GM-CSF, CSFl or G- 
CSF. A combination of growth factors is not required for colony production. 
GM-CFC will produce colonies of granulocytes, macrophages or 
granulocytes and macrophages, the proportions of which can be altered by 
using sub-optimal concentrations of growth factors (Heyworth & Spooncer 
1993).
A high proportion of GM-CFC, (50%), were engaged in DNA synthesis in 
the 15 day fetal liver, this proportion then decreased to 47% in the newborn 
liver, although small this reduction was statistically significant. Thus in 
comparison to the dramatic decline in proportion of cycling HPP-CFC, the 
proportion of GM-CFC actively synthesising DNA remains relatively high. 
The proportion of GM-CFC synthesising DNA in fetal and newborn liver 
was higher than that of adult bone marrow (37%). The difference in the 
proportion of cycling GM-CFC derived from fetal liver and adult bone 
marrow was not as dramatic as the difference in kinetic properties of HPP- 
CFC derived from fetal liver and adult bone marrow. These results suggest 
that GM-CFC, in fetal and newborn liver and in adult bone marrow are 
actively cycling. In contrast to the HPP-CFC derived from adult bone 
marrow which were quiescent. These results correlate with previous 
reports of the kinetic properties of GM-CFC (Cork et al 1982).
There was virtually no difference in the number of GM-CFC colonies 
produced by fetal and newborn liver, 38 and 40 colonies respectively. 
However adult bone marrow produced considerably more colonies than 
either fetal or newborn liver. As with the HPP-CFC data this suggests that
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adult bone marrow contains more GM progenitors than either fetal or 
newborn liver, however a lower proportion of these cells are in cycle. Fetal 
liver and newborn liver both contain fewer GM progenitors, a higher 
proportion of which are in cycle.
The proportion of GM-CFC synthesising DNA remained high in both fetal 
and newborn liver. This coincides with the myelopoietic phase of hepatic 
haematopoiesis observed morphologically (Chapter 3).
The values obtained for the proportion of proliferating GM-CFC in murine 
fetal liver closely correlate with results obtained in human fetal liver. Cork 
et al (1982), demonstrated that in human fetal liver at > 14 weeks gestation, 
more than 30% of GM-CFC were synthesising DNA. In human fetal liver of 
11-14 weeks gestation, only 5% of GM-CFC were in S-phase. In human fetal 
bone marrow however, the proportion of GM-CFC in S-phase remained 
high throughout (30%). This variation of GM-CFC proliferation in the two 
organs suggests that regulation of GM-CFC proliferation is under local 
control. Furthermore incubation of normal bone marrow with 11-14 week 
fetal liver conditioned medium, reduced the proportion of GM-CFC in S- 
phase to < 10%. While medium conditioned with fetal liver >14 weeks 
gestation did not alter the proportion of cycling GM-CFC in normal bone 
marrow, it promoted the proportion of GM-CFC in S-phase in a non­
cycling GM-CFC population. Incubation of non-cycling GM-CFC with fetal 
liver of 11-14 weeks gestation did not promote proliferation.
Unlike the HPP-CFC population, GM-CFC are not sensitive to the CFU-S 
inhibitor. However Cork et al (1982) reported that supernatants from fetal 
liver of 11-18 weeks gestation produced a stimulator of CFU-S which 
increased the proportion of CFU-S in S-phase from < 18% to >33%. Thus 
while human fetal liver of 11-14 week gestation produces an inhibitor of
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GM-CFC, it also produces a stimulator of CFU-S. This demonstrates the 
specificity of these regulators of GM-CFC and CFU-S. Furthermore, the GM- 
CFC stimulator and inhibitor are produced by non-adherent cells (Cork et al 
1982) while the CFU-S regulators are produced by adherent cells (Wright & 
Lord 1977; Dawood et al 1990).
The GM-CFC population does not display kinetic properties similar to the 
HPP-CFC population. The proportion of HPP-CFC synthesising DNA in 
fetal and neonatal liver decreased as development advanced and only 10% 
of HPP-CFC were in S-phase in adult bone marrow. In contrast, the 
proportion of GM-CFC synthesising DNA in the liver decreased only 
slightly from the 15th day of gestation to birth and also remained high in 
adult bone marrow. The GM-CFC population is a more mature 
haematopoietic progenitor cell population than either HPP-CFC or CFU-S 
populations. GM-CFC are considered to be a differentiation product of HPP- 
CFC3 (McNeice et al 1990). The incidence of GM-CFC does not change 
significantly in liver on the 15 day of gestation and in newborn liver. The 
incidence of GM-CFC in the adult bone marrow was significantly higher 
than in either fetal or newborn liver. This observation, together with the 
less specific growth factor requirements for GM-CFC than HPP-CFC, 
provides further evidence that GM-CFC are a more mature lineage 
restricted population.
The observations of Toksoz et al (1980) on CFU-S and CFU-C are similar to 
those reported here for HPP-CFC and GM-CFC. CFU-C are considered to be 
the descendants of CFU-S (Meldrum, Thomas & Riches 1977). The 
proportion of GM-CFC in regenerating bone marrow were observed to 
retain a high cycling rate throughout, while CFU-S were actively 
proliferating initially then subsequently declined to a steady state minimal 
proliferation rate. This observation suggests that regulators exist which are
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specific for CFU-S and HPP-CFC but have no effect on the more mature 
GM-CFC.
4.5 Regulation of Haematopoietic Colony Forming Cells
Control of the proliferative status of HPP-CFC and GM-CFC appears to be 
regulated by a balance between haematopoietic growth factors and a 
number of inhibitory molecules. As previously mentioned regulation is 
considered to be local. The inhibitor and stimulator of CFU-S described by 
Wright & Lord (1977) are produced by macrophages. The CFU-S inhibitor 
has recently been demonstrated to be macrophage inflammatory protein 
(MIP-la), which is produced in normal bone marrow but not in 
regenerating bone marrow (Graham et al 1990). The stimulator detected in 
fetal liver cells was produced by adherent cells (Cork et al 1982; Dawood et 
al 1990). While the GM-CFC inhibitor and stimulator reported in human 
fetal liver was produced by non-adherent cells (Cork et al 1982).
In addition to growth factors, a number of other stem cell specific regulators 
have been defined. TGF-P is known to inhibit all subpopulations of HPP- 
CFC (Keller et al 1990). PGE2 has been shown to inhibit GM-CFC 
proliferation, the same inhibition can also be obtained using Lactoferrin 
(Metcalf 1987). The leukaemic associated inhibitor (LIA), is produced by a 
range of normal cells and myeloid leukaemic cells. LIA inhibits GM-CFC 
proliferation but not leukaemic cell proliferation (Devalia & Linch 1991). 
LIA has many similar properties to the GM-CFC inhibitor detected in early 
human fetal liver, the possibility that these inhibitors represent the same 
factor has not been dismissed (Cork et al 1982). Haemoregulatory peptide 
has also been shown to inhibit proliferation of GM-CFC, in addition this 
peptide also has an inhibitory effect on CFU-S proliferation (Axelrad 1990).
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AcSDKP has been shown to prevent the entry of murine CFU-S into DNA 
synthesis, thus it can protect cells from damage by sublethal irradiation or 
cytotoxic agents. AcSDKP has no effect on cells already engaged in DNA 
synthesis (Lenfant et al 1989).
Positive and negative regulators of haematopoiesis, acting in concert, thus 
appear to provide a mechanism for rapid, reversible and specific 
proliferative responses to changes in haematopoietic demands. In addition 
it has been shown that regulation particularly of the stem cell compartment 
is elicited, in part by essential interactions with the supporting stroma of 
the haematopoietic tissue. The exact role of the stroma and the effects of the 
factors produced by stromal cells on HPP-CFC and GM-CFC remains to be 
determined.
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Chapter 5
Effects of Fetal Liver Extract on Normal and
Irradiated Bone Marrow and Leukaemic
Cells
The observations of Meng and his associates, (in Thomas 1993), revealed 
that the rate of complete remission in patients with acute leukaemia was 
higher (65%) in a group of patients who received infusions of fetal liver 
cells than in the patients who did not receive this treatment (36%). 
Furthermore increasing the number of infusions of fetal liver cells during 
periods of short duration was found to be more beneficial to the patients in 
that the period of severe anaemia was shorter and blood product 
consumption was smaller (Thomas 1993). These observations suggest 
infusion of fetal liver cells has beneficial effects on patients with acute 
leukaemia and aplastic anaemia.
Haematopoietic reconstitution, using fetal liver infusions without 
evidence of engraftment have also been reported. Wu et al (1985) reported 
recovery of patients with aplastic anaemia who were given infusions of 
fetal liver cells. Engraftment of the fetal liver cells was not observed and it 
was concluded that these cells are efficacious in promoting the recovery of 
haematopoiesis in functional deficiencies of the bone marrow. Aplastic 
anaemia has also been successfully treated by infusions of fetal liver 
conditioned medium (Kochupillai et al 1985). Engraftment of the fetal liver 
cells did not take place, thus the fetal liver infusion stimulates 
haematopoietic recovery of the bone marrow. Erythropoiesis was the first
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and most dominant response observed followed by myelopoiesis, unlike 
bone marrow transplantation where myelopoiesis is dominant. Thus 
following fetal liver cell infusion, the bone marrow recovery exhibits a fetal 
pattern of growth.
This investigation was conducted to determine the effects of murine fetal 
liver extract (FLE) on normal and irradiated bone marrow and on 
leukaemic cells. In order to establish whether fetal liver extract could 
influence the formation of HPP-CFC by bone marrow rendered hypoplastic 
by irradiation, adult CBA mice were given various doses of y irradiation 
and sacrificed on the fourth day post-irradiation. A 10% concentration of 
FLE (lml FLE + 9ml supplemented Dulbeccos medium), was added to bone 
marrow cell suspensions and the HPP-CFC content was determined using 
the standard HPP assay, FLE was not added to control groups.
Normal bone marrow was incubated with 10% FLE and serial half dilutions
of FLE to a minimum concentration of 0.31% to determine whether 
diluting FLE would alter its effects. HPP-CFC numbers were determined as 
before.
The effect of FLE on a cloned myelomonocytic leukaemic cell line was also 
investigated to ascertain the influence of FLE on colony formation by 
leukaemic cells. Leukaemic cells were incubated with concentrations of FLE 
and assayed for clonogenic cell production (Chapter 2). The difference in 
colony numbers between control and treated groups was attributed to the 
effect of FLE.
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Results
5.1 Effect of FLE on Normal and Irradiated Bone Marrow
Addition of FLE to irradiated bone marrow reduced the numbers of HPP- 
CFC colonies formed (Table 5.1-1 & Fig. 5.1-1). The number of HPP colonies 
formed by normal bone marrow, which had not been irradiated was 
significantly reduced from 75 to 42 in the presence of FLE (p < 0.0001). A 
78% reduction in HPP colony formation in the presence of FLE was 
observed in bone marrow which had received 2.5 Gy y irradiation. Colony 
numbers were reduced from 27 in the control samples to 6 in the FLE 
treated samples (p < 0.0001). A 63% reduction in colony number was also 
observed in bone marrow given a 5 Gy dose of irradiation, from 16 colonies 
in the control samples to 6 colonies in the presence of FLE (p = 0.001). The 
effect of FLE in bone marrow samples given 7.5 Gy and 10 Gy doses of 
irradiation could not be evaluated as the high irradiation doses perturbed 
colony production in both the control and the FLE treated samples. Colony 
production in both control and FLE treated bone marrow was observed to 
decrease as the dose of irradiation was increased. An increase in the 
number of HPP-CFC produced in the presence of FLE was not observed at 
any dose of irradiation.
Table 5.1-1 Number of HPP-CFC Colonies Formed ZIO^ Irradiated Bone
Marrow Cells
Dose of Irradiation Control BM BM + FLE Reduction (%)
0.0 Gy (n=10) 75 ±3.5 42 ±4.7 44 ± 6.1
2.5 Gy (n=10) 27 ±3.5 6 ±0.8 78 ±2.8
5.0 Gy (n=10) 16 ±1.2 6 ±1.1 63 ±3.7
7.5 Gy (n=10) l±0.5 0 0
10.0 Gy (n=10) 0 0 0
Data expressed as mean ± SE n = number of experiments
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Fig, 5.1-1 Number of HPP-CFC Colonies Formed/10^ Irradiated Bone 
Marrow Cells
The inhibitory effect of FLE was observed to be dependent on the volume 
of FLE used. (Table 5.1-2 & Fig. 5.1-2). Inhibition of HPP-CFC colony growth 
was optimal when lml of FLE was used. A 41% reduction in colony 
numbers was observed from 61 colonies in the untreated samples to 36 
colonies in the FLE treated samples (p = 0.019). At all other concentrations 
of FLE there was no significant difference in colony production in the 
control and FLE treated groups, p » 0.275. Decreasing the volume of FLE 
used, from 0.5ml down to 0.031ml, had no significant effect on the 
formation of HPP-CFC colonies p » 0.296. FLE did not promote the growth 
of HPP-CFC colonies at any concentration used.
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Table 5.1-2 Number of HPP-CFC Formed /1C£ Normal Bone Marrow 
Cells inthe Absence and Presence of FLE
Volume of
FLE (ml)
Control BM BM + FLE No. of
Experiments
1.0 61 ± 3.3 36 ± 3.3 4
0.5 47 ± 12.6 51 ± 2.2 4
0.25 51 ± 7.2 51 ± 2.4 4
0.125 54 ± 2.5 56 ± 3.4 4
0.062 57 ± 2.7 62 ±1.6 4
0.031 59 ± 2.1 59 ± 2.1 4
Data expressed as mean ± S.E.
Fig, 5,1-2 No. of HPP-CFC Formed by Normal Bone Marrow in the
Absence and Presence of FLE
N
o.
 of 
H
PP
 Co
lo
ni
es
Control (no FLE) 
+ FLE
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5.2 Effect of FLE on SA2 Leukaemic Cell Line
The presence of FLE significantly reduced the production of SA2 colonies, p 
« 0.005, (Table 5.2-1 & Fig. 5.2-1). Addition of 0.25ml of FLE to the SA2 cells 
resulted in a 21% reduction in the number of colonies produced. More 
effective inhibition of colony formation was demonstrated in SA2 cells 
which had been incubated with 0.5ml of FLE, when colony production was 
reduced by 33%. The most dramatic effect was observed when SA2 cells 
were incubated with 1ml of FLE. There was a 77% reduction in colony 
numbers from 29 colonies in the controls to 7 colonies in the SA2 treated 
samples.
Table 5.2-1 Number of Colonies Formed by 200 SA2 Leukaemic Cells in 
the Presence and Absence of FLE
Volume of
FLE (ml)
Control SA2 SA2 + FLE Reduction (%)
0.25 (n=6) 29 ± 0.7 23 ±1.2 21 ±1.8
0.50 (n=6) 27 ±1.4 19 ±1.4 33 ±3.2
1.00 (n=6) 29 ± 0.9 7±1.1 77 ±4.8
Data expressed as mean ± SE n = number of experiments
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Fig, 5,2-1 Effect of FLE on Colony Formation By SA2 Leukaemic Cells
Control 
+ FLE
Volume of FLE (ml).
Fetal liver extract showed a marked difference in suppression of SA2 
leukaemic cells and HPP-CFC derived from normal bone marrow (Fig. 5.2­
2). Colony formation of SA2 cells was significantly inhibited at all 
concentrations of FLE used. Growth of HPP-CFC was only suppressed by a 
10 % concentration of FLE, however not to the same degree as the 
suppression of the SA2 cells with this concentration of FLE.
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Fig. 5.2-2 Comparison of the Inhibitory Effects of FLE on Colony
Formation of Normal Bone Marrow Cells and Leukaemic
SA2 Cells
Discussion
5.3 Haematopoietic Regulatory Factors in Fetal Liver
At volumes of less than lml, crude fetal liver extract had no effect on the 
formation of HPP-CFC by normal bone marrow. However lml of crude FLE 
reduced HPP formation by 41%. The effect of FLE on bone marrow rendered 
hypoplastic by irradiation was more dramatic. HPP formation by bone 
marrow given 2.5 and 5 Gy y irradiation was considerably depleted 
following treatment with FLE. The inhibitory effect was most dramatic in
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bone marrow given a 2.5 Gy dose, which was regenerating at the time of 
use. Bone marrow given a 5 Gy dose would not be fully regenerating at four 
days post-irradiation. However the number of colonies produced by FLE 
treated bone marrow given 5 Gy, was not different form the number 
produced by FLE treated bone marrow given 2.5 Gy. Colony production in
7.5 and 10 Gy samples was severely depleted in both the control and FLE 
treated groups. There was no evidence that infusions of crude fetal liver 
extract could improve aplastic anaemia.
While the number of HPP colonies was reduced in the FLE treated samples, 
the size of the colonies had increased (personal observations). Most of the 
HPP colonies were >5mm, which suggests that while FLE may reduce the 
primitive HPP-CFC formation, the number of more mature progenitor 
cells produced is increased by FLE treatment. Increased output of progenitor 
cells is vital for reconstitution of irradiated bone marrow, lml of crude 
murine FLE may induce decreased proliferation of HPP-CFC but increase 
differentiation of these primitive cells to produce essential marrow­
repopulating progenitor cells.
Haematopoietic regulation in fetal liver has been the subject of intense 
investigation in recent years A stimulator of CFU-S has been detected in 
the 30-50K dalton fraction of murine FLE, while inhibitor is detected in the 
50-100K dalton fraction. The concentration and effects of the stimulator 
decrease with gestation as the liver ceases to be the main site of 
haematopoiesis (Dawood et al 1990). In addition to the CFU-S stimulator 
and inhibitor, murine and human fetal liver have been shown to produce 
inhibitor and stimulator of GM-CFC production. Supernatants from fetal 
liver early in gestation produce inhibitor of GM-CFC and supernatants 
from late fetal liver produce stimulator of GM-CFC (Cork et al 1986).
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EGM-CSF and burst promoting factor are released by adherent murine fetal 
liver stromal cells in vitro at around the 15th day of gestation (Thomas 
1993). These factors promote differentiation of stem cells into various 
haematopoietic lineages in addition to stimulating proliferation of 
quiescent CFU-S (Zhao & Wu 1990). Murine fetal liver stromal cells have 
also been shown to produce interleukins 1-7, with the exception of IL-5, and 
stem cell factor at levels almost 20 times higher than bone marrow stromal 
cells (Gutierrez-Ramos, Olsson & Palacios 1992).
The presence of regulatory factors of CFU-S in murine and human fetal 
liver has been well documented, however regulation of the HPP-CFC 
population has not been so well documented. Normal quiescent bone 
marrow HPP-CFC have been shown to respond to the CFU-S stimulator, 
while actively cycling HPP-CFC in regenerating bone marrow respond to 
the CFU-S inhibitor (Robinson & Riches 1991). The CFU-S stimulator can 
be isolated from regenerating bone marrow cells which are actively cycling. 
In 15 day fetal liver, haematopoietic cells are also in cell cycle, however the 
crude fetal liver extract used in this investigation did not promote an 
increase in HPP-CFC production by normal bone marrow cells. It is possible 
that fetal liver contains additional haematopoietic regulators, the effects 
and composition of which have not yet been determined. In the crude 
form, the overall effect of fetal liver extract appears to inhibit proliferation 
of HPP-CFC, it may however promote differentiation of these cells.
Arginase is known to be produced in abundance by fetal liver (Wu, Pei & 
Cong 1989). Arginase has been shown to prevent the growth of normal 
mammalian cells or tumour cells in culture, by depleting essential amino 
acids such as arginine and its precursors in the culture medium. Wu et al 
(1989) demonstrated a significant content of arginase in human fetal liver
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and reported CFU-GM growth was severely depressed following incubation 
with fetal liver supernatant. Fractionation of fetal liver revealed that 
arginase activity was high in the 60K dalton fraction which significantly 
reduced CFU-GM growth and completely suppressed growth of leukaemic 
HL-60 cells. The inhibitory activity observed in this fraction of human fetal 
liver is consistent with the inhibitory activity detected in the 50-100K 
dalton fraction of murine fetal liver (Dawood et al 1990). The 30-60K dalton 
fraction of human FLE did not significantly reduce the growth of HL-60 
cells and arginase could not be detected in this fraction. CFU-S stimulator is 
detected in the corresponding fraction in murine FLE. However Wu and 
his associates reported 100% inhibition of the leukaemic cell line in the 
presence of a < 10K dalton fraction of fetal liver, in which arginase activity 
could not be detected. In contrast to the devastating effects of this fraction 
on leukaemic cells, the effects on CFU-GM growth were minor. Therefore it 
would appear that in addition to arginase another inhibitor of HL-60 
growth is present in crude human fetal liver extract.
Murine FLE has been demonstrated to have suppressive effects on normal 
bone marrow cells, on irradiated bone marrow and on leukaemic SA2 cells, 
lml of FLE depresses colony production in both normal and irradiated bone 
marrow and severely depresses production of colonies by leukaemic cells. 
At volumes of 0.5ml or lower, FLE has no effect on the formation of HPP- 
CFC by normal bone marrow cells. In contrast, FLE was observed to have an 
inhibitory effect on SA2 leukaemic cells at all concentrations. The 
inhibitory effect was more pronounced as the concentration of FLE was 
increased, from a reduction in colony formation of 21% with 0.25ml FLE to 
77% with lml FLE. The inhibitory effects of FLE were more pronounced on 
irradiated bone marrow than on normal bone marrow cells. Optimal effects 
of FLE were observed in bone marrow given 2.5 Gy and 5 Gy y irradiation.
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Both SA2 cells and bone marrow given moderate doses of irradiation are in 
cycle, therefore it is reasonable to assume that the inhibitory effects of FLE 
are more pronounced on cells which are cycling
The human FLE used by Wu et al, like the murine FLE in the present 
investigation, were crude supernatants from centrifuged fetal liver cells. A 
lml FLE inhibited growth of HL-60, CFU-GM and in the present 
investigation SA2 leukaemic cells and HPP-CFC from normal and 
irradiated bone marrow. The FL supernatants in both cases were collected 
directly from centrifuged fetal liver cells without any fractionation or 
incubation at 37°C, and are therefore very crude and very different from 
fetal liver conditioned medium and fractionated fetal liver cells. There 
have been many reports of stimulatory effects of fetal liver conditioned 
medium and from specific fractions of both human and murine fetal liver.
Infusion of fetal liver has been demonstrated to improve remission of 
acute myeloid leukaemia and acute leukaemia patients recovering from 
chemotherapy and aplastic anaemia (Kochupillai et al 1985; Meng et al 
1985). In both investigations there was no evidence of engraftment of the 
fetal liver cells. Izzi et al (1985), reported haematopoietic reconstitution of 
aplastic anaemia and acute leukaemia following fetal liver transplantation. 
The fetal liver cells did not engraft, however they permitted the patients to 
overcome a period of profound aplasia following the conditioning regime, 
by promoting haematopoiesis in the host. The fetal liver cell suspensions 
used by Izzi et al, which had been incubated at 37°C, did not present any 
anti-leukaemic effects. In contrast the crude murine fetal liver extract used 
in the present investigation had a dramatic suppressive effect on the 
growth of leukaemic cells.
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The inhibitory effect of FLE on the leukaemic SA2 cells was more 
pronounced than its suppressive effect on HPP-CFC derived from adult 
bone marrow (Fig. 5.2-2). Growth of SA2 cells was depleted at all 
concentrations of FLE while only 10% FLE had a significant effect on the 
growth of normal bone marrow. This may suggest selective suppression of 
the leukaemic cell line rather than normal bone marrow by murine FLE. 
Similar effects of crude human FLE have been reported by Pei and Wu 
(1990). A low molecular weight fraction of FLE suppressed the growth of 
both human and murine leukaemic cell lines, however CFU-GM growth 
was only mildly suppressed. The suppressive effect of the human FLE was 
also observed to increase as the concentration of FLE was increased.
Pei & Wu also demonstrated the suppressive effect of human FLE on the 
growth of leukaemic cells in long term culture. The number of CFU-GM 
was reduced initially but increased after the 5th day in culture. Providing 
further evidence that the low molecular weight fraction of fetal liver plays 
an important role in the selective degeneration of leukaemic cells. 
Touraine, Royo and Gitton (1990), have also reported anti-leukaemic effects 
of fetal liver cells. Leukaemic mice injected with fetal liver showed a 
dramatic improvement, with almost entire ablation of the leukaemia. The 
fetal liver cells mounted a considerable reaction to the leukaemic cells 
without causing GvH reaction, this finding has very important clinical 
significance.
The inhibitory effect of FLE on leukaemic cells has important clinical 
applications in the treatment of leukaemic patients. At present allogeneic 
bone marrow transplantation is the most effective method of treating 
leukaemia, however in many cases the lack of HLA-identical donors, pose 
obvious problems for successful transplantation. Autologous bone marrow
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transplantation has been considered as a viable alternative, using large 
doses of irradiation and cytotoxic drugs to purge the leukaemic cells from 
the bone marrow before re-infusion into the patient. However it is not 
always possible to remove all the leukaemic cells and the potential for 
relapse exists. Multiple infusions of fetal liver suspensions in leukaemic 
patient following large doses of chemotherapy have resulted in a high 
incidence of complete remission (Wu et al 1989).
The natural tumour suppressor in human fetal liver detected by Wu &c Pei 
(1989) may also exist in murine fetal liver. Investigations could be 
performed on a < 10K dalton fraction of murine fetal liver in order to 
establish whether it selectively suppressed leukaemic cells. The suppressive 
effects of FLE on leukaemic cells described by Wu & Pei and in the present 
investigation could potentially be used to purge leukaemic cells for 
autologous bone marrow transplantation in the treatment of leukaemia. 
Both human and murine FLE inhibit the growth of leukaemic cells lines 
and have less detrimental effects on the growth of normal bone marrow 
cells. The disappearance of leukaemic cells in long term culture could 
prove to be a viable means of detecting ablation of the leukaemic cells from 
the bone marrow and thereby purifying the stem cells prior to re-infusion 
into the patients. Optimal culture conditions for stem cell proliferation 
would have to be established and the number of stem cells to be infused 
into the patient must be determined.
5.4 Fetal Liver Transplantation
Transplants of haematopoietic stem cells derived from fetal liver can 
reconstitute bone marrow function in patients with SCID, 
immunodeficiencies, some inborn errors of metabolism and following
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cancer chemotherapy. Fetal liver transplants are unequivocally associated 
with less GvHD than corresponding bone marrow transplants and thus 
have been considered as a feasible alternative to bone marrow 
transplantation when an HLA-matched donor is not available. The high 
proportion of cycling cells in fetal liver and the absence of mature T- 
Lymphocytes confer potential advantages for fetal liver transplants over 
conventional bone marrow transplants.
Reconstitution of T-cell function in SCID patients and bare lymphocyte 
syndrome has been reported (Touraine et al 1987). Transplants of fetal liver 
and thymus from the same donor have been demonstrated to enhance 
immune reconstitution in SCID patients by providing a syngeneic 
environment for the differentiation of transplanted stem cells into 
lymphocytes. Fetal liver transplants have been used to treat various inborn 
errors of metabolism with only limited success, benefits for the patients 
were only partial and transient. Inborn errors of metabolism have also been 
significantly improved by these dual organ-derived cell transplants 
(Touraine et al 1985). However multiple transplants have to be performed 
in order to establish engraftment of the donor cells.
Fetal liver transplants have also been performed on patients with acute 
leukaemia and aplastic anaemia (Gale 1985). The incidence of engraftment 
is higher in leukaemic patients. Patients with aplastic anaemia have an 
intact immune system and thus graft rejection is not really surprising. 
Leukaemic patients have a functionally depressed immune system due to 
the disease and the pretransplant conditioning regimen. Improved 
engraftment of fetal liver cells may therefore be possible by intensifying the 
pre-and post-transplant immune suppression. Fetal liver transplantation 
has been demonstrated to induce haematopoietic and immune 
reconstitution in humans (Gale 1985; Touraine et al 1987; Roncarolo et al
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1991), sheep and horses (Royo et al 1987), dogs (Prummer et al 1985; Cain & 
Champlin 1989) and mice (Thomas 1971, 1976). However failure of 
engraftment is an all too often outcome of fetal liver transplantation and 
considerably higher numbers of fetal liver cells have to be infused in 
comparison to the number of cells used for bone marrow transplants.
More recently in utero transplantation of fetal liver cells have been 
successfully performed, this technique takes advantage of the 
immunological tolerance of the fetal recipients. Harrison et al (1989) 
reported successful engraftment of fetal liver cells in rhesus monkeys with 
no evidence of GvHD. Successful in utero transplantation has also been 
reported in humans. Touraine (1991), performed transplantation of fetal 
liver cells from 7-10 week old fetuses, in patients with immunodeficiencies, 
thalassemia major and bare lymphocyte syndrome. So far results are very 
encouraging, donor cell engraftment has been demonstrated in transplants 
for all of the forementioned conditions. Thus engraftment difficulties 
which have hampered the advance of fetal liver transplants especially in 
bare lymphocyte syndrome may not be encountered with in utero 
transplants. In addition to the increased probability of graft take with in 
utero transplantation of fetal liver cells other advantages include, 
improved isolation of the fetus in the uterus rather than maintenance in a 
sterile bubble in a hospital and also the fetus itself provides the optimal 
environment for development of the transplanted fetal cells (Touraine et 
al 1992).
5.5 Prospects
Murine embryonic stem (ES) cells are a blastocyst derived cell line which 
can differentiate to produce all the cells of an entire fetus, following 
aggregation with developmentally compromised tetraploid embryos. The
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ES-derived embryos die before birth, however the embryonic liver is a 
source of haematopoietic progenitors which can reconstitute lethally 
irradiated adult mice. The ES cells can be maintained in vitro and thus 
could provide a continuous source of stem cells (Forrester et al 1991). The c- 
myb proto-oncogene has recently been demonstrated to play an important 
role in maintaining the proliferative state of haematopoietic progenitor 
cells. Alteration of the c-myb gene in ES cells causes severe anaemia in the 
resultant mutant mice. This anaemia could not be detected on the 13th day 
of gestation, however severe affects were apparent by the 15th day of 
gestation. It can therefore be assumed that the c-myb gene affects definitive 
haematopoiesis in the fetal liver and not primitive haematopoiesis of the 
yolk sac (Mucenski et al 1991).
These findings in ES cells suggest that fetal liver haematopoietic 
progenitors are susceptible targets for gene transfer and these progenitors 
become resident in the bone marrow of the adult. Introduction of foreign 
genes into haematopoietic stem cells may lead to a better understanding of 
gene expression and the pathogenesis of genetic disorders (Clapp et al 1991). 
There is also potential for correcting genetic defects in vivo. Insertion of 
functioning genes into deficient cells may prove to be a favourable 
alternative to allogeneic cell transplants for some inborn errors of 
metabolism. One of the main obstacles to overcome at the present time is 
the maintenance of corrected gene expression in the hosts.
It is reasonable to assume that in the next few years conventional bone 
marrow and fetal liver transplantation may be replaced by transplantation 
of pure stem cells which can be manipulated to enhance their stimulatory 
and inhibitory effects. The stem cells could be grown and maintained in 
culture eliminating the search for compatible donors and maintenance of 
extensive registers. Research on the murine ES cell line may eventually
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lead to the establishment of a human cell line with similar properties to 
fetal liver cells (Thomas 1993). These cells could be maintained in culture 
and used for transplantation, genetic transfer and synthesis of specific 
regulatory factors to cure or alleviate haematopoietic and genetic disorders
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Chapter 6
Adhesion of HPP-CFC to Stromal Layers in
Vitro
The extravascular stroma of the bone marrow and the fetal liver, serve as 
haematopoietic microenvironments in the two organs, and are required for 
specific lodgement, proliferation and differentiation of haematopoietic 
stem cells in vivo. The importance of the stroma is demonstrated in long 
term cultures in vitro, in which the development of an adherent stromal 
layer is essential for haematopoietic stem cell proliferation and
differentiation. The haematopoietic microenvironment of the stromal 
layer consists of cells and the extracellular matrix.
The ability of adherent stromal layers derived from fetal liver and normal 
bone marrow, to retain HPP-CFC seeded onto the layers and provide a 
suitable microenvironment for the proliferation and differentiation of the 
stem cells was investigated. Stromal layers derived from fetal liver on the 
15th day of gestation and from normal adult bone marrow were established 
and allowed to reach confluence. The layers were irradiated with a known 
dose of y irradiation and re-seeded with a known concentration of 
haematopoietic cells derived from fetal liver or adult bone marrow 6-10 
days later. After 2 hours the supernatant was removed from the layers and 
assayed for the presence of HPP-CFC. The difference in colony number 
produced from haematopoietic samples which had not been incubated with 
a stromal layer and samples which had been incubated with a stromal layer 
for two hours gives a measure on the number of stem cells which had 
adhered to the stromal layer (Chapter 2, pp 53-55).
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Stromal layers derived from Day 17 fetal liver and Day 19 fetal liver were 
established to determine whether these layers could support 
haematopoietic cells seeded onto them in a similar manner to the Day 15 
fetal liver layers. Cell suspensions of 15 day fetal liver or adult bone 
marrow were incubated with the adherent layers for two hours. As before 
the adhesion of HPP-CFC was determined by a reduction in colony 
numbers in the experimental groups when the supernatants were assayed.
Results
6.1 Adhesion of HPP-CFC to Bone Marrow and 15 Day Fetal Liver Stroma
500, 1, 000 or 5, 000 HPP-CFC derived from fetal liver, normal adult bone 
marrow or regenerating bone marrow were incubated with stromal layers 
derived from 15 day fetal liver or adult bone marrow. The difference in 
colony number produced by experimental and control groups is attributed 
to adhesion of the HPP-CFC to the stromal layer. The proportions of HPP- 
CFC which adhered to the irradiated stromal layers are illustrated in Table 
6.1-1 and Fig. 6.1-1.
Table 6.1-1 Proportion of HPP-CFC which Adhere to Stromal Layers (%)
No. of
HPP
seeded stroma
BM->FL
stroma
FL->BM
stroma
FL->FL
stroma
RBM->BM
stroma
500 74 ± 1.3 72 ± 1.0 100 ±0.0 73 ±3.5 72 ±1.1
1000 43 ± 1.3 53 ± 0.9 89 ± 0.9 55 ± 1.9 47 ±2.7
5000 21 ± 2.9 31 ±2.5 72 ±0.8 27 ±1.6 26 ± 3.0
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When a concentration of 6.25 x 105 cells derived from adult bone marrow, 
containing approximately 500 HPP-CFC, was incubated with an irradiated 
bone marrow stromal layer, 74% of the HPP-CFC adhered to the bone 
marrow layer. Seeding 1.25 x 106 bone marrow cells, containing 
approximately 1, 000 HPP-CFC, onto a bone marrow layer resulted in 
adhesion of 43% of the HPP-CFC to the layer. The proportion of HPP-CFC 
which adhered to bone marrow stromal layers was further reduced to 21 % 
when 6.25 x 106 bone marrow cells (~ 5, 000 HPP) were incubated with an 
irradiated bone marrow layer. Adhesion of bone marrow cells to a fetal 
liver derived stromal layer was not significantly different from adhesion to 
a bone marrow stromal layer. 72% of 5, 000 HPP, 53% of 1, 000 HPP and 31% 
of 5, 000 HPP seeded, adhered to the fetal liver stromal layer.
Incubating 5 x 105 cycling fetal liver cells, containing approximately 500 
HPP-CFC with a stromal layer derived from fetal liver resulted in adhesion 
of 73% of the HPP-CFC to the fetal liver layer. The proportion of HPP-CFC 
which adhered to the fetal liver layer was significantly reduced to 55% 
when 1 x 106 fetal liver cells (~1, 000 HPP) were seeded onto the layer. 
Seeding 5 xIO6 (~ 5, 000) fetal liver cells onto the layer further reduced the 
proportion of cells which adhered to the layer to 27%. Very similar results 
were obtained when regenerating bone marrow cells were seeded onto a 
stromal layer derived from adult bone marrow. 72%, 47%, and 26% of the 
500, 1, 000 and 5, 000 HPP respectively, adhered to the bone marrow stromal 
layer.
When 500 fetal liver derived HPP-CFC were seeded onto bone marrow 
layers, no HPP colonies could be detected in the supernatants, it was thus 
assumed that all the HPP-CFC present had adhered to the stromal layer.
The proportion of adherent HPP-CFC was reduced to 89% when 1, 000 HPP-
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CFC were seeded onto the bone marrow layers, this was further reduced to 
72% when 5, 000 HPP-CFC were used. Anova and Freidmans non­
parametric testing showed that the proportion of FL derived HPP-CFC 
which adhered to bone marrow stromal layers was significantly different 
from all other combinations (p < 0.0001), regardless of the concentration of 
HPP. It would thus appear that cycling fetal liver cells preferentially adhere 
to stromal layers derived from adult bone marrow.
The proportions of adherent cells were found to decrease as the
concentration of HPP-CFC was increased in every combination tested.
These proportions were significantly different at each concentration, 
regardless of combination (p < 0.0001).
Fig. 6.1-1 Proportion of HPP-CFC which Adhere to Irradiated Stromal 
Layers
BM->BM Stroma 
BM->FL Stroma 
FL->BM Stroma 
FL ->FL Stroma 
RBM->BM Stroma
No. of HPP Seeded
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While the proportion of adherent cells decreased as the concentration of 
HPP-CFC was increased, the actual number of HPP-CFC which bound to the 
stromal layers increased as the concentration of stem cells was increased 
(Table 6.1-2, Fig. 6.1-2).
Table 6.1-2 Number of HPP-CFC which Adhere to Irradiated Stromal 
Layers
No. of
HPP
seeded stroma
BM->FL
stroma
FL->BM
stroma
FL->FL
stroma
RBM->BM
stroma
500 368 ± 6.4 361 ± 4.8 500 363 ± 17.3 360 ± 5.7
1000 426 ± 13.3 543 ± 8.7 890 ± 8.9 548 ± 18.5 474 ± 27.5
5000 1060 ±143 1570 ±124 3618 ±39 1360± 80 1290 ±151
The results demonstrate that bone marrow stromal layers can
accommodate at least 3, 600 HPP-CFC derived from fetal liver but when 1, 
000 fetal liver HPP-CFC were seeded onto bone marrow stroma only 890 
HPP-CFC adhered to the layer. Similar trends were observed in all other 
combinations, however the number of HPP-CFC which adhered to the 
stromal layers were markedly reduced. Fetal liver stroma could retain at 
least 1570 BM HPP and 1360 FL HPP, however only retained a proportion of 
the initial concentration of stem cells when 500 and 1, 000 HPP were seeded 
onto the stroma. Similarly bone marrow stroma could accommodate at 
least 1050 HPP derived from bone marrow and 1300 HPP derived from 
regenerating bone marrow but adhesion of such numbers of HPP-CFC was
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only observed when an initial inocula of 5, 000 HPP-CFC were seeded onto 
the bone marrow layers.
Fig, 6.1-2 Number of HPP-CFC which Adhere to Irradiated Stromal 
Layers
BM-BM
BM-FL
FL-BM
FL-FL
RBM-BM
No. of HPP Seeded
Ability of Late Gestational Fetal Liver Stromal Layers to Support
Haematopoiesis
Haematopoietic cell suspensions of fetal liver or bone marrow, containing 
approximately 1, 000 HPP-CFC, were observed to adhere to stromal layers 
derived from Day 17 and Day 19 fetal liver (Table 6.1-2 and Fig. 6.1-2). 21% 
of HPP-CFC derived from 15 Day fetal liver adhered to stromal layers
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derived from Day 17 fetal liver and 20% adhered to stromal layers derived 
from Day 19 fetal liver. 23% of HPP-CFC derived from adult bone marrow 
adhered to Day 17 fetal liver stroma and 21% adhered to Day 19 fetal liver 
stroma. Anova showed there was no significant difference in the adhesive 
properties of stroma derived from Day 17 and Day 19 fetal liver, nor in the 
ability of the layers to retain haematopoietic cells derived from fetal liver or 
bone marrow (p = 0.99). The proportion of HPP-CFC, derived from fetal 
liver or bone marrow, which adhered to the Day 17 and Day 19 fetal liver 
stroma was significantly reduced in comparison to the proportion of fetal 
liver or bone marrow HPP-CFC, which adhered to stromal layers derived 
from Day 15 fetal liver (p < 0.0001). This suggests that 15 day fetal liver has a 
greater supportive capacity for haematopoietic stem cells than stromal 
layers derived from fetal liver later in gestation.
Table 6.2-1 Proportion of HPP-CFC which Adhere to Day 17 and 
Day 19 Fetal liver Derived Stromal Layers
Combination Proportion of Adherent 
HPP-CFC (%) Mean + SE
No. of
Experiments
FL-> Dy 15 FL 
stroma
55 ± 1.9 5 i
FL-> Dy17FL 
stroma
21 ±4.2 8
FL-> Dy19 FL 
stroma
20 ±6.4 8
BM-> Dy15 FL 
stroma
53 ±0.9 5
BM-> Dy17 FL 
stroma
23 ± 1.1 4
BM-> Dy19 FL 
stroma
21 ± 1.6 4
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Fig, 6-2-1 Adhesion of Fetal Liver and Bone Marrow HPP-CFC to
Stromal Layers Derived from Day 15, 17 and 19 Fetal Liver
Combination
Discussion
6.3 Adhesion of Haematopoietic Cells to Bone Marrow and Fetal
Liver Microenvironments in vitro
Long-term bone marrow cultures demonstrate the crucial role of the 
stromal cells in supporting proliferation and differentiation of 
haematopoietic precursor cells in vitro. Stromal cell lines derived from 
bone marrow (BM) and fetal liver (FL) have been established by several 
groups to investigate the cellular and molecular interactions with
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haematopoietic cells and to determine any morphological or functional 
differences in the stroma derived from both organs (Dexter et al 1977; 
Shaklai 1989; Vogt et al 1991; Allen 1992; Hata et al 1993). The 
morphological characteristics of stromal layers derived from adult bone 
marrow and fetal liver at 15, 17 and 19 days of gestation are detailed in 
Chapter 3. This Chapter discusses the adhesive properties of BM and FL 
stroma.
HPP-CFC derived from 15 day FL or adult BM were observed readily to 
adhere to stromal layers derived from either 15 day FL or adult BM. There 
was no significant difference in the adhesion of HPP-CFC derived from 
normal bone marrow to adherent layers derived from bone marrow or fetal 
liver, regardless of the concentration of stem cells incubated with the layer. 
Likewise, there was no significant difference in the adhesion of HPP-CFC 
derived from regenerating bone marrow to bone marrow stroma or in the 
adhesion of HPP-CFC derived from fetal liver to fetal liver stroma, for all 
three concentrations of stem cells used. However the loss of HPP-CFC 
derived from fetal liver which were incubated with stromal layers derived 
from adult bone marrow was significantly greater than all the other 
combinations investigated, suggesting preferential adhesion of fetal liver 
cells to bone marrow stroma.
The proportion of HPP which adhered to the stromal layers was dependent 
on the number of HPP seeded onto the layers. When only 500 HPP were 
seeded onto the stromal layers a high proportion of HPP adhered. This 
proportion was moderately reduced when 1000 HPP were seeded onto the 
layers and was further reduced when 5000 HPP were seeded onto the layers. 
This trend was consistently observed in all the different combinations of 
haematopoietic progenitor cells seeded and adherent stromal layers. The 
proportion of FL derived HPP which adhered to BM stromal layers
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remained high throughout, although there was a reduction in this 
proportion as the number of FL cells was increased. When 5000 FL derived 
HPP were seeded onto bone marrow layers the proportion which adhered 
was as high as seeding 500 FL or BM derived HPP onto FL derived stroma, 
or seeding 500 BM or regenerating BM HPP onto BM stroma.
While the proportion of HPP-CFC which adhered to the stromal layers 
decreased as the concentration of stem cells was increased, the actual 
number of HPP-CFC which bound to the stromal layers increased linearly 
with concentration in all five combinations. This indicates that a number 
of HPP-CFC did not adhere to the stromal layers even when the layers had 
sufficient binding sites to accommodate all the HPP-CFC. Both bone 
marrow and fetal liver stromal layers could accommodate at least 1000 
HPP-CFC, however when 1000 HPP-CFC of either bone marrow or fetal 
liver origin were seeded onto the layers, only a proportion of the initial 
concentration were retained by both layers. The decrease in proportion of 
adherent HPP-CFC as their numbers were increased could suggest that 
stromal layers have a specific number of niches in which haematopoietic 
stem cells can be accommodated. Using higher concentrations of 
haematopoietic cells could lead to saturation of the stromal layer, with all 
the binding sites occupied by haematopoietic progenitors. However the 
efficiency of FL derived HPP binding to BM stroma was not markedly 
reduced even at high concentrations (5xl06) of HPP seeded per flask. 
Gordon et al (1987) used concentrations of up to 107 cells, in 35mm petri 
dishes, and reported that in practice the number of binding sites in the 
stroma is not a limiting factor. It would therefore appear that while bone 
marrow and fetal liver stromal layers have niches for support of 
considerable numbers of haematopoietic stem cells, extensive
207
haematopoietic cell binding was only observed in the preferential adhesion 
of fetal liver stem cells to bone marrow stromal layers.
The kinetic properties of HPP derived from FL and those derived from BM 
are very different. A high proportion of HPP-CFC in fetal liver are actively 
cycling, while in the bone marrow HPP are quiescent. The difference in 
kinetic properties could account for the increased adhesion of FL stem cells 
to BM stromal layers. The proportion of HPP-CFC synthesising DNA is also 
high in regenerating BM (~ 40 %), however there was no significant 
difference in the adhesion of regenerating BM or normal BM HPP to bone 
marrow stromal layers. The selective adhesion to BM stromal layers thus 
appears to be a phenomenon unique to FL derived HPP-CFC.
Stromal layers derived from adult bone marrow and fetal liver can 
effectively support haematopoiesis in vitro. Haematopoietic stem cells 
seeded onto the layers must first adhere to the stromal layer prior to any 
proliferation or differentiation (Bentley 1982). This investigation has 
revealed that haematopoietic stem cells will effectively bind to stromal 
layers derived from both adult bone marrow and 15 day fetal liver.
However adhesion of HPP-CFC to stromal layers derived from fetal liver 
on the 17th and 19th days of gestation was significantly reduced compared 
to adhesion of progenitor cells onto 15 day fetal liver stroma. Seeding BM 
or FL cell suspensions (both containing - 1, 000 HPP-CFC) onto 15 day FL 
stroma resulted in adhesion of 53% and 55% of HPP respectively. When the 
same initial inocula were seeded onto stroma derived from 17 day FL 
stroma, only 23% of BM and 21% of FL HPP-CFC adhered to the layer. Day 
19 FL stroma was effective in retaining only 21% of BM and 20% of FL HPP- 
CFC from an initial concentration of 1, 000 HPP.
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These results suggest that while fetal liver has a great supportive capacity 
for haematopoietic cells in vitro, this capacity declines as gestation 
proceeds. As haematopoietic activity in the bone marrow is initiated, there 
is essentially no need for the fetal liver to remain a haematopoietic site and 
thus the capacity of the liver to support haematopoiesis declines. This 
finding is consistent with the morphological changes observed in fetal liver 
in late gestation and neonatal liver (Chapter 3) and also with the decline in 
both the number and cycling status of HPP-CFC in late fetal and neonatal 
liver (Chapter 4).
Within the haematopoietic microenvironment, dynamic cellular 
interactions are constantly occurring, involving stem cells, progenitor cells 
and more mature cells physiologically interacting with stromal cells, 
glycoproteins and ECM. These interactions serve to regulate normal 
haematopoiesis by allowing the communication of regulatory information, 
migration and subsequent homing of stem cells within specific organs for 
presentation of specific growth factors. Membrane interactions between 
progenitor cells and stromal cells are complex and known to involve 
cellular components in addition to polysaccharides and fibrous proteins of 
the ECM (Roberts et al 1987, 1988: Torok-Storb 1992).
Bone marrow stromal cells produce specific ECM components, fibronectin, 
laminin, hemonectin, collagens and proteoglycans. The observations that 
individual cellular elements have only a limited capacity to support 
haematopoiesis compared to the entire stromal layer, suggests that the ECM 
plays a role in facilitating cell lodgement and homing to the marrow 
(Roberts et al 1988). Haematopoiesis can be modulated via ECM production, 
which is thought to be under the control of growth factors. TGF-P
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stimulates collagen and proteoglycan synthesis and a-interferon increases 
glycosaminoglycan synthesis by stromal cells (Axelrad 1990).
The importance of attachment of haematopoietic progenitor cells to the 
stromal layer has been emphasised (Bentley 1982; Heard et al 1982). 
Attachment is thought to be highly selective and essential for the 
subsequent proliferation and differentiation of the haematopoietic cells. 
CFU-E and BFU-E show significant attachment to fibronectin while CFU- 
GM interact with hemonectin a different ECM component (Vuillet-Gaugler 
et al 1990). Growth factors may accumulate in the ECM of stromal cells as 
GM-CSF is bound to glycosaminoglycans produced by marrow stromal cells 
(Gordon et al 1987). Blast progenitors adhere to stromal layers grown in the 
presence of methylprednisolone (MP) but not to stromal layers grown in its 
absence, while more mature progenitors do not show any tendency to 
adhere to either type of stromal layer (Gordon et al 1985). These 
observations suggests that progenitor cells at different stages of maturation 
may occupy different microenvironments in the marrow and that different 
types of microenvironment, like haematopoietic cells, can be classified by 
their cell and growth factor binding capacities. The structure of the marrow 
may determine the distribution of haematopoietic lineages and alterations 
in the stromal cells may influence the differentiation patterns of progenitor 
cells.
Other groups have reported differences in the ability of haematopoietic 
progenitor cells to bind to stroma. Hardy & Minguell (1993) found the 
bipotential FDCP cell line bound very well to bone marrow stroma while 
multi-potential FDCP-mix and B6 Sut cell lines did not bind so well. The 
difference in the binding potential of the progenitor cells was attributed to 
differences in their cell surface membrane structures. Morphological 
examination of the haematopoietic stromal cell interactions revealed
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numerous microvilli and "ruffle-like structures" on the surface of the 
haematopoietic cells which appeared to interact with the stromal cells. 
Microvilli were also observed on the stromal cells and appeared to interact 
with the projections from the haematopoietic cells. Thus it would appear 
that intimate associations between haematopoietic cells and stromal cells 
observed in vivo also occur in long term cultures. Interactions have also 
been described between progenitor cells microvilli and ECM components of 
fibroblasts.
Studies by Hata et al (1993), have demonstrated the ability of 15 day fetal 
liver hepatocytes to support BM and FL cells. Separation of the 
haematopoietic progenitor cells from the stroma by Millicell filters had no 
adverse effects on the maintenance of haematopoiesis, suggesting that the 
fetal hepatocytes release soluble growth factors into the culture. GM-CSF 
and M-CSF were detected and assumed to be released by the hepatocytes, 
however IL-1, IL-3 and IL-6, which are well documented haematopoietic 
regulators were not detected. It is possible therefore that binding of 
haematopoietic cells to fetal liver stroma is not essential for their 
subsequent proliferation and differentiation. Thus fetal liver stromal cells 
may be able to exert regulatory factors on progenitor cells in their close 
proximity without the need for cell adhesion molecules.
The regulatory interactions between stromal cells and haematopoietic cells 
seem to be determined by mutual recognition and adhesive processes. The 
maturation of haematopoietic cells is thought to involve an orderly 
regression of cytoadhesive properties of stem cells and their progeny Allen 
& Testa 1991). Progenitor cells may thus respond to proliferation and 
differentiation signals by changes in their cytoadhesive properties, such 
changes may alter their capacity to bind to the stroma, promote migration 
to the sinus wall and subsequent release into the circulation. It is also
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possible that progenitor cells themselves may modulate the expression of 
receptors on their cell surface for stromal cells and ECM, thereby 
determining their own differentiation pathway. Progenitor cells can 
synthesise chondroitin sulphate proteoglycan which is unique to these cells 
and is thought to play a role in the binding of progenitor cells to the 
stroma. Homing protein is present on the surface of CFU-S and CFU-GM, it 
is not found on marrow or spleen stromal cells. Homing protein shows 
specificity for galactosyl and mannosyl residues, both of which are essential 
for cell binding. Differentiation of erythroid cells is normally associated 
with loss of this protein (Tavassoli & Minguell 1991).
Among the ECM components, fibronectin is thought to be the most 
effective for inducing adhesion and re-organisation of cytoskeletal 
structures. Haematopoietic cells are thought to recognise the locus of the 
fibronectin-cell attachment domain and readily adhere to the stromal cells. 
Integrins which are structurally related to fibronectin are thought to be 
involved in the recognition and adhesion of haematopoietic cells to 
stromal cells. The fibronectin-adhesion property is known to deteriorate 
with erythroid cell development and thus end-stage cells can be released 
into the circulation (Vuillet-Gaugler et al 1990).
Hemonectin is a cytoadhesive glycoprotein which shows lineage and organ 
specific attachment properties for cells of the granulocyte lineage, which 
may localise granulocytic cells in close proximity to specific growth factor 
producing stromal cells. Hemonectin expression is also lost as maturation 
proceeds and release of mature granulocytes into the circulation ensues 
(Dexter et al 1990).
Collagen is an essential matrix protein for the proliferation and
organisation of the marrow stromal cells. Collagens are thought to
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participate in the adhesive interactions by binding directly to the progenitor 
cells or by acting as anchorage receptors for proteoglycans (Dexter et al 1990).
Proteoglycans play a major role in haematopoiesis however the
mechanism of action of stromal proteoglycan is not well understood. They 
are thought to be involved in adhesion of progenitor cells to the stroma 
and to bind growth factors for presentation to the progenitor cells . Hence 
proteoglycans can direct compartmentalisation and molecular orientation 
of haematopoietic growth factors and subsequently direct specific lines of 
haematopoiesis (Gordon et al 1987; Roberts et al 1988).
AcSDKP which is known to inhibit quiescent CFU-S from entry into the 
cell cycle, has been shown to enhance binding of haematopoietic cells to 
stroma (Aizawa et al 1992). This enhancement is thought to occur through 
AcSDKP activation of stromal cells to express binding molecules (Lenfant et 
al 1989).
It is possible that the decreased adhesive properties of stromal layers 
derived from day 17 and day 19 fetal liver are due to decreased expression of 
one or a combination of ECM components, growth factors or proteoglycans. 
Expression of these molecules in late fetal liver derived stroma has not 
been documented. The findings of Hata et al (1993), that haematopoietic 
cells do not have to bind to 15 day fetal liver layers for regulation via 
growth factors, suggests that cell adhesion molecules are not necessary in 
long term fetal liver cultures. The reduced binding affinity of day 17 and 
day 19 fetal liver stromal layers may therefore be due to a reduction in 
growth factor production by the stromal cells rather than decreased 
numbers of cell adhesion molecules. Stromal cells derived from fetal liver 
deserve further investigation to clarify the expression of cell adhesion 
molecules and regulatory molecules, or lack of these factors and to
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document the changes which occur in expression of such factors in 
haematopoietically declining fetal liver.
The mechanisms of functional binding of haematopoietic cells to stroma 
remain unclear. Homing of haematopoietic cells to bind to specific stromal 
cells is thought to be an important phenomenon in haematopoiesis 
(Zanjani et al 1993). In the present investigation, HPP-CFC derived from FL 
were found to selectively adhere to BM derived stroma. Selective adhesion 
of progenitor cells to BM stroma has been previously reported. Gordon et al 
(1985), reported selective adhesion of blast-CFC (Bl-CFC) to bone marrow 
stromal layers, grown in the presence of MP, containing numerous fat cells. 
More mature progenitors did not selectively adhere to these layers. Stromal 
layers grown in the absence of MP, which do not contain fat cells, did not 
remove Bl-CFC or mature progenitors from the supernatant. Similarly 
Riley & Gordon (1987), reported that Bl-CFC adhered efficiently to adult 
bone marrow stromal layers but did not adhere so efficiently to stromal 
layers derived from fetal liver or fetal bone marrow.
Van Den Heuvel et al (1991), demonstrated that stroma derived from 
haematopoietically active organs supported GM-CFC proliferation in vitro 
better than stroma from organs in which haematopoiesis was declining or 
had just begun. Adult bone marrow displayed the highest ability to support 
GM-CFC regardless of whether the progenitor cells were of fetal liver, 
splenic or bone marrow origin. The predominantly erythroid nature of the 
fetal liver microenvironment and lymphoid environment of the spleen 
could account for this difference (Thomas 1971).
Binding of Bl-CFC to BM stroma does not require calcium or magnesium 
ions nor does it require known cell adhesion molecules, suggesting that the 
requirements for interaction between stromal cells and progenitor cells are
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provided entirely by the stromal layer (Gordon et al 1990). An inverse 
relationship between sialic acid content and adhesiveness has been 
reported (Gordon et al 1990). A high sialic acid concentration is thought to 
mask cell adhesion molecules on the more mature haematopoietic cells 
and thereby reduce adhesion. However the binding properties of Bl-CFC are 
not affected by neuraminidase treatment, which reduces sialic acid 
concentration, indicating that early haematopoietic progenitors may not 
express cell adhesion molecules (Gordon et al 1990). This finding has 
important implications in haematopoietic development.
Lack of expression, or masking, of cell adhesion molecules on fetal liver 
progenitor cells would prevent these cells from being "trapped” in the fetal 
liver environment and could promote migration of these cells from the 
liver to the spleen and bone marrow. Cell adhesion molecules expressed by 
haematopoietic cells are thought to be tissue specific which could explain 
the selective adhesion of Bl-CFC to adult bone marrow stromal layers 
(Bearpark & Gordon 1989). Expression of cell adhesion molecules by fetal 
liver progenitor cells has not been documented. Lack of expression of 
adhesion molecules by HPP-CFC would prevent the stem cells from 
remaining in the liver and promote migration to the bone marrow. 
Alternatively fetal liver HPP-CFC may express cell adhesion molecules 
which are specific for adult bone marrow receptors which could explain 
their selective adherence to bone marrow stroma.
While cell adhesion molecules may not be required, heparan-sulphate 
proteoglycan is however necessary for the binding of Bl-CFC to stroma and 
reinforces the idea that lineage and stage specific environments exist in the 
bone marrow (Gordon et al 1988). Segregation of haematopoietic progenitor 
cells in the bone marrow stroma, through specific binding molecules 
would facilitate their regulation and interaction with specific growth
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factors, to promote the development of a particular cell lineage. Other 
proteoglycans may be instrumental in the homing of haematopoietic stem 
cells, while another class of membrane associated proteoglycans is thought 
to be involved in the developmental regulation of erythroid cells 
(Tavassoli et al 1990). ECM components form only one group of molecules 
involved in the homing phenomenon, others include homing protein and 
cytoadhesive molecules.
6.4 Homing
Homing of haematopoietic progenitor cells is the phenomenon which 
permits intravenous transplantation of bone marrow cell suspensions. 
Evidence suggests that homing is the initial event in haematopoiesis and is 
responsible for stem cell migration from the yolk sac to the fetal liver and 
subsequently to the spleen and bone marrow (Moore & Metcalf 1970). It is 
generally accepted that homing involves intimate membrane interactions 
between the haematopoietic cells and the stromal cells in order for self­
renewal, proliferation and differentiation to occur (Tavassoli & Hardy 
1990). Progenitor cells which home to the bone marrow must interact with 
the luminal surface of the sinusoidal epithelium separating the vascular 
and extravascular compartments of the bone marrow. The cells migrate 
through fenestrations in the endothelial layer into the haematopoietic 
compartment where they recognise and bind to lineage specific stromal 
cells (Tavassoli & Hardy 1990).
Homing protein is considered to be responsible for the initial recognition of 
stroma by haematopoietic cells and enables the stem cells to identify and 
subsequently lodge within a specific niche (Hardy & Minguell 1993). This 
interaction however is of relatively low affinity and stabilisation is
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provided through ECM interactions which are of higher affinity (Tavassoli 
et al 1990). Incubation of haematopoietic progenitors with IL-3 and GM-CSF 
increases the density of homing protein. In lethally irradiated mice the 
concentration of homing protein is increased, and as a result the seeding 
efficiency of haematopoietic progenitor cells increases concomitantly with 
an increase in the adherence of these cell to stromal layers (Tavassoli & 
Minguell 1991).
Homing of transplanted haematopoietic stem cells to the bone marrow is 
blocked in the presence of galactosyl and mannosyl BSA, by inhibiting the 
action of the homing protein. In contrast homing of stem cells to the spleen 
is not affected by these synthetic neoglycoproteins (Aizawa & Tavassoli 
1988). This finding suggests that different mechanisms are involved in the 
recognition and homing of transplanted stem cells in the two sites. It is 
likely that the mechanism of recognition of the fetal liver by
haematopoietic stem cells and migration to this organ are also different.
While it is generally accepted that during the course of ontogeny 
haematopoietic cells migrate from the fetal liver and home to the bone 
marrow, the course and mechanism of this migration has not been 
delineated. As maturation proceeds the haematopoietic activity of the liver 
decreases (Chapters 3 & 4), this could be due to loss of its capacity for 
haematopoietic support and maintenance, as a result the stem cells migrate 
to the bone marrow which can provide a suitable microenvironment for 
proliferation and differentiation of stem cells. Alternatively the fetal liver 
haematopoietic stem cells may be pre-programmed to home to the bone 
marrow and ontogenic maturation of the stem cells may change their 
homing capacity. Such an ontogenic maturation could be expression of cell 
adhesion molecules which are specific for bone marrow receptors or other 
cell surface molecules which condition the homing and adhesion of fetal
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liver stem cells to the bone marrow (Houssaint & Hallet 1988). Thus the 
decrease in haematopoietic activity of the fetal liver may be a result of 
egression of progenitor cells to the bone marrow. These two possibilities are 
not necessarily exclusive.
The present investigation has revealed that stromal layers derived from 
fetal liver on the 15th day of gestation can adequately support 
haematopoietic stem cells derived from fetal liver and from adult bone 
marrow. BM and 15 day FL stromal layers were both capable of binding and 
supporting bone marrow derived stem cells. Similar results have been 
reported for the support of both fetal liver and bone marrow derived GM- 
CFC by human fetal liver and adult bone marrow stromal layers (Slaper- 
Cortenbach et al 1987).
The preferential adhesion of fetal liver HPP-CFC to bone marrow stroma 
could be ascribed to the natural migration of fetal liver stem cells to the 
bone marrow in vivo. This observation is consistent with reports of 
selective adhesion and homing of sheep FL stem cells to the bone marrow 
in vivo (Zanjani et al 1993). This group demonstrated that haematopoietic 
stem cells derived from fetal liver, preferentially homed to the bone 
marrow when injected, intraperitoneally, into fetuses between 60-80 days of 
gestation (term 145 days), even though the fetal liver was the main site of 
haematopoiesis at this stage. Prior to development of the bone marrow, 
haematopoietic stem cells injected into sheep fetuses homed to the liver or 
the spleen. Zanjani and colleagues propose the existence of a hierarchy of 
homing sites, in which the bone marrow has the highest affinity for the 
homing of transplanted haematopoietic stem cells. A similar hierarchy of 
affinity for haematopoietic cells may be responsible for the homing of stem 
cells from the yolk sac to the fetal liver.
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Alternatively the ECM proteins and cell adhesion molecules of the bone 
marrow stromal cells may bind fetal liver derived stem cells more 
effectively than stem cells of bone marrow origin. The expression of 
homing protein or adhesion molecule receptors on fetal liver progenitors 
has, as yet, not been delineated. Fetal liver stem cells may express a higher 
concentration of homing protein than bone marrow stem cells and 
consequently selectively migrate and adhere to the bone marrow.
Conversely, fetal liver haematopoietic cells may not express homing 
protein or specific cell adhesion molecule receptors. Differentiation in the 
erythroid lineage is associated with the loss of homing protein (Tavassoli & 
Hardy 1990). Erythropoiesis is the predominant form of haematopoiesis in 
the fetal liver, thus the fetal liver progenitors which have been maintained 
in an erythroid microenvironment may not express significant 
concentrations of homing protein. Lack of homing protein or adhesion 
molecule receptors would permit fetal liver progenitor cells to effectively 
bind to any part of the bone marrow stroma, unlike the selective binding of 
bone marrow stem cells to specific stromal environments. Hence bone 
marrow stroma may have the capacity to support considerably higher 
numbers of fetal liver stem cells which don not require such specific 
binding sites, compared to bone marrow stem cells. Selective adhesion of 
bone marrow stem cells to specific stromal sites permits the stroma to 
dictate the proliferation and differentiation of the stem cells along a 
particular lineage by presentation of specific growth factors. It is interesting 
to note that migration of stem cells to the spleen is not mediated through 
homing protein (Tavassoli 1990). This molecular recognition mechanism 
may exist only in the bone marrow, while fetal liver and splenic 
microenvironments may provide, as yet undetermined alternative 
mechanisms for the homing of stem cells.
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6.5 Clinical Implications
Interactions of haematopoietic cells with stromal cells may have important 
clinical implications. Abnormal interactions could contribute to the 
evolution or manifestation of haematological disorders, either through 
defective stroma or unusual interactions of haematopoietic cells. Aberrant 
interactions of haematopoietic cells with stromal cells in patients with CML 
and AML have been effectively exploited for in vitro purging of bone 
marrow cells in these patients (Clark et al 1992). Studies by Gordon et al 
(1987), have revealed altered adhesive interactions between primitive 
progenitor cells and stromal cells in CML. Bl-CFC derived from CML 
patients adhere to stromal layers grown in the presence and absence of 
methylprednisolone.
This finding suggest that CML cells are less discriminating than normal 
progenitor cells and consequently have an advantage to normal cells as 
they can adhere to and proliferate at additional sites within the bone 
marrow stroma. The CML progenitors do not adhere to MP layers as 
efficiently as normal Bl-CFC (Gordon et al 1987). This finding has serious 
implications in the early release of CML cells into the blood, these blood- 
borne metastases result in secondary tumour growth at other sites within 
the body. Eaves et al (1986) demonstrated that progenitor cells from patients 
with CML undergo continuous cycling in cell culture both in the presence 
and in the absence of a stromal layer. Normal haematopoietic cells cycle 
only after medium changes in stromal cultures. These observations suggest 
that CML progenitor cell cycling is not regulated by stromal cells, leading to 
early expansion of CML, this is likely to play a crucial role in 
leukaemo genesis.
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The use of new techniques to determine the molecular basis of
cytoadhesive interactions between stem cells and stromal cells and to 
define the nature of defective interactions with haematopoietic stem cells 
and stromal cell in a number of haematological conditions should lead to 
advances in bone marrow transplantation therapy (Clark et al 1992).
Effective haematopoiesis is the product of interplay between
haematopoietic stem cells and the supporting stroma, which provides a 
favourable environment for the maintenance of regulated proliferation 
and differentiation. Fetal liver stem cells seeded onto bone marrow stroma 
proved to be the most favourable combination for adhesion of stem cells 
and subsequent maintenance of haematopoiesis in the present 
investigation. It is not very surprising to find bone marrow stroma has a 
high affinity for fetal liver cells, otherwise migration of haematopoietic 
stem cells to the bone marrow might not occur and the initiation of 
haematopoietic activity in the marrow could be perturbed as a result. There 
would be no advantage to having a favourable soil for growth and 
maintenance of seeds if the soil was not sown with seeds to support 
(Tavassoli 1989).
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Chapter 7
General Discussion
7.1 Haematopoietic Activity in the Fetus and Early Neonate
Haematopoiesis is sustained by a pool of pluripotent stem cells which are 
capable of extensive self-renewal to maintain their numbers and also 
differentiation into progenitor cells which are committed to various 
haematopoietic lineages. Pluripotent progenitor cells have been identified 
which differentiate into mature lineage restricted cells, which in turn feed 
into the mature blood cell pool. The complex mechanism controlling the 
proliferation and differentiation of stem cells and progenitor cells in 
mammals has not been fully elucidated. In both humans and mice a 
variety of glycoprotein regulators have been purified and the 
corresponding genes have been cloned (Plumb & Pragnell 1988).
Ontogenic development of the haematopoietic system involves a series of 
co-ordinated changes in embryonic and early fetal life. The first generation 
of haematopoietic cells proliferate in the yolk sac and extra-embryonic 
mesenchyme. Yolk sac haematopoiesis is then replaced by the liver which 
continues to accommodate blood cell production till birth (Keleman et al 
1979).
The morphological investigations of fetal and newborn liver conducted in 
the present investigation revealed an increase in the haematopoietic 
activity of the fetal liver to a maximum on the 15th day of gestation. This 
activity was then observed to decline as gestational age advanced to a
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minimum observed in the liver of the 10 day neonate. These findings are 
consistent with the changes in site of haematopoietic production during 
development. The murine liver has assumed haematopoietic activity from 
the yolk sac by the 10th day of gestation (Hata et al 1993). In the present 
investigation the number of haematopoietic cells together with the 
number of hepatocytes and macrophages increase steadily from the 12th 
day of gestation. In the liver of the 14 and 15 day fetuses, the parenchyma 
was densely packed with cells of all haematopoietic lineages, resulting in 
considerable distortion to the contours of the central hepatocytes or 
macrophages which were surrounded by haematopoietic cells, to form the 
classic erythroblastic islands first described by Bessis.
Erythroid cells were the predominant lineage of haematopoietic cells in the 
liver samples examined, especially in fetal liver, suggesting the fetal liver 
stem cells are restricted in their differentiation capacity or that the 
microenvironment is primarily inducive to erythropoiesis (Thomas 1970). 
The cells were observed arranged around a central macrophage or 
hepatocyte and closely associated with the cytoplasmic extensions of the 
central cell. Granulocytes and monocytes were present in significant 
numbers from the 14th day of gestation onwards. They were commonly 
observed on the periphery of erythroid clusters associated with the 
processes of the central cell. Megakaryocytes were also observed at this stage 
in development, usually in close association with hepatocytes. They were 
never observed as integral components of the cell clusters.
The number of haematopoietic cells in fetal liver was observed to decline 
from the fifteenth day of gestation. Granulocytes and monocytes occupied 
more central positions in the cell clusters as the number of erythroid cells 
decreased. Lymphoid cells were observed closely associated with mixed 
lineage clusters in the liver of the newborn mouse. Haematopoietic clusters
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were restricted to single -lineage cells in the liver of the 10 day neonate. The 
cell clusters were no longer dispersed throughout the hepatic parenchyma 
but were limited to isolated areas in close proximity to the sinusoids 
(Rossant 1986).
While the number of haematopoietic cells decreased from the 15th day of 
gestation, a considerable increase in both size and number of hepatocytes 
was observed. This increase was also observed in vitro in long term fetal 
liver cultures. Hepatocytes which had been closely associated with 
haematopoietic cells were morphologically distinct from those which had 
not (Emura et al 1984). In newborn and neonatal liver, hepatocytes had a 
more regular outline than their fetal liver counterparts whose contours 
were distorted by the high number of haematopoietic cells. Adjacent 
hepatocytes were closely associated through apposition of their cells 
membranes or via interdigitating cytoplasmic processes. Cannalicular 
structures were observed between hepatocytes in vitro which may 
represent the in vivo bile cannaliculi. The intimate relations of adjacent 
hepatocytes could be associated with the change in function of the 
hepatocytes from a stromal element of a haematopoietic
microenvironment to a parenchymal component of the metabolic liver 
(Medlock & Haar, 1983). At birth the bone marrow becomes the main site of 
haematopoiesis in mammals, while the liver assumes its function as the 
main metabolic organ of the body. The adult liver however retains its 
ability to function as a site of haematopoietic production in extreme 
circumstances.
The increase in the haematopoietic activity of fetal liver to reach a peak on 
the 15th day of gestation followed by a subsequent decline in activity in late 
fetal and neonatal liver was mirrored in studies of the kinetic properties of 
blood cell precursors derived from fetal and neonatal liver (Chapter 4).
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Investigation of the cycling status of HPP-CFC derived from fetal, newborn 
and neonatal liver revealed a peak in the proportion of cells synthesising 
DNA in the liver of the 15 day fetus (53%), corresponding with the 
observed peak in haematopoietic activity. The proportion of cells in cycle 
progressively declined with gestational age to 28% in the newborn liver 
and further declined to 13% in the liver of the 8 day neonate. This decline 
in the proportion of HPP-CFC engaged in DNA synthesis corresponds to 
the morphological observations of minimal haematopoietic activity in the 
8 day neonate, when the bone marrow has assumed the role as the main 
site of haematopoietic production. A similar trend was observed in the 
number of HPP colonies produced by fetal and neonatal liver. Fetal liver 
produced a high number of HPP colonies, this was maximal on the 15th 
day of gestation. Colony production then declined to a minimum in the 
liver of the 8 day neonate.
In contrast to the kinetic properties of HPP-CFC, the cycling status of GM- 
CFC did not alter dramatically from that of the 15 day fetal liver (50%) to 
that of the newborn liver (43%). This high proportion of cycling GM 
progenitors in late fetal and newborn liver correlates with the in vivo 
myelopoietic phase of haematopoiesis observed in 18 day fetal, newborn 
and neonatal liver.
7.2 Cellular Interactions in Haematopoiesis
An array of cellular interactions control the production of blood cells in 
haematopoietic organs. The stromal cells of each organ provide an 
appropriate environment for the proliferation and differentiation of stem 
cells. Haematopoietic cell interactions have been elucidated in vivo in
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animal models and more recently in vitro using long term culture systems 
(Cline & Golde, 1979).
The first recognition of cellular associations and interactions during 
haematopoiesis was probably Bessis' report of the erythroblastic island in 
1958. In the present investigation erythroblastic islands were numerous in 
haematopoietically active fetal liver, their numbers progressively declined 
with the decrease in haematopoietic activity in newborn and neonatal 
liver. In addition to Bessis1 classic erythroblastic island, composed of a 
central macrophage surrounded by a ring of erythroblasts, many 
haematopoietic cells were observed to form clusters around a central 
hepatocyte in a similar manner. Indeed the number of haematopoietic 
clusters with a central hepatocyte outnumbered those with a central 
macrophage. Thus both hepatocytes and macrophages can function as the 
central cell of a haematopoietic island. This arrangement is thought to be 
essential for the differentiation of both erythroid cells and hepatocytes 
(Emura et al, 1985).
The central cells of the haematopoietic islands extended long cytoplasmic 
processes which were closely apposed to the adjacent haematopoietic cells 
and occasionally completely surrounded the blood cell precursors. These 
intimate associations are considered to play a significant role in the 
development of haematopoietic cells. Desmosomes and gap junctions were 
evident in regions of membrane apposition. These observations of direct 
cell-cell communication in erythroblastic islands have been previously 
reported, (Fukuda 1974: Rosendaal 1991), and their presence indicates the 
potential for the transfer of substances between the central cell and the 
developing haematopoietic cells.
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The gradients of differentiation observed in the clusters suggests that less 
mature cells are more dependent on the central cell. Shaklai (1989), suggests 
the more mature cells may migrate along the cytoplasmic processes of the 
central cell to occupy peripheral positions within the islands. The clusters 
in fetal liver were not restricted to cells of the erythroid lineage, granuloid, 
monocytic and lymphoid cells were usually observed in peripheral 
positions (Jones 1970: Grossi et al 1985). It may be that these cells are less 
dependent on the central cell than the erythroblasts alternatively the large 
number of erythroblasts present may prevent occupation of central 
positions by cells of other lineages.
In the liver of the 10 day neonate, the cell clusters were associated with 
hepatocytes only and, like haematopoietic clusters in the bone marrow, 
were composed of blood cell precursors of a single lineage. The number and 
distribution of the clusters were restricted. These findings have been 
reported by Grossi et al (1985) and Rossant et al (1986), who suggest that 
progenitor cells in the 10 day neonate are not multipotential but committed 
to specific lineages and thus give rise to single-lineage clusters.
Erythroblastic islands have also been reported in vitro in long term bone 
marrow cultures (Allen & Dexter 1982). Like their in vivo counterparts, 
cytoplasmic extensions of the central macrophages were closely associated 
with the haematopoietic cells. Vesicular activity and gap junctions in 
regions of membrane apposition has been reported (Rosendaal 1991: Allen 
1992). In the present investigation haematopoietic clusters were observed 
in vitro composed of central macrophages surrounded by granulocytes, in 
both bone marrow and fetal liver cultures. Granulocytes were also observed 
in close association with hepatocytes in fetal liver cultures, providing
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further evidence that both macrophages and hepatocytes can support 
haematopoiesis.
Hardy & Minguell (1993), observed microvilli and "ruffle-like" structures 
on the surface of haematopoietic stem cells which interacted with 
microvilli on the surface of stromal cells. Similar interactions were 
observed between progenitor cell microvilli and ECM components of 
fibroblasts. It would thus appear that the electron microscopic observations 
of intimate associations between haematopoietic cells and stromal cells in 
vivo, also occur in vitro in long term culture.
The role of erythroblastic islands has been debated for many years. The 
scavenger role of the central macrophage in removing extruded nuclei and 
old blood cells is generally accepted, however the provision of growth 
factors and nutrients to developing blood erythroblasts has not yet been 
conclusively proven and remains controversial. Other unsolved problems 
relating to erythroblastic islands include:- is the central cell essential for 
differentiation and maturation of erythroblasts? Erythropoiesis can take 
place in vitro in the absence of macrophages, however the haemoglobin 
content and membrane organisation of the resulting erythroblasts are not 
akin to those of erythroblasts in vivo (Mohandas 1991). This finding 
suggests that the macrophages have an important role to play in the 
regulation of gene expression.
What factors produced by the central cell act on haematopoietic cells? 
Bessis' rhopheocytic vesicles were numerous between the central cells and 
adjacent blood cell precursors in the present investigation. The cells in 
closest proximity to the central cell were observed to have a greater 
concentration of ferritin than peripheral cells, suggesting ferritin is more 
essential for the earlier precursor cells (Breton-Gorius 1991). However the
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direction of transfer of the ferritin could not be discerned. It is possible that 
the ferritin could travel in both directions from the central cell to the early 
precursors, as these cells mature they may no longer require high 
concentrations of ferritin, and excess ferritin could be removed by the 
central cell (Pollycove 1991).
Macrophages can produce a variety of regulatory molecules including Epo, 
G-CSF, M-CSF, GM-CSF, IL-1, TNF-a, TGF-p, fibronectin (Rich 1986;
Nathan 1987). Epo and CSF production by murine fetal liver macrophages 
is reported to be maximal in cultures of day 14 and day 15 fetal liver cells 
(Zucali 1977). This correlates with the in vivo peak of erythropoiesis in the 
liver of the 15 day fetus in the present study. Macrophages respond to 
varying concentrations of oxygen by increasing or decreasing the 
production of Epo and CSF accordingly (Rich 1986).
Hepatocytes are considered to produce substances which are essential for 
the development of erythroblasts (Medlock & Haar 1983). Hata et al (1993), 
demonstrated the production of GM-CSF and M-CSF by murine fetal liver 
hepatocytes, providing further evidence for their role as a haematopoietic 
supporting cell. The focal nature of the haematopoietic cell clusters both in 
vivo and in vitro, together with the observations of cellular interactions, 
rhopheocytic vessicles, gap junctions and desmosomes, provides the ideal 
environment for the provision of growth and regulatory factors to the 
blood cell precursors by the central cells.
The mechanism by which the blood cell precursors recognise and remain 
in close association with the central cell is unclear. Recognition of stromal 
cells in the bone marrow by haematopoietic stem cells occurs by means of a 
homing protein which has galactosyl and mannosyl specificities (Hardy & 
Minguell 1993). Different recognition mechanisms are thought to be
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involved in the hepatic and splenic microenvironments which as yet have 
not been investigated (Aizawa & Tavassoli 1988). Interaction of 
haematopoietic cells with macrophages in fetal liver is thought to occur 
through a divalent-cation dependent adhesion receptor, mediated by 
calcium. This receptor also operates in erythroblast-macrophage 
interactions in adult bone marrow, together with a divalent-cation 
independent receptor, which has been characterised as a glycoprotein 
produced exclusively by bone marrow macrophages (Crocker et al 1990, 
1991).
ECM proteins consisting of collagens, laminin, fibronectin and
proteoglycans are essential for the maintenance of haematopoiesis in long 
term bone marrow cultures (Zuckerman et al 1985). Fibronectin has an 
important role to play in the attachment of haematopoietic cells to stromal 
layers. Adhesion of CFU-E precursors is inhibited by antifibronectin 
antibodies (Coulombel et al 1992). Loss of fibronectin receptors results in 
the loss of adherence to the stromal layers. This phenomenon is especially 
important for reticulocytes which then migrate into the supernatant in 
long term cultures (Bernard 1991).
Heparan sulphate proteoglycan (HS-PG) is a CAM which is necessary for 
the binding of blast-CFC to stromal layers in vitro (Gordon et al 1988). 
Information on CAM's and ECM proteins of fetal liver cultures is however 
minimal. Macrophages and hepatocytes can both produce fibronectin and 
haematopoietic regulatory molecules. Thus blood cells precursors could 
attach to central cells and proliferate in response to specific growth factors 
presented to them. However Gordon et al (1990), reported that binding of 
very early progenitor cells to bone marrow stroma did not involve known 
CAM's. Thus binding of fetal liver haematopoietic cells to fetal liver 
stroma may not involve HS-PG, but instead as yet unknown CAM's.
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Further investigation is required to elucidate the binding of fetal liver 
blood cell precursors to hepatic stromal cells.
The biological importance of attachment of haematopoietic cells to stromal 
cells and ECM proteins for proliferation and differentiation of stem cells is 
unknown. It is likely that at least some of the forementioned features will 
contribute to the elusive role played by the microenvironment in the 
overall process of haematopoiesis (Mel 1991).
7.3 Haematopoietic Microenvironments
Haematopoietic cell clusters form only a part of the haematopoietic 
inductive microenvironment, in which supportive stromal cells provide a 
favourable environment for the maintenance of haematopoiesis. The 
haematopoietic stroma is thought to be essential for the proliferation and 
differentiation of stem cells (Tavassoli & Takahashi 1982). The biological 
interactions of stromal cells with primitive haematopoietic progenitors can 
reconstitute all the haematopoietic lineages within an irradiated host 
(Greenberger 1991).
Fetal liver and bone marrow stroma both in vivo and in vitro provide 
suitable microenvironments for the proliferation and differentiation of 
haematopoietic stem cells. Maintenance of haematopoiesis in vitro was 
dependent upon the establishment of an intact stromal layer. Stromal 
layers of both bone marrow and fetal liver origin were found to support 
haematopoietic stem cells seeded onto them regardless of whether the stem 
cells were of bone marrow or fetal liver origin. Granuloid progenitors were 
observed in fetal liver in vivo, however there is very little granulopoiesis 
in this organ. In vitro the dramatic shift from erythropoiesis to
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myelopoiesis suggests that all the necessary information for granulocyte 
production is present in the cells of fetal liver and that the culture 
conditions used promote their proliferation. It is not known how this 
change to granulopoiesis results, it could be through the selective survival 
or proliferation of cells producing the necessary factors for granulopoiesis. 
Alternatively it could occur through alteration of the regulatory pathways 
of the haematopoietic cells or the microenvironment to suppress 
erythropoiesis and promote granulopoiesis.
Stroma derived from day 17 and day 19 fetal liver could also support 
exogenous stem cells seeded onto them. However the haematopoietic 
activity in these cultures was sustained for a shorter period of time than in 
cultures of 15 day fetal liver stroma. This correlates with the in vivo 
observations of a morphological decline in fetal liver after the 15th day of 
gestation. The stromal environment of fetal liver on days 17 and 19 of 
gestation may be less suitable for haematopoiesis than that of day 15 and 
consequently the stem cells will migrate to the bone marrow and spleen 
where the stroma provides a more suitable microenvironment for 
haematopoiesis.
Haematopoietic stem cells seeded onto established stromal layers must first 
adhere to the layer prior to any proliferation or differentiation. Stromal 
layers derived from fetal liver on the 15th, 17th and 19th days of gestation 
and adult bone marrow could effectively bind a significant number of 
haematopoietic stem cells regardless of their origin. However stromal 
layers derived from day 17 and 19 fetal liver could not bind stem cells as 
effectively as day 15 fetal liver layers. The reduced haematopoietic activity 
in these layers could thus be a result of ineffective binding of 
haematopoietic stem cells to the layers. Thus the haematopoietic decline in 
fetal liver could be due, in part, to the less favourable stromal
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microenvironment in late gestation, which has a reduced binding capacity 
for stem cells.
Haematopoietic stem cells which were derived from fetal liver were found 
to selectively adhere to stromal layers derived from adult bone marrow. 
This adhesion was significantly greater than all other combinations of stem 
cells and stromal layers investigated. The number of fetal liver HPP which 
adhered to the bone marrow stromal layers increased linearly as the 
number of HPP seeded was increased. Zanjani et al (1993), reported 
selective adhesion and homing of fetal liver stem cells to the bone marrow 
in vivo, at the time when fetal liver was the main site of haematopoiesis. 
Selective adhesion of Bl-CFC to bone marrow stroma has been reported by 
Gordon et al (1985). However mature progenitors did not display this 
selective adhesion.
The reasons for the selective adhesion of fetal liver stem cells to bone 
marrow stroma are unclear. Why should bone marrow stroma bind fetal 
liver cells more effectively than bone marrow stem cells? The difference in 
kinetic properties of cycling fetal liver HPP and quiescent bone marrow 
HPP cannot be a contributory factor, as RBM cells which are also in cycle did 
not display preferential adhesion to bone marrow stromal layers. Zanjani et 
al (1993) propose a hierarchy of homing sites in which the bone marrow 
has the highest affinity for homing of transplanted haematopoietic stem 
cells. Alternatively the fetal liver stem cells may be pre-programmed to 
migrate from the liver microenvironment to that of the bone marrow. 
Homing of stem cells to the bone marrow could be considered as part of the 
maturation process of fetal liver stem cells.
It is not known how one tissue loses its potential to support
haematopoiesis while another tissue gains this potential. The decline in
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haematopoietic activity of the liver could be a result of changes in the 
microenvironment making it less suitable for haematopoiesis, 
alternatively it could be a consequence of egression of stem cells to the bone 
marrow, or indeed a combination of both these factors (Houssaint & Hallet 
1988). The applications of newer techniques to study the kinetics of 
haematopoietic cells during migration and gestational maturation should 
provide some insight into the change in site of blood cell production 
(Zanjani et al 1993).
The selective adhesion observed in the present investigation could be 
explained by the hypothesis that, under the conditions of this assay, a 
greater proportion of HPP-CFC derived from fetal liver are capable of 
adhering to stromal layers than HPP-CFC derived from adult bone marrow. 
Combining this factor with the possibility that BM stroma may contain a 
greater number of binding sites than fetal liver stroma provides an 
explanation why adhesion in the combination of fetal liver HPP and bone 
marrow stroma was significantly greater than all other stem cell-stromal 
combinations (Fig. 7.3). The actual functional mechanisms of 
haematopoietic stem cells binding to stroma are not known, however it is 
thought to be highly selective and essential for the development of 
haematopoietic cells. Membrane interactions of progenitor cells and 
stromal cells are very complex and are known to involve cellular 
components, ECM proteins and CAMs (Roberts et al 1988; Torok-Storb 
1992).
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Progenitor cells attach to specific ECM proteins, CFU-E and BFU-E attach to 
fibronectin, CFU-GM however interact with haemonectin (Vuillet-Gaugler 
et al 1990). Bl-CFC adhere only in methylprednisolone grown stromal 
layers while mature progenitors do not display this preference. HS-PG is 
necessary for the binding of Bl-CFC to stroma (Gordon et al 1988), while 
another class of proteoglycan is thought to be involved in regulation of 
erythroid cells (Tavassoli et al 1990). Thus progenitor cells may occupy 
specific environmental niches within the bone marrow, each
microenvironment could be classified by their cell binding and growth 
factor presentation capacities. In this manner the structure of the marrow 
could determine the distribution and differentiation of haematopoietic 
cells lineages (De Haan et al 1993). Alternatively progenitor cells may have 
the capacity to modulate the expression of stromal cell and ECM receptors 
on their cell surfaces, such as chondroitin sulphate and homing protein, 
and thereby determine their own differentiation pathway (Long 1992).
The morphological observations of fetal liver in vivo, in the present study, 
indicate that in contrast to the bone marrow microenvironment, lineage 
specific environmental niches do not exist in fetal liver. Granulocytes and 
monocytes were commonly observed as structural components of cells 
clusters together with erythroblasts. These mixed lineage clusters 
predominated in fetal liver, only in the liver of the 10 day neonate were 
single-lineage clusters observed, resembling those described in adult bone
marrow.
The multiple types of haematopoietic cell interactions in the bone marrow 
microenvironment require the presence of specialised cell surface 
structures which mediate cell adhesion and transmit signals from the 
stromal cells to growth factors and ECM. These systems represent a
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powerful mechanism for directing and localising cellular responses 
(Tavassoli et al 1990; Long 1992). Such a system has not been documented 
for haematopoietic regulation in the fetal liver microenvironment. It is not 
known whether fetal liver stem cells bind to fetal liver stromal cells in a 
manner similar to the binding of BM stem cells to BM stroma, or indeed 
whether functional binding is necessary in the hepatic microenvironment 
where the close associations of stem cells and stromal cells might suffice.
Expression of ECM molecules by fetal liver cells has received very little 
attention. Both fetal liver macrophages and hepatocytes can synthesise 
collagen, whether fetal liver macrophages have the capacity to produce 
other ECM proteins, like their bone marrow counterparts, is not known. 
Fetal liver GAGs have been shown to be inefficient in presenting GM-CSF 
to haematopoietic stem cells and thus may not be involved in growth 
factor presentation in the fetal liver microenvironment. Hata et al (1993) 
demonstrated that fetal liver macrophages and hepatocytes in vitro could 
release soluble growth factors which acted on haematopoietic cells in the 
vicinity.
Gordon's report (1990), that primitive Bl-CFC did not express known CAMs 
could also hold true for the primitive fetal liver stem cells. Lack of 
expression or masking of CAMs in the fetal liver environment would 
prevent the stem cells from being trapped and could promote their 
migration to the bone marrow. Alternatively during ontogenic maturation 
fetal liver cells may express CAMs which are specific for bone marrow 
receptors.
It is not known whether fetal liver stem cells express homing protein in 
the same concentration as bone marrow stem cells, if at all. Lack of 
expression of homing protein or specific CAMs by fetal liver stem cells
237
would permit these cells to bind effectively to any part of the bone marrow 
stroma and not be restricted to localised microenvironments like bone 
marrow stem cells. Hence bone marrow stroma may have the capacity to 
accommodate a greater number of fetal liver stem cells than those of bone 
marrow origin.
Fetal liver stem cells have properties which are similar to those of stem 
cells in patients with chronic myeloid leukaemia. CML progenitors are less 
discriminating than normal progenitors and thus can adhere to and 
proliferate in a large number of sites in the bone marrow which are not 
normally occupied by haematopoietic cells. Much remains to be learned 
regarding the role of ECM, CAMs and other as yet unidentified molecules 
in the binding of stem cells to stromal cells. Greater understanding of these 
interactions will increase our knowledge of normal stem cell biology and 
the behaviour of leukaemic cells.
7.4 Haematopoietic Regulation
Haematopoietic stem cells carry the entire genetic information which is 
required to amplify the stem cell subpopulation and to proliferate into 
differentiated progeny. The number of stem cells is maintained at a 
relatively constant level indicating that the mechanisms exist whereby 
stem cell numbers can be retained despite their differentiation into lineage 
restricted precursor cells (Clark et al 1992). Regulation of these processes is 
elicited in part by the intimate associations of the stem cells with stromal 
cells of that particular microenvironment. The microenvironment 
regulates stem cell and progenitor cell lodgement, proliferation, 
differentiation and release of mature blood cells into the circulation.
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Intimate associations of stem cells and stromal cells are thought to be 
essential for the regulation of haematopoiesis. Stromal cells are known to 
produce growth factors essential for effective haematopoiesis (Verfaillie 
1992). In addition ECM proteins and CAMs are thought to play important 
roles in binding of stem cells and presentation of growth factors. Loss of 
attachment to stromal cells will promote the migration of mature cells into 
the circulation (Coulombel 1992). Bone marrow haematopoiesis is 
considered to be regulated through co-operation of all these factors, though 
exactly how this co-operation is operative remains to be determined.
Most haematopoietic growth factors are locally synthesised by stromal cells, 
evidence suggests that growth factors can be cell associated as a complex 
linked to the stromal cell surface by proteoglycans. Alternatively the 
growth factors could be secreted as a soluble form which is then absorbed 
onto ECM components such as HS-PG (Roberts et al 1988). Both of these 
forms of growth factor presentation act as adhesive ligands binding the 
stem cells to the stromal cells. It is not known whether CAMs play a role in 
determining the lineage differentiation of the stem cells (Long 1992).
Stromal cells also play a role in returning primitive haematopoietic cells to 
a quiescent state. TGF-p and MIP-la produced by stromal cells in culture are 
thought to be responsible for inhibition of primitive haematopoietic stem 
cell proliferation in concert with growth factors (Eaves et al 1991). Thus 
stromal cells can produce diverse and opposing local control functions to 
promote and inhibit stages of haematopoiesis. The actual mechanism by 
which the majority of stem cells are held in growth arrest is not known.
The model of attachment without proliferation is one which could be most 
relevant to in vivo haematopoiesis (Greenberger 1991).
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Haematopoietic regulation in the fetal liver microenvironment has not 
been so well documented. Fetal liver haematopoiesis was observed to 
involve intimate associations of stem cells with central macrophages and 
hepatocytes in the present investigation. Both fetal liver macrophages and 
hepatocytes can produce regulatory factors and fibronectin however 
information is lacking on the involvement of ECM proteins and CAMs in 
the fetal liver environment. The observations of gap junctions and 
desmosomes during EM studies of fetal liver are consistent with the local 
release of substances from the central macrophage or hepatocyte to the 
adjacent blood cell precursors. Rosendaal (1991) demonstrated dye coupling 
of stromal cells and haematopoietic cells and proposed that 
communication via gap junctions may play a role in maintaining 
precursor cells which would otherwise differentiate through exposure to 
growth factors. The findings of Hata et al (1993) that fetal liver stromal cells 
can release soluble growth factors into culture suggests that ECM proteins 
and CAMs may not play such a significant role in fetal liver 
haematopoiesis. The presence of mixed lineage clusters in fetal liver could 
be attributed to lack of expression of known CAMs by fetal liver stem cells. 
Fetal liver haematopoietic, cells may express unidentified CAMs which 
permit progenitor cells of different lineages to associate with the same 
stromal cells.
Proliferation of haematopoietic stem cells appears to be controlled locally by 
factors which regulate the proportion of stem cells in cycle. The proportion 
of HPP-CFC synthesising DNA in adult bone marrow was only 10%, 
indicating they are quiescent. In contrast 53% of 15 day fetal liver HPP-CFC 
were actively cycling. A stem cell specific stimulator of DNA synthesis is 
present in fetal liver at this stage in gestation (Dawood et al 1990).
Stimulator production declines from the 15th day of gestation, which
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coincides with the decline and cessation of hepatic haematopoiesis in the 
neonate. Thus in the fetal liver microenvironment, a high proportion of 
cycling stem cells exists concomitantly with high concentrations of 
stimulator (Dawood et al 1990).
The stem cell regulatory mechanism is different in the bone marrow 
microenvironment. The quiescent stem cell population in the bone 
marrow is maintained by an inhibitor of DNA synthesis, which can reduce 
the proportion of cycling cells in regenerating tissue (Riches et al 1981).
Stem cell cycling is increased by a stimulator of DNA synthesis in 
regenerating or stressed tissue (Wright & Lord 1977). Stem cell numbers 
play an important role in this regulatory process, a low number of stem 
cells results in decreased inhibitor production and increased stimulator 
production. Similarly high stem cells numbers decrease stimulator 
production and increase inhibitor production. An inverse relationship 
between stem cell number and stimulator production appears to exist in 
the bone marrow microenvironment, unlike that of fetal liver where a 
direct relationship is observed (Dawood et al 1990).
Positive and negative regulators of haematopoiesis acting in concert with 
the forementioned associations of stromal cells and stem cells provide 
mechanisms for rapid and specific proliferative responses to changes in 
haematopoietic demands. The elucidation of the requirements for optimal 
stem cell growth should result in improvements of culture systems to yield 
in vivo reconstitution of haematopoiesis.
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7.5 Haematopoietic Stem Cells
The kinetic properties of the HPP-CFC2 subpopulation, evaluated in this 
investigation were found to be very similar to those of the CFU-S 
population, both in fetal liver and adult bone marrow. The proportion of 
fetal liver derived HPP engaged in DNA synthesis (53%) correlates with the 
30-40% of fetal liver derived CFU-S in S-phase (Thomas et al, 1981). In 
adult bone marrow only 10% of HPP were synthesising DNA, a similar 
reduction in the cycling status of bone marrow derived CFU-S has been 
reported (Thomas et al 1981). The reduction in HPP-CFC numbers 
throughout gestation mirrors the reduction in CFU-S numbers reported by 
Dawood et al (1990). In addition to the similarities in kinetic properties, 
HPP-CFC and candidate pre-CFU-S populations share many phenotypic 
characteristics including specific stem cell markers (Bertoncello et al 1992). 
The kinetic properties of HPP-CFC established in this investigation are also 
similar to those of early erythroid progenitors of fetal liver and bone 
marrow origin (Peschle et al 1981).
However bone marrow derived HPP-CFC have been shown to be less 
sensitive to the CFU-S regulators than the CFU-S population (Robinson & 
Riches 1991), and hence the HPP-CFC population may be a more primitive 
haematopoietic stem cell population than CFU-S. A hierarchy has been 
determined within the CFU-S population by their sensitivity to 
haematopoietic regulators, 5FU treatment and Rh-123 uptake. The very 
primitive day 16 CFU-S is more sensitive to inhibitor and are Rh dull.
More mature CFU-S populations are more sensitive to stimulator and are 
Rh bright (Bertoncello et al 1992). A similar hierarchy has recently been 
determined in the HPP population. HPP-CFC 1 population, which is Rh dull 
and resistant to 5FU treatment has been proposed as a candidate pre-CFU-S
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(McNeice et al 1990). The HPP-CFC2 and more lineage restricted HPP-CFC3 
subpopulations are Rh bright and severely depleted by 5FU treatment 
(McNeice et al 1988; Bertoncello et al 1992). These similarities between the 
in vitro HPP-CFC and the in vivo CFU-S populations, confirm the proposal 
that HPP-CFC are a developmentally early haematopoietic precursor cell 
population with properties closely related to those of the true 
haematopoietic stem cell.
The GM-CFC population is known to be a more mature precursor cell 
population than the HPP-CFC. The results of the present study were in 
accordance with this. The number of GM-CFC engaged in DNA synthesis 
remained relatively high in fetal and neonatal liver, in sharp contrast to 
the reduction observed in the proportion of cycling HPP over the same 
period. GM-CFC derived from adult bone marrow were also found to be 
actively cycling, in accordance with previous reports (Cork et al 1982). Like 
HPP-CFC, the number of GM-CFC colonies produced by fetal and neonatal 
liver was lower than that of the bone marrow. It can be assumed therefore 
that fetal and neonatal liver contain fewer HPP and GM progenitors than 
adult bone marrow however, the proportion of cells in cycle is higher in 
fetal and neonatal liver than in the bone marrow. The kinetic properties of 
GM-CFC are similar to a more mature population of erythroid precursors 
(m-BFU-E) described by Peschle et al (1981). The proportion of cycling m- 
BFU-E is found to be high in both fetal liver and adult bone marrow.
Variations in concurrent GM-CFC proliferation in fetal liver and fetal bone 
marrow suggest stem cell regulation is controlled locally. Human fetal liver 
of 11-14 weeks gestation produces an inhibitor of GM-CFC proliferation, 
while liver > 14 weeks produces a GM-CFC stimulator (Cork et al 1982). 
GM-CFC, unlike HPP-CFC, are not sensitive to CFU-S regulators. Indeed 
fetal liver produces CFU-S stimulator and GM-CFC inhibitor concurrently
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and these regulators are produced by adherent and non-adherent cells 
respectively (Wright & Lord 1977: Cork et al 1982). Similarly it is proposed 
that CFU-S regulators have no effect on the CFU-C population, direct 
descendants of CFU-S (Toksoz et al 1980). The CFU-C, like GM-CFC and m- 
BFU-E, retain a high cycling activity in adult bone marrow.
It is apparent that classes of haematopoietic progenitor cells exist, each with 
their own specific growth factor requirements and distinct kinetic 
properties. Marked differences in the kinetic properties of corresponding 
fetal and adult derived primitive progenitors were observed in the present 
investigation and have been previously reported (Peschle et al 1981: 
Thomas et al 1981). Ontogenic maturation of haematopoietic stem cells is 
associated with a decline in their proliferative activity. All fetal liver 
progenitor cells appear to be actively cycling, irrespective of their lineage 
and differentiation state, while in adult bone marrow differentiation of 
quiescent primitive stem cells is associated with an increase in the 
proliferative activity of the descendants.
7.6 Regulatory Factors Produced by Fetal Liver
Fetal liver is known to produce a number of haematopoietic regulatory 
factors, CFU-S regulators (Dawood et al 1990), GM-CFC regulators (Cork et 
al 1982, 1986), EGM-CSF and BPF (Zhao & Wu 1990), Arginase (Wu et al 
1990), Epo (Rich 1986) and all the interleukins except IL-5 (Guiterrez-Ramos 
et al 1992). These regulators have been isolated from fractionated fetal liver 
or detected in conditioned medium produced by fetal liver cells incubated 
at 37OC.
The CFU-S stimulator detected by Dawood et al (1990) was isolated from 
fractionated fetal liver cells and was found to be present at high 
concentrations on the 15th day of gestation. In the present investigation
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however, a 10% concentration of crude 15 day fetal liver extract (FLE) was 
found to have an inhibitory effect on HPP formation by normal bone 
marrow cells, while lower concentrations had no effect. The inhibitory 
effect of FLE was more pronounced on regenerating bone marrow cells 
reducing colony formation by 78%. The overall effect of FLE on primitive 
HPP formation appears to be inhibitory. The size of the colonies produced 
in the presence of FLE had increased to 5mm on average. Thus while crude 
FLE may inhibit proliferation of primitive HPP it may promote the 
differentiation of stem cells.
The fetal liver extract was also observed to inhibit colony formation by SA2 
leukaemic cells. Inhibition of SA2 formation was directly related to the 
concentration of FLE used. Greatest inhibition was observed when SA2
cells were incubated with lml FLE. Both SA2 leukaemic cells and RBM cells 
are actively cycling, while normal bone marrow cells are not. It would 
therefore appear that the inhibitory effect of crude FLE was more 
pronounced on actively cycling cells. Touraine et al (1990), reported 
complete leukaemic ablation following infusion of fetal liver cells into 
leukaemic mice.
Similar effects have been reported by Wu et al (1989) using human FLE. A 
10% concentration of human FLE was found to inhibit CFU-GM growth 
and growth of the leukaemic HL-60 cell line. Fractionation of human fetal 
liver revealed the presence of arginase, a known inhibitor of normal and 
tumour cell growth, in the 60K dalton fraction. It was not detected in the 
30-60 K dalton fraction, which had no suppressive effects on either normal 
or leukaemic cells. This is consistent with the detection of a CFU-S 
stimulator in this fraction (Dawood et al 1990). Leukaemic cell growth was 
completely inhibited in the presence of a <10 K dalton fraction of fetal liver 
however, while only a weak suppressive effect was observed on CFU-GM
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growth. Arginase activity could not be detected in this fraction of human 
FLE. These findings suggest that fetal liver contains additional regulatory 
factors which as yet have not been identified. Izzi et al (1985) reported 
haematopoietic reconstitution of aplastic anaemia and acute leukaemia 
patients following fetal liver transplant, however the fetal liver cells did 
not have an anti-leukaemic effect. The fetal liver extract used by Izzi et al 
had been incubated at 37°C and cryopreserved, unlike the crude extract used 
in the present investigation.
It is thus apparent that haematopoietic stimulators and inhibitors are 
present in different molecular weight fractions of fetal liver, which can 
have different effects on a variety of cells. The results of Wu et al (1989) on 
the low molecular weight fraction indicate that an as yet unidentified 
suppressor exists which displays preferential suppression of leukaemic 
cells. Futhermore the distribution of this new inhibitor has been reported 
to be similar to arginase in that it is mainly detected outside the fetal liver 
cells or it could be stored in the ECM (Wu, Wong & Pei 1989). However the 
overall effect of crude murine FLE in the present investigation and human 
FLE (Wu et al 1989), was the inhibition of leukaemic and regenerating cells 
at all concentrations of FLE, while normal bone marrow cell proliferation 
was only affected by high concentrations of FLE.
The leukaemic suppressor in the low molecular weight fraction of human 
fetal liver may also exist in murine fetal liver. This deserves further 
investigation to determine its existence in murine FL and whether it effects 
are more pronounced in the fractionated form than in crude FLE. The anti­
leukaemic effect of FLE has important clinical applications in the purging 
of leukaemic cells for autologous bone marrow transplantation.
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7.7 Clinical Applications
Fetal liver and bone marrow are abundant sources of haematopoietic stem 
cells and progenitors, which in a suitable microenvironment can 
differentiate into various lines of blood cells. Stromal cell in both organs 
have important roles to play in the regulation and control of 
haematopoiesis. The mechanism which governs the switch in 
haematopoietic production sites from fetal liver to bone marrow remains 
elusive. Likewise why should the erythroid lineage predominate in fetal 
liver while granulopoiesis predominates in the bone marrow? Many 
questions remain unanswered regarding the complicated process of 
haematopoiesis in both fetal liver and bone marrow.
When considering the haematopoietic potential of the cell clusters 
observed in fetal liver and adult bone marrow, the molecular mechanisms 
underlying the cellular associations must also be considered, including 
recognition, adhesion, production and presentation of regulatory factors 
and release of mature progenitors. At least some, if not all, of these features 
make a significant contribution to the role played by the
microenvironment in the overall process of haematopoiesis.
A number of haematological disorders can be attributed to abnormal 
interactions of stromal cells with haematopoietic cells, caused by progenitor 
cell defects or defective stroma. Clinical progress in this field is likely to 
advance through the application of molecular techniques to define the 
nature of abnormal stem cell-stromal interactions. Purging of bone marrow 
cells in leukaemic patients by suppressors such as FLE could be further 
enhanced by modification of the adhesive interactions between the 
leukaemic cells and the stromal cells.
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Elucidation of optimal cell growth requirements would have enormous 
significance in transplantation therapy by allowing expansion of 
progenitors, endowed with properties of fetal liver cells, which could be 
transplanted to facilitate rapid engraftment and reduction of antigenic 
treatment. Primitive stem cells maintained in culture could be used for 
genetic transfer or could be manipulated to synthesise specific regulatory 
factors to alleviate genetic and haematological conditions when infused 
into the host.
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Chapter 8
Conclusions and Further Work
8.1 Conclusions
The haematopoietic activity of murine fetal liver increases from the 10th day of 
gestation to reach a peak on the 15th day of gestation, when the number of 
actively cycling primitive stem cells is maximal. Hepatic haematopoiesis is 
predominantly erythroid in nature, however cells of all other lineages are also 
observed. There appear to be two waves of haematopoiesis in the fetal liver, 
the first is a wave of erythropoiesis, this is followed by a wave of myelopoiesis 
which never exceeds that of erythropoiesis.
As maturation proceeds, the haematopoietic activity of the liver declines 
together with a decline number and cycling activity of primitive stem cells. 
Megakaryocyte numbers are observed to decline concomitant with erythrocyte 
numbers while the number of hepatocytes increases. Hepatocytes which 
appeared late in gestation and had not been associated with haematopoietic 
cells were structurally different from those which had. The hepatocytes were 
changing to elements which function in the metabolic role of the liver, rather 
than supportive stromal cells in haematopoietically active liver. Stroma 
derived from fetal liver at the 17th and 19th days of gestation has a reduced 
capacity to support haematopoietic cells, compared to that of 15 day fetal liver. 
Thus in addition to the decline in haematopoietic cell number late in gestation,
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the stromal elements of the fetal liver are also changing reducing their capacity 
to support haematopoiesis.
The bone marrow assumes the role as the main site of haematopoietic 
production at birth. There is some haematopoietic activity in neonatal liver, 
which closely resembles that of the bone marrow in that haematopoietic cell 
clusters are composed of single-lineage cells and these clusters are restricted to 
isolated foci. Primitive stem cells derived from neonatal liver are relatively 
quiescent like those of adult bone marrow. At this stage the liver functions as 
the main metabolic organ of the body with cessation of hepatic haematopoiesis 
as a result.
Intimate associations of haematopoietic cells with stromal cells are essential for 
haematopoiesis. Haematopoietic activity in vitro was dependent upon the 
presence of a confluent stromal layer to which haematopoietic cells must first 
adhere. Fetal liver and bone marrow stromal layers could adequately support 
blood cell production, regardless of the origin of the haematopoietic cells. Fetal 
liver haematopoietic cells selectively adhered to bone marrow stromal layers. 
This preferential adhesion could not be attributed to the difference in kinetic 
properties of fetal liver and bone marrow derived stem cells. Bone marrow 
stroma may have a greater number of binding sites for haematopoietic cells 
than fetal liver stroma and fetal liver stem cells may be more adherent than 
bone marrow stem cells. This preferential adhesion may promote the in vivo 
migration of haematopoietic cells from the fetal liver to the bone marrow.
Haematopoietic cells clusters were abundant in haematopoietically active fetal 
liver in vivo and in vitro. Gradients of differentiation could be discerned 
within the clusters, the more mature cells occupied peripheral positions and 
may therefore be less dependent on the central cell. Once mature, the cells 
leave the cluster environment and migrate towards the sinusoids for release
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into the circulation. Macrophages and in particular hepatocytes function as 
central supporting cells of the haematopoietic clusters in the fetal liver 
microenvironment. Central macrophages are responsible for the removal of 
extruded nuclei and cell debris. Haematopoietic clusters in fetal liver were 
composed of mixed-lineage cells, thus lineage specific microenvironments do 
not exist in fetal liver, unlike neonatal liver and adult bone marrow.
The extensive areas of membrane apposition of central cells and blood cell 
precursors, where gap junctions and desmosomes were observed, provide 
ideal conditions for the transfer of regulatory factors between the cells. 
Rhopheocytic vesicles were numerous, indicating ferritin may be transferred 
between the central cells and adjacent blood cell precursors, however the 
direction of transfer could not be determined. The central cells may thus have 
the capacity to direct proliferation and differentiation of blood cell precursors 
with which it is associated, through provision of exogenous substances.
The kinetic properties of fetal liver stem cells differ from those of bone marrow 
stem cells. A high proportion of fetal liver HPP-CFC are engaged in DNA 
synthesis, while in the bone marrow microenvironment these stem cells are 
quiescent. Quiescence in the bone marrow population is maintained by 
proliferation inhibitors produced in response to high numbers of cycling stem 
cells, while in the fetal liver microenvironment a large cycling stem cell 
population is maintained by proliferation stimulators. The proportion of 
cycling stem cells in fetal liver declines as maturation proceeds. The kinetic 
properties of the in vitro HPP-CFC are very similar to those of the in vivo 
CFU-S, in both fetal liver and adult bone marrow, indicating the HPP-CFC 
population is a primitive stem cell population with very similar properties to 
the true haematopoietic stem cell. A more mature class of progenitor cells, 
GM-CFC, are actively cycling in both fetal and neonatal liver and also in adult 
bone marrow. These progenitor cells are regulated by specific factors which
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have no effect on the HPP-CFC population. Thus while stem cells and 
progenitor cells are actively cycling in the fetal liver microenvironment, only 
progenitor cells are cycling in the adult bone marrow. However the actual 
number of stem cells and progenitor cells especially, is higher in adult bone 
marrow than fetal or neonatal liver.
Fetal liver is known to produce both haematopoietic stimulators and 
inhibitors. In a crude form, fetal liver extract had an inhibitory effect on 
regenerating bone marrow stem cells and leukaemic cells. The quiescent stem 
cell population of adult bone marrow was inhibited by lml of fetal liver 
extract, however at lower concentrations there was no effect. The overall 
inhibitory effect of fetal liver extract is more pronounced on actively cycling 
stem cells and leukaemic cells, this finding has important clinical applications 
in the treatment of leukaemia. Fetal liver extract did not promote the 
proliferation of stem cells, however colony size was increased in its presence. 
Thus while crude fetal liver extract inhibits proliferation of primitive cycling 
stem cells it may promote differentiation of these cells into more mature 
progeny.
8.2 Further Work
Fetal bone marrow stromal layers could be used to test their ability to bind 
HPP-CFC to establish whether the decrease in supportive capacity of day 17 
and day 19 fetal liver stromal layers is accompanied by an increase in the 
supportive capacity of stromal layers derived from fetal bone marrow.
It may be possible to determine the number of binding sites available in 
stromal layers by increasing the number of HPP-CFC seeded onto the layers. 
When all the available sites for HPP-CFC are occupied, increasing the
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concentration of HPP-CFC further should not effect the number of cells which 
bind to the layer, presumably a plateau will be observed.
Mature progenitor cells could be incubated with adherent stromal layers in 
order to determine whether they display preferential binding for bone marrow 
stromal layers.
Anti-fibronectin antibodies could be used to determine whether the binding of 
fetal liver blood cells precursors to fetal liver stromal layers requires 
fibronectin, which is necessary for adhesion of bone marrow stem cells to 
bone marrow stroma.
The < 10K dalton fraction of murine fetal liver extract could be investigated in 
order to establish whether it preferentially suppressed leukaemic cells rather 
than normal blood cells precursors. Also whether the effects of fetal liver 
extract on leukaemic cells are more pronounced in fractionated or crude forms.
The effects of murine fetal liver extract could be tested on more mature 
progenitors (GM-CFC) to establish whether it has different effects on primitive 
and more mature progenitor cells.
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Morphological relationships of differentiating blood cell
precursors to adjacent macrophages and hepatocytes in murine
liver. By ALLISON BLAIR (supervised by D. BRYNMOR THOMAS), 
University of St. Andrews.
Contrasting patterns of concurrent haematopoiesis in the liver and in the bone 
marrow of the human fetus have been attributed to differences in the 
environments available for the differentiation of blood cell precursors in the 
two situations (Thomas J. Anat 110,1971). These differences may reflect 
different relationships between blood cell precursors and stromal cells which 
have been demonstrated in vitro (Gordon et al, Exp. Hematol 18,1990). The 
present investigation has been devised to provide information about these 
relationships in the hope that it will contribute to an understanding of the 
interactions between the early precursors of blood cells and the cells in their 
immediate vicinity which appear to be of fundamental importance for the 
regulation of haematopoiesis (Dexter et al, Phil. Trans. Roy. Soc. Lond. 327B, 
1990).
Samples of liver were obtained from CBA mice on the fifteenth day of 
gestation, the day of birth and the eighth day of the neonatal period; fixed in 
glutaraldehyde; post-fixed in osmium tetroxide; embedded in araldite resin 
and prepared for examination using a Philips 301 electron microscope.
Extensive haematopoiesis was evident on the fifteenth day of gestation when 
distinctive clusters of cells were observed. These cells were arranged around 
central macrophages or around central hepatocytes. Cytoplasmic extensions 
from the macrophages and hepatocytes were intimately related to adjacent 
blood cell precursors, some of which were surrounded by these extensions. By
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the end of the first week of the neonatal period, when the number of clusters 
had decreased, the cytoplasmic extensions were shorter and their arrangement 
was very much simpler. In the clusters of blood cell precursors differentiation 
gradients were observed, the most highly differentiated cells being furthest 
from the central cell. The form and arrangement of cytoplasmic extensions and 
the distribution of rhopheocytotic vesicles is consistent with the extensive 
interchange of materials between hepatocytes and blood cell precursors as well 
as between macrophages and blood cell precursors.
The cellular relationships which have been observed are compatible with the 
existence of environmental compartments in which single blood cell 
precursors or small groups of blood cell precursors can be subjected to the 
influence of regulatory factors in circumscribed microenvironments which are 
isolated from one another.
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An electron microscopical study of the relationships between
differentiating blood cell precursors, macrophages and
hepatocytes in murine fetal liver. By ALLISON BLAIR, SAMANTHA 
SUISSA and D. BRYNMOR THOMAS, University of St. Andrews.
The interactions between blood cell precursors and the cells in their immediate 
vicinity, which appear to be of fundamental importance for the regulation of 
haematopoiesis (Dexter et al. Phil. Trans. Soc. Lond. 327B, 1990), may be 
different in the liver from those in the bone marrow, reflecting different 
relationships in the two situations, which have been demonstrated in vitro by 
Gordon and her associates (Exp. Hematol. 18,1990). In the present 
investigation attention has been focused upon the relationships between blood 
cell precursors and stromal cells in murine fetal liver in vivo.
Samples of fetal liver were obtained from CBA mice on the fifteenth day of 
gestation, on the eighteenth day of gestation and on the day of birth; fixed in 
glutaraldehyde; postfixed in osmium tetroxide; embedded in araldite resin and 
prepared for examination using a Philips 301 electron microscope.
The cellular relationships which have been observed will be demonstrated. 
These relationships are consistent with extensive interchange of materials 
between hepatocytes (H) and blood cell precursors (erythroblasts E, fig. 1), as 
well as between macrophages and blood cell precursors, and are compatible 
with the existence of environmental compartments in which single blood cell 
precursors or small groups of blood cell precursors can be subjected to the 
influence of regulatory factors in circumscribed microenvironments which are 
isolated from one another by cytoplasmic extensions derived from stromal 
cells (arrows) (Blair and Thomas, J. Anat 237,1991).
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The Proliferative Status of Cells Derived from Murine Fetal Liver which 
form Colonies in vitro (high proliferative potential colony forming cells- 
HPP-CFC). By ALLISON BLAIR, A.C. RICHES, S.N. ROBINSON and D. 
BRYNMOR THOMAS, School of Biological and Medical Sciences, 
University of St.Andrews.
The proliferative status of the cells derived from murine fetal liver which 
establish macroscopic colonies in the spleens of irradiated recipients (FL. 
CFU-S) is different from that of similar cells derived from murine bone 
marrow (BM.CFU-S). Whereas most of the FL.CFU-S are engaged in DNA 
synthesis, most of the BM.CFU-S are not. An in vitro assay has now been 
successfully used to study the kinetic properties of cells which are very 
similar to the kinetic properties of CFU-S (Robinson and Riches, Journal of 
Anatomy, 1991). In the present investigation this assay has been used to 
evaluate the kinetic properties of HPP.CFC derived from murine fetal liver 
during the last week of gestation and the first week of the neonatal period. 
The proportion of HPP.CFC in fetal liver which is synthesizing DNA falls 
from 53 * 2% on day 15 of gestation to 13 ± 1% on
day 8 of the neonatal period, when it approximates to the proportion of 
HPP.CFC which is synthesizing DNA in the bone marrow of adult mice (10 
± 1%).
The high proportion of hepatic HPP.CFC synthesizing DNA during the 
latter pat of gestation coincides with the availability of a stem cell specific 
stimulator of DNA synthesis and the decrease in the proportion of HPP.CFC 
synthesizing DNA during the first week of the neonatal period coincides 
with the disappearance of this putative regulator (Dawood et al, Journal of 
Anatomy, 1990). The difference between the proliferative status of FL.CFU-S 
and that of BM.CFU-S is reflected in the difference between the proliferative 
status of HPP.CFC in murine fetal liver and that of HPP.CFC in the bone 
marrow of adult mice. The similarities between the kinetic properties of 
CFU-S and those of HPP.CFC derived from bone marrow which have 
previously been emphasised are reflected in similarities between the kinetic 
properties of CFU-S and those of HPP.CFC derived from murine fetal liver.
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The Adhesive Properties of Cells Derived from Murine Bone 
Marrow or from Murine Fetal Liver which form Colonies in vitro 
(high proliferative potential colony forming cells-HPC). By
ALLISON BLAIR and D.BRYNMOR THOMAS, School of Biological and 
Medical Sciences, University of St Andrews.
The adhesive properties of blood cell precursors which form colonies in 
vitro (high proliferative potential colony forming cells-HPC) have been 
studied. The kinetic properties of these cells are similar to those of CFU-S to 
which they appear to be closely related (Blair et al, Journal of Anatomy 182: 
129,1993).
HPC and adherent stromal layers (ASL's) derived from murine fetal liver 
(FL) on the 15th day of gestation or from the bone marrow (BM) of young 
adult mice have been used for this purpose. HPC.FL and HPC.BM have 
each been incubated with FL.ASL's or BM.ASL's for 2 hours at 37°C. The 
reduction in the number of colonies established during the fourteen days 
following such incubation has been used to evaluate the adhesion of HPC 
to ASL's.
The loss of HPC, which can be attributed to adhesion, is similar when 
HPC.FL are incubated with FL.ASL's, HPC.BM are incubated with FL.ASL's 
or HPC.BM are incubated with BM.ASL's but the reduction in the number 
of colonies formed following the incubation of HPC.FL with BM.ASL's is 
very much greater suggesting preferential adhesion.
Such preferential adhesion of HPC.FL to BM.ASL's is consistent with the 
hierarchy of homing envisaged by Zanjani et al. (Blood 81: 399, 1993). The 
preferential adhesion which has been demonstrated would promote the in 
vivo transfer of haematopoiesis from the liver to the bone marrow.
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A mechanism which may promote the transfer of haematopoiesis from the 
liver to the medullary cavities. By ALLISON BLAIR and D. BRYNMOR 
THOMAS. School of Biological and Medical Sciences, University of St. Andrews
The orderly transfer of haematopoiesis from extra-medullary sites to the 
medullary cavities during the course of ontogeny may be necessitated by a 
deterioration in the quality of the haematopoietic microenvironments available 
in the extra-medullary sites (Thomas et al. Journal of Anatomy, 155,1987); 
facilitated by preferential migration of blood cell precursors from the extra­
medullary sites to the medullary cavities (Zanjani et al. Blood, 81,1993) and 
enhanced by the retention of blood cell precursors in the medullary cavities. 
The present analysis of the adhesion of early blood cell precursors to stromal 
cells maintained in vitro has been devised to contribute to an evaluation of the 
latter possibility.
Early blood cell precursors which form colonies in vitro (high proliferative 
potential colony forming cells = HPP.CFC) derived from murine fetal liver (FL) 
on the 15th day of gestation or from the bone marrow (BM) of young adult 
mice were incubated on adherent stromal layers (ASLs) derived from each of 
these two sources. Following the incubation of 5,000 HPP.CFC on ASLs for 2 
hours at 37°C:-
27 ± 1.6 FL.HPP.CFC remained adherent to FL. ASLs
31 ± 2.5 BM.HPP.CFC remained adherent to FL. ASLs
21 ± 2.9 BM.HPP.CFC remained adherent to BM.ASLs
in contrast:-
72 ± 0.8 FL.HPP.CFC remained adherent to BM.ASLs 
similar results were obtained throughout the range from 500 to 5, 000 
incubated HPP.CFC.
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These results cannot be attributed to the difference in kinetic properties of 
HPP.CFC derived from fetal liver and from bone marrow. However they can 
be explained by supposing that the proportion of FL.HPP.CFC which are 
capable of adhering to ASLs is more than double the proportion of 
BM.HPP.CFC that are capable of doing so and that the number of binding sites 
available in unit area of BM.ASLs is more than double that for FL.ASLs. The 
remarkable affinity of FL.HPP.CFC for BM.ASLs is compatible with the notion 
that early precursors of blood cells are more likely to be retained and to 
accumulate in the medullary cavities than in fetal liver.
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